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Zusammenfassung 
 
Die Entwicklung der N-heterozyklischen Carbene (NHCs) als Liganden für 
Übergangsmetallkatalysatoren hat sich als sehr fruchtbar auf dem Gebiet der 
homogenen Katalyse erwiesen. Um diese Ligandenfamilie für die Katalyse zu 
erweitern, stellt diese Dissertation eine Reihe von neuen NHC-Liganden her, die 
substituierte Naphthylgruppen als Seitenketten aufweisen. Durch das Einführen 
geeigneter Stereozentren im N-heterocyclischen Teil dieser Liganden können optisch 
reine Liganden hergestellt werden. Die Liganden wurden sowohl in normalen als auch 
in asymmetrischen, Metal-katalytischen Umwandlungen verwendet und diese 
Dissertation beinhaltet neue Katalysemethoden für die Bildung verschiedener C-C 
Bindungen. 
Kapitel 2 beschreibt die Synthese und Charakterisierung einer neuen Klasse von 
leicht zugänglichen NHCs mit gesättigten und ungesättigten N-Heterozyklen, die 
alkylierte Naphthyl Seitenketten beinhalten. Durch sorgfältige Abstimmung und 
Erweiterung der Substituenten an den Positionen 2 oder 2,7 der Naphthyl Seitenketten 
wurden NHC-Moleküle erzeugt, die praktisch nur die anti-Konformation annehmen. 
Wenn sowohl die 2- und 7-Positionen der Napthyleinheiten mit Cyclooctylgruppen 
substituiert werden, kann ein bemerkenswert aktiver Palladiumkatalysator 
synthetisiert werden, der bei Raumtemperatur Suzuki-Miyaura Reaktionen von 
sterisch äusserst anprussvollen Arylgruppen zulässt. Kapitel 3 befasst sich mit der 
Synthese und katalytischen Verwendung von chiralen NHC Liganden. Diese wurden 
durch Einlagerung von C2-symmetrischen Diaminen in ihren heterozyklischen Ring  
erhalten. Wenn die Position 2 des Naphthylring mit einer 3-Pentylgruppe belegt wird, 
entstehen drei diastereomere NHC Salze und deren Palladiumkomplexe konnten 
leicht abgetrennt werden. Ihr Einsatz als Katalysatoren bei der α-Arylierung von 
Amiden wurde in der Synthese von chiralen 3-Allyl-3-aryl-Oxindolen getestet. Des 
Weiteren wurde ein diastereomerenreines NHC Salz durch die Einführung einer 
Cyclooctylgruppe in Position 2 der Naphtylketten erhalten. Der entsprechende 
Palladiumkomplex wurde in einer neuen, Palladium-katalysierten asymmetrischen 
Synthese von 3-Aryl-3-Fluor-Oxindolen verwendet und ergab Produkte mit 
ausgezeichneten Enantioselektivitäten. Kapitel 4 beschreibt die asymmetrische 
Ringöffnung oxabizyklischer Alkene mit Grignard-Reagenzien unter Verwendung 
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desselben diasteromerenreinen NHC Liganden. Der dazu verwendete chirale NHC-
Cu-Komplex katalysiert die asymmetrische Reaktion zwischen einer Reihe von 
oxabicyclischen Alkenen und alkylgrignard Reagenzien und die resultierenden 
Produkte lagen in guten Ausbeuten, hohen ee- und Diastereoselektivitäten vor. 
Phenyl- und allylgrignard Reagenzien konnten auch verwendet werden und das 
Endprodukt wurde in guten Ausbeuten und moderaten ee's erhalten. In Kapitel 5 
beschreiben wir die Synthese eines neuen NHC Liganden mit einem chiralen N-
Heterozyklus und Naphthyl Seitenketten mit 4-Heptylsubstituenten in der Position 2. 
Die Imidazoliniumsalze lagen als drei verschiedene Isomere vor. Diastereomerenreine 
Palladiumkomplexe dieser Liganden wurden nach einfacher Säulenchromatographie 
erhalten. Eine der resultierenden Verbindungen (Sa,Sa-[Pd]) wurde in der 
asymmetrischen Suzuki-Miyaura und Kumada Kupplungsreaktion getestet, die zu 
chiralen Biarylen in hohen Ausbeuten und mäßigen Enantioselektivitäten führte. 
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Abstract 
 
The recent development of N-heterocyclic carbenes (NHCs) as ligands for 
transition metal catalysts has proved to be very fruitful in the field of homogeneous 
catalysis. In order to expand the family of versatile NHC systems for catalysis, this 
dissertation introduces a series of new NHC ligands that incorporate substituted 
naphthyl groups as side chains. These new NHC ligands could be made optically pure 
by introducing appropriate stereocenters on the N-heterocyclic part of the ligand. The 
ligands were used in both normal as well as asymmetric catalytic transformations and 
this thesis covers catalysis involving various C-C formation strategies. 
Chapter 2 describes the synthesis and characterization of a new class of easily 
accessible NHCs with saturated and unsaturated N-heterocycles that incorporate 
alkylated naphthyl side chains. Through carefully tuning and enlarging the 
substituents on positions 2 or 2,7 of the naphthyl side chains, NHC molecules were 
generated that display a very strong preference to assume only the anti conformation. 
We found that when both 2- and 7-positions were substituted with cyclooctyl groups 
and a saturated N-heterocycle was employed, a remarkably active palladium 
precatalyst for the Suzuki-Miyaura coupling giving tetra-ortho-substituted biaryls at 
room temperature was formed. In Chapter 3, the NHC study was expanded to their 
chiral counterparts by introducing the chiral regime of C2-symmetric diamines into 
their heterocyclic backbone. When the 2-position of the naphthyl ring was substituted 
with 3-pentyl groups, three diastereomers were generated and their palladium 
complexes were easily separated. Their use as catalysts was tested in the α-arylation 
of amides for the synthesis of chiral 3-allyl-3-aryl-oxindoles. Furthermore, a 
diastereomerically pure NHC salt was obtained by the introduction of a cyclooctyl 
group to the 2-position. Its palladium complex was tested in a new, palladium-
catalyzed asymmetric synthesis of 3-aryl-3-fluoro-oxindoles and excellent 
enantioselectivities were obtained. Chapter 4 discloses the asymmetric ring-opening 
of oxabicyclic alkenes with Grignard reagents using the same diasteromerically pure 
NHC ligand. The preformed chiral NHC-copper complex catalyzes the asymmetric 
reaction between a series of oxabicyclic alkenes and alkyl Grignard reagents and the 
resulting products were afforded in good yields, high ee's and excellent 
diastereoselectivities. Phenyl and allyl Grignard reagents were also tolerated giving 
VII 
the final product in good yields and moderate ee’s. In chapter 5, we report the 
synthesis of a new NHC ligand with a chiral N-heterocycle and naphthyl side chains 
having 4-heptyl in the 2-position. The imidazolinium salts showed the existence of 
three different isomers in these NHC structures. Diastereomerically pure palladium 
complexes incorporating these ligands were obtained after simple chromatography. 
One of the resulting compounds (SaSa-[Pd]) was tested in the asymmetric Suzuki-
Miyaura and Kumada coupling that formed atropisomeric biaryls in high yields and 
moderate enantioselectivities.  
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Chapter 1 
 
Introduction 
 
In chemistry, a carbene is a divalent carbon species linked to two adjacent groups 
by a covalent bond and it possesses two non-bonding electrons and six valence 
electrons. The general formula is RR'C:, but the carbon can instead be double-bonded 
to one group. Carbenes are classified as either singlets or triplets depending upon their 
electronic structure. Singlet carbenes are spin-paired and the molecule adopts an sp2 
hybrid structure. Triplet carbenes have two unpaired electrons. They may be either 
linear or bent, i.e. sp or sp2 hybridized, respectively (Figure 1). Most carbenes have a 
nonlinear triplet ground state, except for those with nitrogen, oxygen, or sulfur atoms, 
and halides directly bonded to the divalent carbon.1 
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Figure 1. Singlet and triplet carbenes. 
 
At the beginning of the carbene chemistry, carbenes were considered to be too 
reactive to be isolated. However, their use in organic chemistry dates back to the 
1950s when Döring used chloroform to generate dichlorocarbene which could be 
added to olefins.2 In 1964, the reactive species was introduced to organometallic 
chemistry by Fischer who reported the first carbene complex 
W(CO)5[(=C(OCH3)(CH3)].3 From then on, the majority of carbene research was 
focused on transition metal carbene complexes. Metal carbene complexes are often 
classified into two types. The "Schrock carbenes", named after Richard R. Schrock, 
are characterized by a more nucleophilic carbene carbon center; this species typically 
features higher valent metals (Figure 2).4 "Fischer carbenes", named after Ernst Otto 
Fischer, feature strong π-acceptors at the metal and are electrophilic at the carbene 
carbon atom. A Fischer carbene is predominantly a σ-donor via the lone pair, but the 
empty π orbital on carbon is also a weak acceptor for π back donation from the M(dπ) 
orbitals (Figure 2).3 
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Figure 2. Schrock and Fischer carbene 
 
The nature of the substituents bound to the carbene carbon have profound effects 
on the stability, reactivity and electronics of the carbenes.5 The concept that carbenes 
could be stabilized by π interactions with donor atoms was first developed by 
Wanzlick.6 When at least one of the donor atoms is nitrogen and are part of a cyclic 
structure, the stabilized carbene system is known as an N-heterocyclic carbene or 
NHC. The main contribution to the stability of NHCs comes from the strong􏰀σ-
electron-withdrawing and the π-electrons-donating character of nitrogen atoms. The 
existence of stable NHCs was proposed by Wanzlick et al. at the beginning of the 
1960s,6,7 and supported by the first independent reports by Öfele and Wanzlick of 
transition metal complexes containing NHC ligands around 1970 (Figure 3).8 
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Figure 3. The earliest NHC transition metal complexes and the first isolated free carbene 
 
However, no diaminocarbene had been isolated with relatively high stability, i.e. 
without tendency to dimerize until the milestone report of Arduengo et al. of a stable 
crystalline carbene in 1991.9 The first stable NHC was based on the imidazol-2-
ylidene ring and had adamantyl groups as substituents on the N atoms (IAd, Figure 
3), enjoying thermodynamic as well as kinetic stability in the absence of oxygen and 
moisture. Since Arduengo’s report, interest in the area has greatly intensified. Due to 
their strong σ-electron-donating properties, NHC ligands form stronger bonds with 
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metal centers than most classical ligands, such as phosphines, thus giving transition 
metal complexes that are generally resistant to decomposition and can thus be used as 
precatalysts without an excess of ligand.  
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Scheme 1. First example of organometallic catalysis using NHC 
 
Early on in the development of NHC moieties as ancillary ligands, it was 
recognized that they could serve as alternatives to the polular phosphines in 
transition-metal-catalysis. However, in the last two decades, the exponential growth 
of the number of applications of NHCs in catalysis has promoted them to the status of 
“well-established ligands in catalysis”. The potential of this class of compounds to 
serve as spectator ligands in transition-metal complexes was recognized in 1995 by 
Herrmann et al., using the NHC-Pd complex 1 to promote Heck reactions (Scheme 
1).10 Soon thereafter, the exploitation of the remarkable potential of NHC ligands in 
(asymmetric) catalysis began.11 The most important example is the ruthenium 
metathesis catalyst developed by Grubbs and co-workers, for which the Nobel Prize 
was awarded.12 Replacement of one of the two tricyclohexylphosphine ligands in the 
generation I Grubbs catalyst with the bulky carbene SIMes led to significant 
improvements in terms of catalyst stability, activity, and substrate range in subsequent 
generations (Figure 4). 
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Figure 4. The 1st and 2nd generation Grubbs catalysts 
 
In the passed two decades a great number of NHC-bearing catalysts with very 
different structures have been designed (Figure 5). In many cases these catalysts 
exhibited better activity than the corresponding phosphine-based catalysts for a 
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particular application. Besides the above-mentioned Ru-catalyzed metathesis of 
olefins, they also showed numerous applications in other transformations.11 
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Figure 5. The general stuctures of different types of NHCs 
The introduction of N-heterocyclic carbenes as ligands for transition metal 
catalysts and as organic catalysts on their own has put this class of compounds at the 
forefront of current research efforts.11,12b-c Whereas hundreds of NHCs with various 
structural motifs (Figure 5) have been synthesized and tested in catalysis, bulky, 
monodentate aryl-substituted imidazol-2-ylidenes (2,4,6-mesityl-substituted IMes and 
2,6-isopropylphenyl-substituted IPr) and their saturated imidazolin-2-ylidene 
counterparts (SIMes and SIPr) still remain the only ligands that represent a truly 
viable alternative to phosphines, both in terms of versatility and reactivity (Figure 6). 
Presumably, the perpendicular arrangement of the aryl side chains, combined with the 
steric bulk on the aromatic rings, leads to a situation where these ligands confer 
stability to unsaturated and reactive metal centers during catalysis and where 
decomposition of the catalyst through unwanted metal–ligand interactions is rarely 
observed. Equally important for their widespread use and success is the simple fact 
that IMes/SIMes and IPr/SIPr are stable as free carbenes, making them easy to handle 
and manipulate. In this context, it is of note that most structures based on saturated 
imidazolin-2-ylidenes dimerize readily to give enetetramines. This renders saturated 
NHCs considerably less amenable to catalysis and restricts access to stable 
modifications of this ligand class. In fact, the tendency of saturated NHCs towards 
dimerization is so pronounced that very few stable imidazolin-2-ylidenes are known 
in the literature.13,14 
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Figure 6. The most common NHCs 
 
The H atoms in positions 4, 5 of the saturated imidazolin-2-ylidene ring is a key 
structural feature for the introduction of asymmetry in the NHC ring, which opens the 
door to the use of chiral NHCs in asymmetric synthesis. In 2001, Grubbs introduced 
the chirality to the imidazole ring by using the commercially available chiral diamines 
(1R, 2R)-diphenylethylenediamine and (1R, 2R)-diaminocyclohexane (2 and 3, Figure 
7).15 In 2010, Blechert designed and synthesized a monosubstituted carbene 4 (Figure 
7) which showed good selectivity in the asymmetric ring opening cross metathesis 
(AROCM). 16 Recently, Murakami reported the synthesis of the novel chiral N-
heterocyclic carbene ligands 5 with rigid backbones and applied them to the 
palladium-catalyzed enantioselective intramolecular α-arylation of amides (Figure 
7).17 
 
N N
Ph Ph
R R
N N Mes
iPr
Ph
N N
R R
N N
R R
2 3 4 5  
 
Figure 7. Chiral NHC ligands by introducing chirality to 4 and/or 5 positions of the N-heterocycle 
 
In 2008, we have described the synthesis of a series of saturated NHCs that 
incorporate substituted naphthyl side chains. In both the NHC salts and the free 
carbenes, introduction of substituted naphthyl side chains gives rise to C2-symmetric 
(rac) and Cs-symmetric (meso) atropisomers which can not interconvert into each 
other (Scheme 2). We demonstrated that this new naphthyl-based NHC ligand family 
presents high reactivities in palladium-based coupling reactions, in ruthenium-based 
metathesis and in the organocatalytic ring-opening alkylation of epoxide.18 
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Scheme 2. Atropisomers in NHCs incorporating substituted naphthyl side chains 
 
We have shown that the introduction of a chiral N-heterocycle in this NHC system 
led to three diastereomers in the salt stage. Pure palladium complexes incorporating 
these ligands were obtained after successful separation of their diastereomeric 
mixtures. These obtained palladium complexes were tested in the α-arylation of 
amides to generate 3-aryl-3-methyl/allyl chiral oxindoles (Scheme 3). We found that 
generally the (Ra,Ra)-isomer gave the best result in terms of reactivities and 
selecetivities.19 
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Scheme 3. (Ra,Ra)-isomer in α-arylations of amides 
 
We reasoned that the fluxionality of the resulting ligands might be tunable by 
adjusting the size of the substituents at the 2- and 7-positions of the naphthyls. In this 
way, the ratio of the isomers in the NHC salts can be modified and the reactivity and 
selectivity of the corresponding complexes will be increased. 
The objective of the work described in this dissertation is to develop this new 
family of promising NHC ligands. Their use in homogeneous catalysis, especially in 
asymmetric catalysis, will lead to the discovery of new reactivity and/or high 
selectivity in novel and challenging transformations. 
In chapter 2, we highlight the dramatic increase of the reactivity of such NHC-
containing catalyst systems by putting a cyclooctyl group in the 2- position of the 
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naphthyl side chain. We disclose the first catalyst system which is able to efficiently 
catalyze Suzuki-Miyaura coupling at room temperature forming bulky tetra-ortho-
substituted biaryls from bromides and chlorides. Advanced DFT calculations show 
how the ligand’s steric properties, which are inherently associated to its symmetry, 
leave two of four quadrants that represent the ligands overall steric environment 
relatively open. 
Based on the work disclosed in chapter 2, we then expanded the new NHC family 
to chiral NHC ligands for asymmetric catalysis by introducing a chiral backbone 
(chapter 3). Based on the chiral regime of C2-symmetric starting diamines, the 
naphthyl-based chiral NHC ligands were readily prepared. Unsuspectedly, there is 
only one diastereomer existing in the corresponding NHC salt. The enantiopure NHC 
ligand can then be transferred onto a palladium complex, which was tested in the 
asymmetric synthesis of 3-aryl-3-fluoro-oxindoles. The biologically important 
oxindoles were obtained with good yields (up to 94%) and excellent 
enantioselectivities (up to >99% ee). DFT calculations are offered to rationalize the 
excellent selectivity. 
Encouraged by the good result from chapter 3, we studied this ligand in another 
asymmetric transformation, namely the ring-opening of oxabicyclic alkenes (chapter 
4). For doing that, we synthesized a copper complex containing this NHC ligand 
whose structure was elucidated by an X-ray diffraction study. The enantioselective 
ring-opening of oxabicyclic alkenes with Grignard reagents afforded the products in 
high yields, high enantioselectivities and excellent trans diastereoselectivities. We 
also report two rare examples of asymmetric ring-opening with phenyl- and allyl-
Grignard reagents, respectively. 
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Biaryls via NHC-Palladium Catalyzed Suzuki-Miyaura 
Couplings 
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2.1 Abstract 
We describe the synthesis of a series of new saturated and unsaturated NHCs that 
incorporate alkylated naphthyl side chains. Through carefully tuning and enlarging the 
substituents on positions 2 or 2,7 of the naphthyl side chains, NHC molecules were 
generated that display a very strong preference to assume only the anti conformation. 
We found that when both 2- and 7- positions were substituted with cyclooctyl groups 
and a saturated heterocycle was employed, an NHC ligand is created that in 
combination with a palladium precursor results in a remarkably active catalyst for 
Suzuki-Miyaura couplings. This represents the first catalyst system that can promote 
the Suzuki-Miyaura coupling to form bulky tetra-ortho-substituted biaryls from aryl 
bromides and chlorides at room temperature. The key point is the introduction of a 
C2-symmetric NHC ligand with appropriately substituted naphthyl side chains. 
Advanced DFT calculations show that two of the four quadrants in the ligand are 
relatively open and the other two are hindered, a factor that results in the excellent 
activity. 
 
2.2 Introduction 
The affirmation of N-heterocyclic carbenes as ligands for transition metals 
catalysts and as organic catalysts proved to be an important innovation in the field of 
catalysis.1,2 Especially useful in this respect (so far) have been N-heterocyclic 
carbenes with five-membered heterocyclic structures first reported by Arduengo et al., 
such as imidazol-2-ylidene 1 and the saturated heterocyclic imidazolidin-2-ylidene 
derivatives 2.3,4 
 
N N
Me
MeMe Me
Me
Me
1
N N
2  
 
Whereas dozens of structural variations of NHCs 1 and 2 exist nowadays, the 
overwhelming majority incorporates the unsaturated central N-heterocycle of 1. The 
reason for this lies in the surprisingly different stabilities of unsaturated and saturated 
NHCs. While dimerization of aromatically stabilized N-heterocyclic carbenes of type 
1 is thermodynamically unfavorable even for small N-substituents like Me,5,6 
formation of the enetetramine dimer of 2 occurs readily. This renders saturated NHCs 
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considerably less amenable to catalysis and restricts access to stable modifications of 
this ligand class, as the substituents at the nitrogen atoms need to be very bulky. The 
demarcation line separating stable from unstable carbenes may be established and lies 
somewhere between tBu/iPr for N-alkyl substituents and Mes/Ph for aromatic side 
chains.7-9 
In catalysis, work in the last decade has shown that monodentate NHCs with bulky, 
aryl-substituted side chains are the overall most successful design. As such, 2,4,6-
mesityl-substituted IMes and 2,6-isopropylphenyl-substituted IPr and their saturated 
imidazolin-2-ylidene counterparts (SIMes and SIPr) still remain the only ligands that 
represent a truly viable alternative to phosphines, in terms of both versatility and 
reactivity.  
Our entry in this fascinating field of research began with the design and the 
synthesis of stable saturated free carbenes that feature substituted naphthyl side 
chains.10 We reasoned that this architecture would mimic well the original SIMes and 
SIPr ligand systems, offering at the same time a scaffold that is less hindered in 
proximity to the potential metal binding site and that can be functionalized more 
readily with a wide range of substituents, tuning both its steric and electronic 
properties (Figure 1). 
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Figure 1. Imidazolin-2-ylidenes with phenyl (left) and naphthyl (right) side chains 
 
The substitution pattern confers to these molecules a high degree of conformational 
stability, generating in solution a mixture of anti and syn conformers (Figure 1). 
Detailed NMR study on the fluxional behavior of this class of carbenes showed that, 
even at high temperature, interconversion between the conformers is not possible if 
sterically demanding substituents are present in position 2 of the naphthyl side chains 
(R1 in Figure 1).11 This encouraged us to attempt the separation of the syn and anti 
isomers for some of these molecules but this process, up to now, has been successful 
only when the NHC was incorporated into a stable metal complex. Recent studies 
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performed in our laboratory also indicated that, for some type of metal-catalyzed 
transformations, organometallic catalysts containing NHCs in the anti isomeric form 
perform better then the ones in the syn form.12 
These reasons prompted us to attempt the synthesis of molecules displaying a 
conformational preference for only one of the two isomers. Herein, we describe the 
synthesis of a series of new saturated NHCs that incorporate alkylated naphthyl side 
chains. With the aim of minimizing the formation of the syn isomer, we selected a 
bulky, linear alkyl substitutent as well as more rigid, cyclic alkyl derivatives of 
various sizes. 
Transition metal catalyzed cross couplings have become some of the most 
powerful and widely used method to construct C-C bonds.13 Among them, the Suzuki-
Miyaura coupling,14 has emerged as a particularly attractive and practical tool for 
synthetic organic chemistry.15 Indeed, within the last decade, several limitations of 
this methodology have been successfully adressed by using bulky, electron-rich 
monodentate phosphines or sterically demanding NHC ligands.16 One of the few 
challenges remaining in the Suzuki-Miyaura coupling reaction involve 
transformations with sterically demanding substrates that lead to tetra-ortho-
substituted products. Especially in cases where aryl chlorides are used, the relatively 
poor nucleophilicity of the arylboron reagents results in diminished catalytic 
activities.17 In 2004, Glorius and coworkers showed for the first time that aryl 
chlorides can indeed be coupled to aryl boronic acids to generate such tetra-ortho-
substituted biaryls at elevated temperature (110 °C) by employing a very bulky, yet 
flexible derivative of their bioxazoline-derived NHC ligands in combination with a 
Pd(II) metal salt.18 More recently (2009) and following the same concept of ‘flexible 
steric bulk’ of the NHC ligand, Organ and coworkers used complex Pd-PEPPSI-IPent 
as the catalyst for the Suzuki-Miyaura couplings to form bulky tetra-ortho-substituted 
biaryls at milder conditions (65 °C).19 Since then, various other ligand systems have 
been shown to effect similar couplings involving aryl chlorides when appropriate 
heating is employed.20 To date, systems that work at room temperature have not been 
reported for the construction of these important tetra-ortho-substituted biaryl 
structures via the Suzuki-Miyaura coupling.21 
Herein we describe the application of our NHC ligand systems in the Palladium-
catalyzed Suzuki-Miyaura couplings to give tetra-ortho substituted biaryl and present 
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conclusive evidence on the reasons leading to their superior behavior in these 
reactions. 
 
2.3 Results and Discussion 
The synthesis of the NHC salt is relatively straightforward and generally high 
yields were obtained. Bromination of the alkylnaphthalenes (Scheme 1) was achieved 
in all cases with excellent yield and with perfect regioselectivity for position 1 of the 
naphthalene when performing the reaction at low temperature (-78 °C) using 
equimolar amounts of Br2 with CH2Cl2 as the solvent. The following double 
Buchwald-Hartwig coupling with ethylenediamine in the presence of Pd2(dba)3 (5 
mol%), (±)-BINAP (12 mol%) and NaOtBu (2.1 eq) generated diamines in good 
yields and high purity after chromatographic purification. Ring-closing of the 
respective diamines in the presence of triethyl orthoformate as reagent/solvent and 
NH4BF4 furnished the desired imidazolinium salts 3a-h in generally good yields 
(Scheme 1). Table 1 reports the yields for the ring formation step and the ratio of 
conformers (syn respectively anti) observed. To have a more general overview, data 
concerning naphthyl-based NHC salts already reported by our group are also shown.10 
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N N
R1
R1
BF4
 i) Br2, CH2Cl2, -78°C; ii) ethylenediamine, Pd2(dba)3, rac-BINAP, NaO
tBu, toluene, 110°C; 
iii) NH4BF4, HCO2H (cat.), HC(OEt)3, 100°C,
R2
R2
R2
R2=H or R1=R2
R1
Br
R2  ii)
NHHN
iii) N N
R2
R1
R2
R1
BF4
R1 R1
R2 R2
3a-h
 
 
Scheme 1. General synthesis of the NHC salts featuring naphthyl side chains 
 
Tendentially, yields are slightly lower when starting with diamines that contain 
very bulky substituents in position 2 of the naphthalene moiety (Table 1, entries 1-7) 
and with precursor molecules with 2,7-dialkylated precursors (Table 1, entires 8-13), 
probably reflecting an increasingly difficult approach of the nucleophile in the 
reaction sequence. Concerning the syn/anti-ratio of the NHC salts, we note that when 
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small alkyl groups and linear, flexible alkyl chains are present in positions 2 or 2,7 of 
naphthalene rings (entries 1-3 and 8-9 in Table 1), the two possible conformers were 
Table 1. Yields and syn-anti ratio for compounds 3a-3h, 3d’, 3h’ and previously reported 
imidazolinium salts containing naphthalene wingtips 
 
(2)-SIHeptNap.HBF4 (3a)
imidazolinium salt syn-anti ratioa
(2)-SICypentNap.HBF4 (3b)
(2)-SICyheptNap.HBF4 (3c)
(2)-SICyoctNap.HBF4 (3d)
(2,7)-SICypentNap.HBF4 (3e)
(2,7)-SICyNap.HBF4 (3f)
(2,7)-SICyheptNap.HBF4 (3g)
(2,7)-SICyoctNap.HBF4 (3h)
(2)-SIMeNap.HBF4
b
(2,7)-SIPrNap.HBF4
b
(2)-SICyNap.HBF4
b
50 : 50
22 : 78
17 : 83
50 : 50
5 : 95
15 : 85
10 : 90
50 : 50
50 : 50
27 : 72
50 : 50
43 : 57
(2)-SIPrNap.HBF4
b
yield (%)
75
58
60
35
50
48
29
88
56
78
60
75
entry
5
6
7
10
11
12
13
1
9
4
2
3
(2,7)-SIMeNap.HBF4
b 50 : 50808
(2)-ICyoctNap.HCl (3d') 0 : 1003014
(2,7)-ICyoctNap.HCl (3h') 8 : 924615
 
a The ratios were deduced from NMR analysis. b These compounds have been reported before (ref. 10) 
 
formed in almost equal amounts. The same trend was observed when a small, cyclic 
ring was present in position 2 or 2,7 (entry 4 and 10 in Table 1). Increasing 
progressively the bulkiness of the cyclic alkyl substituents (entries 5-7 in Table 1) 
favors the formation of the anti conformer. When large cyclic alkyl groups are present 
in both positions 2 and 7, the syn conformer becomes strongly disfavored and, in the 
best case (entry 11), a 95:5 anti-syn ratio is obtained. 
N N
Cyoct
Cyoct
N N
Cyoct Cyoct
ClCl
N N
Cyoct
Cyoct
Cyoct
Cyoct
N N
Cyoct
Cyoct
Cyoct
Cyoct
ClCl
3d'
3h'
100 0:
92 : 8  
Figure 2. Unsaturated NHC salts 
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Since using cyclooctyl group as the substitution at 2- and 7- positions lead to the 
remarkable preference of anti conformer (entries 7 and 13), the unsaturated carbene 
salts 3d’ and 3h’ were also synthesized (Figure 2). As expected, the 3h analogue 3h’ 
presented 92% of the anti isomer. Surprisingly and to our delight, salt 3d’, which 
contains the unsaturated backbone and 2-position substituted naphthyl side chains, 
showed exclusively the formation of the anti isomer. 
Reaction of NHC ligands with both saturated and unsaturated N-heterocycles 
incorporating 2- or 2,7-cyclooctyl groups on the naphthalene side chains with 
Pd(cin)Cl dimer (cin = cinnamyl) and appropriate workup gave the four complexes 
(anti-A, B, C, D) depicted in Table 3 in good yields as single isomers (anti-
configured) 
 
Table 2. Base and solvent screening for biaryl synthesis using anti-A.a 
 
Br (HO)2B
Pd cat. anti-A (2 mol%)
Base, Solvent
   RT, 24 h  
 
Entry Base Solvent Conversion (%) Yield
1
2
3
4
5
6
7
8
9
10
11
12
13
14
KHMDS
KOtBu Toluene 100 100
LiOtBu Toluene 0 0
NaOtBu Toluene 13 11
NaOMe Toluene 72 7
Toluene 0 0
K3PO4 Toluene <5 <5
KOH Toluene <5 <2
K2CO3 Toluene 0 0
KOtBu Benzene 100 100
KOtBu Dioxane 10 7
KOtBu DME 0 0
KOtBu THF 0 0
KOtBu Ether 37 36
KOtBu CH2Cl2 30 13
15 KOtBu tBuOH 8 7
16 KOtBu iPrOH 100 0
(%)
 
a Reaction conditions: 0.125 mmol (1 equiv) of bromide,  1.5 equiv of boronic acid, 2.5 equiv of base, 
2 mol% of Pd complex, in solvent (1ml), RT, 24h; GC yield with dodecane as internal standard. 
 
At the outset of our study, we wanted to find out the optimized condition for the 
Suzuki-Miyaura coupling. Using 2 mol% of anti-A as the catalyst, the choice of base 
17 
and solvent in the reaction between 2,4,6-trimethylphenyl bromide and 2,6-
dimethylphenyl boronic acid were screened at room temperature and the results are 
summarized in Table 2. When toluene was used as the solvent, KOtBu showed to be 
the best base by giving full conversion and quantitative yield by GC analysis (entry 
1). The use of other bases such as LiOtBu, NaOtBu, KHMDS, K3PO4, KOH and 
K2CO3 afforded no or little conversion (entries 2-3, entries 5-8). NaOMe as the base 
gave good conversion (72%, entry 4), however, with low yield (7%). This can be 
attributed to the side reaction of dehalogenation whose mechanism is demonstrated in 
Scheme 2. The alkoxide attacks at the metal center followed by β-hydride elimination 
and then reductive elimination of the arene from the metal(II)-hydride complex 
occurs. The solvent screen revealed that benzene gave the same excellent result as 
toluene showing full conversion and quantitative yield (entry 9). Because of the 
toxicity of benzene, we chose toluene as the solvent for the rest of the study. Ethereal 
solvents such as dioxane, DME and THF showed little reactivity (entries 10-12) while 
diethyl ether gave moderate conversion and yield (entry 13).  Using isopropanol in 
combination with KOtBu decomposed the starting material completely via 
dehalogenation (entry 16). KOiPr from deprotonation of iPrOH with KOtBu played 
the same role as NaOMe displayed in Scheme 2. The importance of the presence of  
an α-proton in the alkoxide in the dehalogenation can be highlighted by the 
comparison of tBuOH and iPrOH, where the former did not afford any 
dehalogenation product (entry 15).  
 
(NHC)Pd (0)
(NHC)Pd
(NHC)Pd Ar
O
Me
Ar
X
ArX
NaX
(NHC)Pd
Ar
H
H H
O
ArH
NaOMe
 
 
Scheme 2. Mechanism of NHC-Pd catalyzed dehalogenation 
 
To explore the effect of these new NHC ligands on biaryl formation in more 
difficult Suzuki-Miyaura couplings (coupling with chloride), we chose the reaction 
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between 2,4,6-trimethylphenyl chloride and 2,6-dimethylphenyl boronic acid (Table 
3). Under optimized reaction conditions, the four new catalyst systems were 
benchmarked against their commercially available, SIPr/IPr-modified congeners 
(Nolan’s catalysts) as well as Organ’s Pd-PEPPSI-IPent system, currently the most 
powerful precatalyst for such transformations. At room temperature, these reference 
systems resulted in low product yields (entries 1-5, GC yields). In entries 4/5, we used 
Organ’s previously reported reaction conditions,7 which deteriorated the reaction 
outcome. Gratifyingly, all catalysts incorporating the new NHC structures showed 
higher conversions/yields than the benchmark systems. Among the four substructures 
tested, anti-C clearly stands out as being particularly effective as it shows both high 
conversions and yields at room temperature. 
 
Table 3. Screening of precatalysts in a representative example of room temperature Suzuki-Miyaura 
coupling.[a] 
 
Entry Pd-complex Conversion (%) Yield (%)
3
anti-A 45 39
8 anti-C
1 39 35
(IPr)Pd(cin)Cl 40 33
6
Pd-PEPPSI-IPent
95 90
33 29
7 anti-B 60 51
9 anti-D
(SIPr)Pd(cin)Cl
65 61
2
5
Pd-PEPPSI-IPent 20 14[b]
Pd-PEPPSI-IPent 7 >5
[c]
4
anti-A anti-B anti-C
(SIPr)Pd(cin)Cl (IPr)Pd(cin)Cl
anti-D
Pd-PEPPSI-IPent
N
Cl
N N
Cyoct
Cyoct
Pd
Cl
Ph
Cyoct
Cyoct
N N
Cyoct
Cyoct
Pd
Cl
Ph
Cyoct
Cyoct
N N
Cyoct
Cyoct
Pd
Cl
Ph
N N
Cyoct
Cyoct
Pd
Cl
Ph
N N
PdClPd
Cl
Ph
Pd
Cl
Ph
Cl
N NN N
Cl (HO)2B
Pd cat. (2 mol%)
KOtBu, Toluene
     RT, 24 h
Precatalysts:
Reaction:
 
 
[a] Conditions: 25 ºC, toluene (1 ml), 24 h, Ar-Cl (0.125 mmol), Ar-B(OH)2 (0.250 mmol), KOtBu 
(0.312 mmol), 2 mol% Pd-cat.; conversions/yields determined by GC with internal standard; [b] KOtBu 
(0.375 mmol), tBuOH (0.5 mL), 4 Å M.S.; [c] KOH (0.375 mmol), dioxane (0.5 ml).  
 
We then proceeded in evaluating the coupling of a variety of hindered aryl 
bromides (Table 4) and aryl chlorides (Table 5) employing precatalyst anti-C. As can 
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be seen from the data reported in Table 4, high isolated product yields were normally 
obtained at room temperature within short reaction times when employing aryl 
bromides. In entry 2, where the coupling proceeded very slowly at room temperature, 
slight heating (65°C) was applied, leading to a dramatic increase in reactions rates. 
Indeed, entry 5 shows that as little as 0.2 mol% of catalyst suffices for the reaction to  
 
Table 4. Suzuki-Miyaura couplings generating tetra-ortho-substituted products starting with aryl 
bromides catalyzed by anti-C.[a] 
 
Yield (%)Time (h)
12 96
12 85
O
16 95
Ar Ar'
N
O
20 70
18 67
20 88
O
10 91
72 80
2 96[b]
3 92[b][c]
N
N
12 97[b][c]
2
2
1
0.5
0.2
2
1
2
2
2
2
Pd [mol%]Entry
1
2
3
4
5
7
8
9
10
11
12
O
O
O
O
15 9226
ArBr Ar'B(OH)2
anti-C (cat.)
KOtBu, Toluene
Ar Ar'
 
[a] Conditions: 25 °C, toluene (3.2 ml), Ar-Br (0.4 mmol), Ar-B(OH)2 (0.6 mmol), KOtBu ( 1.0 
mmol); isolated products yields; [b] 65 °C; [c] toluene (2 ml). 
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go to completion. More sterically demanding 2,6-diethylphenylbromide could also be 
coupled with 2,6-dimethylphenyl boronic acid at room temperature in acceptable 
yield (entry 10). Two representative tetrasubstituted heterobiaryls were also 
successfully synthesized in good yields (entries 11, 12). 
Table 5 shows examples for the synthesis of tetra-ortho-substituted biaryls starting 
from the corresponding aryl chlorides. Again, a variety of hindered biaryls with a 
broad substitution pattern were prepared smoothly at room temperature. In two cases 
when sterically demanding and electron-rich arylchlorides are used, slight heating was 
necessary for complete conversion (entries 2, 3). In cases where reactivity was good 
at room temperature, slight heating permitted the use of much lower catalyst loadings 
(entries 8, 12, 13). Using the corresponding NHC/Pd(dba)2 precatalyst system instead 
of anti-C completely surpresses the coupling reaction at room temperature (entries 4 
vs 5), meaning that the catalytically active 12-electron NHC-Pd0 complex is not 
generated in the former case. Interestingly, the present system also displayed excellent 
chemoselectivity, favoring Suzuki-Miyaura couplings over the Heck reaction scenario 
(entries 15, 16). Precatalyst anti-C also promotes less difficult Suzuki-Miyaura 
coupling reactions, as evidenced from data gathered in entry 18. The last two entries 
in Table 5 also highlight just how different the reactivities are when moving from a 
tri- to a tetra-ortho-substituted coupling product. 
This last observation, together with the uniquely high reactivity of anti-C, 
prompted us to investigate the present catalytic system further. As a first approach, we  
 
Figure 3. Overlay of the molecular structures of anti-B (grey) and anti-C (yellow). Cinnamyl, chloride 
and hydrogens omitted for clarity. 
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Table 5. Suzuki-Miyaura couplings generating tetra-ortho-substituted products starting with aryl 
chlorides catalyzed by anti-C.[a] 
 
MeO
O
O
O
O
Yield (%)Time (h)
8 78
16 82
Ar Ar'
18 71
20 78
24 72
8 80[b]
2 72[b]
20 92
20 86
2
1
2
2
2
2
1
2
2
2
Pd [mol%]Entry
1
2
3
4
6
8
9
14
15
18
8 8927
O
1
0.5
0.2
2 20 <10[c]
0.5 1.5 85[b][d]
10 90
1 91
[b]
1.5 88[b][d]
7 80[b][d]
0.05 15 80
[e]
10
11
12
13
16
5
ArCl Ar'B(OH)2
anti-C (cat.)
KOtBu, Toluene, RT
Ar Ar'
17 2 12 91
 
[a] Conditions: 25 °C, Toluene (3.2 ml), Ar-Cl (0.4 mmol), Ar-B(OH)2 (0.8 mmol), KOtBu (1.0 mmol), 
anti-C; isolated products yields; [b] 65 °C; [c] 2 mol% Pd(dba)2/(2,7)-SICyoctNap; [d] 2 ml toluene; 
[e] 25 °C, iPrOH (0.5 mL), Ar-Cl (0.5 mmol), Ar-B(OH)2 (1.1 eq), 0.05 mol % anti-C, KOtBu (1.3 eq). 
22 
 
 
grew single crystals of anti-C and of the unsaturated NHC-Pd derivative that lacks the 
7-cyclooctyl groups on the naphthalene units (anti-B) in order to compare their 
structures in the solid state (Figure 3).22  
One notes that these anti-configured NHCs lead to idealized C2-symmetry of the 
ligand framework, in contrast to the commonly used IPr/SIPr or Organ’s IPent ligands, 
which result in structures of C2v symmetry. Between the NHC ligands in anti-B and 
anti-C, the main difference resides in the way the naphthyl side chains are twisted 
with respect to the central metal atom. The introduction of additional steric crowding 
(7-cyclooctyl) leads to a structure in anti-C where the 2-cyclooctyl groups point into 
the space occupied by the metal.23 
To further understand the difference between the catalytically preferred NHC 
ligand of anti-(2,7)-SICyoctNap and the more established SIPr ligand, we calculated 
the buried %VBur of the two NHC ligands,24,25 The simple %VBur of the NHC ligands 
in anti-C (41.5%) and (SIPr)Pd(cin)Cl (34.9%) show that our ligand is bulkier than 
SIPr. That an overall more bulky NHC ligand behaves better in catalysis involving 
sterically more demanding substrates is not unusual and the term of ‘flexible steric 
bulk’ has been introduced to account for this phenomenon.16b,18a,19 At least in a 
catalytic coupling scheme that follows the classical path (i.e. no secondary 
reactivity/decomposition), this concept is nevertheless at odds with what one would 
expect. For this reason we decided to perform a more detailed analysis by evaluating 
the %VBur in the single quadrants around the Pd center and we plotted them as steric 
contour maps (Figure 4) for both (SIPr)Pd(cin)Cl (left) and anti-C (right), [24a,d,e] 
Splitting the total %VBur into quadrant contributions quantifies any asymmetry in the 
way the ligand wraps around the metal.26 Within this approach, the quadrant %VBur of 
SIPr is rather constant (%VBur ~35%), while the quadrant %VBur values of anti-(2,7)-
SICyoctNap are largely different. Two quadrants heavily hindered (top left and 
bottom right, %VBur ~53%), two quadrants clearly more open (top right and bottom 
left, %VBur ~30%) creating a groove that possibly can host bulky substrates. 
 
 
 
 
 
23 
 
 
 
 
 
 
 
 
 
Figure 4. Steric maps of the NHC ligands in (SIPr)Pd(cin)Cl and anti-C complexes. 
 
Figure 5. Transition state of the reductive elimination for (SIPr)Pd(Ar)(Ar’) (left) and [anti-(2,7)-
SICyoctNap]Pd(Ar)(Ar’) (right). 
 
 
We therefore turned our attention to the catalytic step where sterics play the crucial 
role, namely the transmetallated (NHC)Pd(Ar)(Ar’) [where Ar = 2,4,6-
trimethylphenyl and Ar’ = 2,6-dimethylphenyl] intermediate and the following 
reductive elimination. We first calculated the total energy of the system when going 
from the starting naked (NHC)Pd(0) species (set at 0 kcal/mol), to the transmetallated 
(NHC)Pd(Ar)(Ar’) intermediate according to equation 1. 
 
(NHC)Pd +ArCl +Ar’B(OH)2 +KOtBu→(NHC)Pd(Ar)(Ar’) +KCl +tBuOB(OH)2 (1) 
 
 
This approach eliminates the specific way the two aryl moieties are loaded onto the 
metal. Loading of these two aryls onto the (NHC)Pd(0) species (eq 1), is favored for 
both (SIPr)Pd (by 23.8 kcal/mol) and [anti-(2,7)-SICyoctNap]Pd (by 30.7 kcal/mol). 
This in turn means that the groove created by the anti-(2,7)-SICyoctNap ligand is able 
to more readily accommodate (by 6.9 kcal/mol) the bulky aryl fragments than SIPr. 
An identical preference (6.9 kcal/mol) is also calculated at the level of the following 
 
24 
transition state (overall 15 kcal/mol higher in energy) leading to the coupled Ar-Ar’ 
product. Representations of these transition states for both complexes show a 
distorted T-shaped geometry (Figure 5). As already evidenced by the steric contour 
map of Figure 2, the structures shown in Figure 3 perfectly illustrates how the open 
quadrants in anti-(2,7)-SICyoctNap are able to host the ortho methyl groups of the 
aryl substituent cis to the NHC ligand. Differently, in presence of the SIPr ligand the 
same ortho methyl groups interact repulsively with the NHC ligand. In other words, 
the special steric characteristics of anti-(2,7)-SICyoctNap facilitate loading and 
releasing of the bulky aryl groups from the metal by creating a groove that is able to 
accomodate the ortho methyl groups of the aryl moieties. Together with the overall 
very bulky nature of this ligand, this translates into the clearly superior catalytic 
performance that we see in these Suzuki-Miyaura couplings.  
 
2.4 Conclusion 
 
In summary, we disclose the first catalyst system that is able to efficiently perform 
the Suzuki-Miyaura coupling to form bulky tetra-ortho-substituted biaryls from aryl 
bromides and chlorides at room temperature. The central feature of the catalyst sees 
the introduction of a C2-symmetric NHC ligand with appropriately substituted 
naphthyl side chains. This simple modification to the well-known ligand systems 
allows for a dramatic increase in catalytic performance in these difficult Suzuki-
Miyaura coupling reactions, apparently leaving the already high activity in less 
demanding coupling reactions unaffected. Advanced DFT calculations show that the 
‘flexible steric bulk’ of our ligand is inherently given by its symmetry, which leaves 
two of the four quadrants relatively open, thus enhancing the reactivity of the system 
with respect to the crucial, sterically demanding NHC-Pd(Ar)(Ar’) intermediate and 
the following reductive elimination step.  
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2.5 Experimental Part 
2.5.1 General: All reactions were carried out using standard Schlenk or glovebox 
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(Mecaplex or Innovative Technology) techniques under nitrogen. KOtBu was used 
after sublimation. 2,6-Diisopropylchlorobenzene27 and 2,4,6-
triisopropylbromobenzene28 were prepared according to literature. Imidazolinium 
salts were prepared according to our previous report.29 All other reagents were used as 
received unless otherwise noted. Solvents were purchased in the best quality 
available, degassed by purging thoroughly with nitrogen and dried over molecular 
sieves of appropriate size. Alternatively, they were purged with argon and passed 
through alumina columns in a solvent purification system (Innovative Technology). 
Solvents for NMR spectroscopy were degassed with nitrogen and dried over 
molecular sieves. NMR spectra were collected on AV2 400 or AV2 500 MHz Bruker 
spectrometers. Chemical shifts are given in ppm. The spectra were calibrated to the 
residual 1H and 13C of the solvent. Multiplicities are abbreviated as follows: singlet 
(s), doublet (d), triplet (t), quartet (q), doublet-doublet (dd), quintet (quint), septet 
(sept), multiplet (m), and broad (br).  High-resolution electrospray ionization mass 
spectrometry was performed on a FinniganMAT 900 (Finnigan MAT95, San Jose, 
CA; USA) double-focusing magnetic sector mass spectrometer (geometry BE). GC 
analysis was done on a ThermoQuest TraceGC2000. GC-MS analysis was done on a 
Finnigan Voyager GC8000 Top. X-ray crystallography was performed on a 
NoniusKappaCCDarea-detector diffractometer using graphite-monochromated Mo 
Kradiation ( = 0.71073 Å) and an Oxford Cryosystems Cryostream 700 cooler. 
 
2-Cyclooctyl-1-nitronaphthalene. 4.40 g (18.5 mmol) 2-cyclooctylnaphthalene and 
13 g dry MgSO4 were added into 50 ml of CH2Cl2. Then 1.30 ml 
of fuming nitric acid was added dropwise in 1h. Let the mixture 
gradully warm to room temperature and keep stirring overnight. 
After filtration, the solution was concentrated and then refluxed in 150 ml ethylacetate 
in the precense of 16.6 g SnCl2•2H2O for 2h. After the solution was cooled to r.t., the 
solvent was evaporated in vacuo and the residue was chromatographed on silica gel 
(n-hexane:CH2Cl2 3:1) giving 1.80 g (35%) of the title compound as a yellowish oil. 
1H NMR (CDCl3, 400 MHz): 7.88 (d, J =8.7 Hz, 1H), 7.83 (d, J = 8.0 Hz, 1H), 7.64 
(d, J = 8.4 Hz, 1H), 7.56 (td, J = 6.8, 1.1 Hz, 1H), 7.50 (td, J = 6.8, 1.1 Hz, 1H), 7.42 
(d, J = 8.7 Hz, 1H), 2.98-2.92 (m, 1H), 1.87-1.54 (m, 14H). 13C {1H} NMR (CDCl3, 
100 MHz):146.32, 138.71, 132.19, 130.77, 128.61, 128.07, 126.89, 124.94, 124.50, 
121.68, 39.28, 34.92, 26.85, 26.65, 26.31. HRMS (EI): m/z: calcd for 
NO2
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C18H21NO2[M]+: 283.1572; found: 283.1570. 
 
1-Amino-2-cyclooctylnaphthalene. 2-cyclooctyl-1-nitronaphthalene (3.0 g, 10.6 
mmol) was dissolved in 100 mL of technical grade methanol. This 
solution was transferred into a high pressure autoclave and Pd on 
carbon (5% wt. Pd, 300 mg) was added. After purging with 
formier gas and hydrogen, the autoclave was charged with 50 bar of H2. After stirring 
at room temperature for 48 hours, the pressure was released and the reaction mixture 
filtered through celite. After concentration, the residue was purified by flash column 
chromatography on silica-gel (n-hexane:CH2Cl2 1:1) to get title product as a white 
solid (2.50 g, 93%). 1H NMR (CDCl3, 400 MHz): δ = 7.80 (d, J = 7.7, 1H), 7.78 (d, J 
= 7.2, 1H), 7.48-7.40 (m, 2H), 7.35 (s, 2H), 4.16 (s, 2H), 3.01-2.96 (m, 1H), 1.94-1.68 
(m, 14H). 13C {1H} NMR (CDCl3, 100 MHz):  136.97, 132.76, 128.74, 128.59, 
125.82, 125.12, 124.08, 120.91, 118.98, 38.79, 33.64, 27.16, 26.74, 26.71. HRMS 
(EI): m/z : calcd for C18H23N [M]+: 253.1830; found: 253.1830. 
 
N,N’-Bis(2-cyclooctylnaphthalene)ethylenediimine.  1-Amino-2-
cyclooctylnaphthalene (2.28 g, 9.0 mmol) and 6 drops of 
gracial acid were disssolved in 25 ml of technical grade 
methanol at 50°C. Then aqueous glyoxal solution (40% wt, 
653 mg)  in 6 ml of methanol was added dropwise by syringe 
in 30 min. Let the mixture cool down to r.t. and keep stirring 
overnight. The yellow precipitate was filtered off, washed with cold methanol and 
dried under vacuum to lead to the title compound as a yellow powder (1.7 g, 72%).1H 
NMR (CDCl3, 400 MHz): δ = 8.45 (s, 2H), 7.84-7.78 (m, 4H), 7.68 (d, J = 8.7 Hz, 
2H), 7.49-7.45 (m, 6H), 3.25-3.20 (m, 2H), 1.87-1.63 (m, 28H). 13C {1H} NMR 
(CDCl3, 125 MHz): 164.99, 144.39, 134.55, 132.53, 130.35, 128.10, 126.33, 125.74, 
125.69, 125.62, 123.43, 37.59, 35.29, 27.41, 26.95, 26.62. HRMS (EI): m/z : calcd for 
C38H45N2 [M+1]+: 529.35773; found: 529.35787. 
 
1,3-Bis(2-cyclooctylnaphthalen-1-yl)imidazolium chloride. Paraformaldehyde (48 
mg, 1.60 mmol) was added to 0.60 ml of a 4 N solution of HCl in dioxane ( 2.4 
mmol). The mixture was stirred and gently warmed until complete dissolution of the 
solid. In another flask, N,N’-Bis(2-cyclooctylnaphthalene)ethylenediimine (430 mg, 
NH2
N N
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0.81 mmol) was gently warmed in 4 ml THF until it completely disolved. At room 
temperature, the paraformaldehyde solution was added dropwise 
into the diimine solution slowly. The mixture was stirred 
overnight and the precipitate was filtered and then disolved in 2 
ml of MeOH. 20 ml of ether was added into this solution to get 
the precipitate again. The precipitate was collected and dry 
under vacuum. The title compound was obtained as a white solid ( 140 mg, 30% 
yield, only one isomer was observed). 1H NMR (DMSO-d6, 500 MHz): δ = 10.46 (s, 
1H), 8.86 (s, 1H), 8.34 (d, J = 8.4 Hz, 2H), 8.20 (d, J = 7.8 Hz, 2H), 7.83-7.67 (m, 
6H), 7.16 (d, J = 7.9 Hz, 2H), 2.64 (br, 2H), 2.04-1.46 (m, 28H). 13C {1H} NMR 
(DMSO-d6, 125 MHz): 145.66, 140.88, 132.47, 132.26, 129.21, 129.16, 129.12, 
127.65, 127.40, 126.22, 125.90, 120.65, 49.07, 39.02, 35.12, 34.75, 26.83, 26.61, 
26.28, 26.04, 25.95. HRMS (ESI): m/z : calcd for C39H45N2 [M-Cl]+: 541.35773; 
found: 541.35761. 
 
2,7-Dicyclooctyl-1-nitronaphthalene. 3.60 g (10.3 mmol) 2,7-
dicyclooctylnaphthalene and 12 g dry MgSO4 were added 
into 120 ml of CH2Cl2. Then 2.40 ml of  nitric acid (66 %) 
was added dropwise into this suspension in 20 min at 0 °C. 
Allowed the mixture gradully warm to room temperature and keep stirring for 1.5 h. 
After filtration, the solution was concentrated and the residue was dissolved in 120 ml 
ethylacetate and the obtained solution was refluxed in the precense of 7.0 g 
SnCl2•2H2O for 2h. After the solution was cooled to r.t., the solvent was evaporated 
in vacuo and the residue was chromatographed on silica gel (n-hexane:CH2Cl2 10:1) 
giving 2.80 g (70%) of the title compound as a yellowish oil. 1H NMR (CDCl3, 400 
MHz): 7.82 (d, J =8.6 Hz, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.39-7.24 (m, 3H), 2.93-2.88 
(m, 2H), 1.84-1.58 (m, 28H). 13C {1H} NMR (CDCl3, 100 MHz):151.19, 146.22, 
138.59, 130.79, 130.40, 128.13, 127.26, 124.62, 123.91, 118.38, 45.33, 39.35, 34.92, 
34.87, 27.20, 26.82, 26.70, 26.62, 26.32, 26.28. HRMS (EI): m/z: calcd for 
C26H35NO2[M]+: 393.2668; found: 393.2667. 
 
1-Amino-2,7-dicyclooctylnaphthalene. 2,7-dicyclooctyl-1-nitronaphthalene (2.52 g, 
6.40 mmol) was dissolved in 50 mL of CH2Cl2. This solution was transferred into a 
high pressure autoclave and the solvent was evaporated by purging N2 flow on the 
N N
Cl
NO2
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above of the sulution. 100 ml of technical grade methanol 
and Pd on carbon (5% wt. Pd, 300 mg) were added and 
the autoclave was closed. After purging with formier gas 
and hydrogen, the autoclave was charged with 50 bar of H2. After stirring at 50 °C for 
48 hours, the pressure was released and the reaction mixture was filtered through 
Celite. After concentration, the residue was purified by flash column chromatography 
on silica-gel (n-hexane:CH2Cl2 3:1) to get title product as a white solid (1.40 g, 60%). 
1H NMR (CDCl3, 500 MHz): δ = 7.66 (d, J = 8.4, 1H), 7.55 (s, 1H), 7.26-7.21 (m, 
3H), 4.11 (s, 2H), 2.95-2.89 (m, 2H), 1.92-1.60 (m, 28H). 13C {1H} NMR (CDCl3, 
125 MHz):  147.37, 136.60, 131.15, 128.89, 128.66, 125.48, 124.91, 124.12, 118.86, 
117.79, 45.52, 35.12, 33.63, 27.22, 26.71, 26.67, 26.39. HRMS (EI): m/z : calcd for 
C26H37N [M]+: 363.2926; found: 363.2923. 
 
N,N’-Bis(2,7-dicyclooctylnaphthalene)ethylenediimine. 1-Amino-2,7-
dicyclooctylnaphthalene (1.05 g, 2.88 mmol) and 4 drops of 
gracial acid were disssolved in 90 ml of technical grade 
methanol at 70°C. Then aqueous glyoxal solution (40% wt, 
210 mg)  in 6 ml of methanol was added dropwise by syringe 
in 20 min. Let the mixture stir at 70 °C overnight. The yellow 
precipitate was filtered off, washed with cold methanol and 
dried under vacuum to lead to the title compound as a yellow 
powder (0.96 g, 89%).1H NMR (CDCl3, 400 MHz): δ = 8.45 (s, 2H),7.74 (d, J = 8.4 
Hz, 2H), 7.62 (d, J = 8.5 Hz, 2H), 7.56 (s, 2H), 7.40 (d, J = 8.6 Hz, 2H), 7.34 (dd, J = 
8.4, 1.6 Hz), 3.18-3.14 (m, 2H), 2.90-2.86 (m, 2H), 1.86-1.56 (m, 56H). 13C {1H} 
NMR (CDCl3, 100 MHz): 164.78, 148.62, 144.06, 134.43, 130.94, 128.12, 126.06, 
125.92, 125.49, 124.93, 120.37, 45.66, 38.11, 35.27, 35.12, 33.69, 27.25, 27.20, 
27.13, 26.95, 26.67, 26.64, 26.42. HRMS (ESI): m/z : calcd for C54H73N2 [M+1]+: 
749.57683; found: 749.57661. 
 
1,3-Bis(2,7-dicyclooctylnaphthalen-1-yl)imidazolium chloride. Paraformaldehyde 
(80 mg, 2.67 mmol) was added to 2.0 ml of a 4 N solution of HCl in dioxane ( 8.0 
mmol). The mixture was stirred and gently warmed until complete dissolution of the 
solid. In another flask, N,N’-Bis(2,7-dicyclooctylnaphthalene)ethylenediimine (1.0 g, 
1.34 mmol) was gently warmed in 4 ml THF until it completely disolved. At room 
NH2
N N
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temperature, the paraformaldehyde solution was added dropwise 
into the diimine solution at 60 °C slowly. The mixture was stirred 
at the same temperature overnight and the precipitate was filtered 
and then disolved in 10 ml of CH2Cl2. 200 ml of ether was added 
into this solution to get the precipitate again. The precipitate was 
collected and dry under vacuum. The title compound was 
obtained as a white solid (490 mg, 46% yield). From NMR 
analysis two isomers existed in the ratio of 92:8. (Due to overlap of most of the 
signals of minor and major isomer, only the one related to the major will be 
presented). 1H NMR (CDCl3, 500 MHz): δ = 9.38 (s, 1H), 8.49 (s, 2H), 8.00 (d, J = 
8.6 Hz, 2H), 7.89 (d, J = 8.5 Hz, 2H), 7.54-7.48 (m, 4H), 6.89 (s, 2H), 2.78 (br, 2H), 
2.51-2.47 (m, 2H), 1.95-1.48 (m, 56H). 13C {1H} NMR (CDCl3, 125 MHz): 152.04, 
144.25, 131.98, 131.29, 129.61, 129.23, 128.49, 126.96, 125.88, 124.25, 117.48, 
46.84, 41.89, 35.14, 34.98, 33.29, 33.21, 28.19, 27.76, 27.31, 26.84, 26.28, 26.21, 
26.10, 25.92, 25.78, 24.21. HRMS (ESI): m/z : calcd for C55H73N2 [M-Cl]+: 
761.57683; found: 761.57696. 
 
N N
Cyoct
Cyoct
Pd
Cl
Ph
Cyoct=
anti-A
N N
Cyoct Pd
Cl
Ph
syn-A
Cyoct
anti-(2)-(SICyoctNap)Pd(cin)Cl syn-(2)-(SICyoctNap)Pd(cin)Cl  
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][1,3-bis(2-cyclooctylnaphthalen-1-yl)-
imidazolin-2-ylidene] palladium(II) (anti-A and syn-A). 1,3-Bis(2-
cyclooctylnaphthalen-1-yl)-imidazolinium tetrafluoroborate (750 mg, 1.19 mmol), 
KOtBu (133 mg, 1.19 mmol) and [Pd(cinnamyl)Cl]2 (308 mg, 0.60 mmol) were 
mixed together in a round flask in the glovebox. Dry THF (45 mL) was added and the 
mixture was stirred at room temperature for 16 h. The solvent was removed in vacuo, 
and the residue was separated by flash chromatography on siliga gel (n-hexane 
:EtOAc 1:7→1:4) to afford two atropisomers (812 mg, 85%). Elemental analysis (%, 
based on the rac-isomer): calcd for C48H55ClN2Pd · 2EtOAc: C, 68.77; H, 7.32; N, 
2.86. Found: C, 70.23; H, 6.99; N, 2.35. HRMS (ESI): m/z : calcd for C48H55N2Pd [M-
Cl]+: 765.34115; found: 765.34116. 
N N
Cl
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Data for anti-A are as follows (760 mg, 80% yield): 1H NMR (CDCl3, 500 MHz): δ = 
8.07 (br, 2H), 7.88-7.84 (m, 4H), 7.54-7.24 (m, 6H), 6.94 (s, 3H), 6.66 (br, 2H), 4.61-
4.20 (m, 5H), 3.89 (br, 1H), 3.64 (br, 2H), 3.02-2.83 (m, 1H), 2.38-2.25 (m, 2H), 
1.95-1.74 (m, 27H). 13C {1H} NMR (CDCl3, 125 MHz):213.79, 146.34, 146.12, 
138.46, 138.34, 137.22, 136.36, 133.00, 132.90, 132.78, 132.60, 132.48, 131.11, 
130.93, 129.49, 129.30, 128.76, 128.24, 128.19, 128.15, 128.08, 127.90, 127.70, 
127.68, 127.64, 127.41, 127.34, 126.74, 126.62, 126.51, 126.38, 125.94, 125.86, 
125.76, 125.02, 124.96, 124.832, 109.91, 109.57, 106.18, 106.13, 91.45, 90.90. 89.28, 
88.02, 82.05, 59.74, 54.07, 53.93, 53.78, 51.33, 50.56, 48.92, 48.32, 38.89, 38.35, 
37.82, 37.76, 36.99, 35.93, 34.91, 34.27, 28.3, 28.03, 27.49. 27.15, 26.90, 26.86, 
26.76, 26.63, 26.58, 26.48, 26.17. 25.83.  
Data for syn-A are as follows (52 mg, 5% yield): 1H NMR (CDCl3, 500 MHz): δ = 
8.06 (br, 2H), 7.94-7.86 (m, 4H), 7.70-7.68 (m, 1H), 7.60-7.55 (m, 4H), 7.48-7.45 (m, 
1H), 6.97 (s, 3H), 6.70 (br, 2H), 4.29 (br, 4H), 4.16-4.14 (m, 1H), 3.72 (d, J = 12.2 Hz, 
1H), 3.57 (br, 1H), 3.46 (br, 1H), 2.65-2.58 (m, 2H), 2.31 (br, 1H), 1.89-1.65 (m, 
22H), 1.33-1.24 (m, 3H), 0.88-0.85 (m, 2H). 13C {1H} NMR (CDCl3, 125 MHz): 
215.11, 147.97, 147.47, 138.79, 133.21, 132.98, 132.46, 132.35, 131.02, 130.81, 
129.43, 129.17, 128.94, 128.84, 128.17, 127.91, 127.57, 127.28, 126.82, 126.60, 
126.45, 126.31, 125.71, 125.51, 123.63, 123.26, 109.87, 86.83, 54.31, 53.50, 50.50, 
39.36, 38.96, 36.48, 36.09, 34.42, 34.08, 33.69, 27.76, 26.85, 26.70, 26.61, 26.56, 
22.63, 14.36. 
Cyoct=
N N
Cyoct
Cyoct
Pd
Cl
Ph
anti-B
anti-(2)-(ICyoctNap)Pd(cin)Cl  
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][1,3-bis(2-cyclooctylnaphthalen-1-yl)-
imidazol-2-ylidene] palladium(II) (anti-B). 1,3-Bis(2-cyclooctylnaphthalen-1-
yl)imidazolium chloride (200 mg, 0.34 mmol), KOtBu (38 mg, 0.34 mmol) and dry 
THF (20 ml) were stirred for 5 h in a round flask in the glovebox. Then 
[Pd(cinnamyl)Cl]2 (44 mg, 0.085 mmol) was added and the mixture was stirred at 
room temperature for 20 h. The solvent was removed in vacuo, and the residue was 
separated by flash chromatography on siliga gel (n-hexane:EtOAc 5:1) to afford only 
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one atropisomer (140 mg, 50%). Elemental analysis (%): calcd for C48H53ClN2Pd: C, 
72.08; H, 6.68; N, 3.50. Found: C, 72.16; H, 6.72; N, 3.42.  HRMS (ESI): m/z : calcd 
for C48H53N2Pd [M-Cl]+: 763.32550; found: 763.32555. 1H NMR (CDCl3, 500 MHz): 
δ = 7.97-7.94 (m, 2H), 7.86 (br, 2H), 7.57-7.45 (m, 8H), 7.36 (s, 2H), 6.97 (s, 3H), 
6.76 (s, 2H), 4.69-4.63 (m, 0.5H), 4.41 (br, 0.5H), 4.00-3.93 (m, 1H), 3.21-3.15 (m, 
2H), 2.74 (br, 0.5H), 2.63 (bt, 0.5H), 1.99 (s, 1H), 1.96 (s, 1H), 1.79-1.60 (m, 27H). 
13C {1H} NMR (CDCl3, 125 MHz): 186.33, 186.05, 185.45, 145.53, 145.34, 138.58, 
138.36, 136.48, 132.42, 132.38, 132.22, 132.20, 132.19, 132.15, 131.43, 131.03, 
130.24, 128.27, 128.13, 127.87, 127.76, 127.51, 127.41, 127.04, 126.19, 125.36, 
125.29, 124.92, 124.73, 124.61, 109.43, 109.02, 105.70, 90.04, 89.07, 87.38, 51.33, 
48.71, 47.73, 38.73, 38.34,37.13, 36.17, 34.53, 34.31, 33.82, 27.31, 27.19, 27.13, 
26.73, 26.65, 26.56, 26.34, 26.29, 26.15, 25.98. 
 
Cyoct=
N N
Cyoct
Cyoct
Pd
Cl
Ph
Cyoct
Cyoct
anti-C
anti-(2,7)-(SICyoctNap)Pd(cin)Cl  
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][1,3-bis(2,7-dicyclooctylnaphthalen-1-yl)-
imidazolin-2-ylidene] palladium(II) (anti-C). 1,3-bis(2,7-dicyclooctylnaphthalen-1-
yl)-imidazolinium tetrafluoroborate (388 mg, 0.46 mmol), KOtBu (51 mg, 0.46 
mmol) and [Pd(cinnamyl)Cl]2 (120 mg, 0.23 mmol) were mixed together in a round 
flask in the glovebox. Dry THF (40 mL) was added and the mixture was stirred at 
room temperature for 16 h. The solvent was removed in vacuo, and the residue was 
separated by flash chromatography on siliga gel (n-hexane:EtOAc 5:1) to afford one 
atropisomers (400 mg, 86%). Elemental analysis (%): calcd for C64H83ClN2Pd: C, 
75.20; H, 8.18; N, 2.74. Found: C, 75.43; H, 8.15; N, 2.59.  HRMS (ESI): m/z : calcd 
for C64H83N2Pd [M-Cl]+: 985.56068; found: 985.56063. 1H NMR (CDCl3, 400 MHz): 
δ = 7.84-7.72 (m, 6H), 7.52-7.47 (m, 2H), 7.41-7.37 (m, 2H), 6.99-6.98 (m, 3H), 
6.85-6.78 (m, 2H), 4.78-3.85 (m, 6H), 3.52 (br, 2H), 3.01 (br, 2H), 2.76-2.22 (m, 2H), 
1.95-0.83 (m, 56H). 13C {1H} NMR (CDCl3, 125 MHz): 212.89, 212.55, 211.33, 
149.04, 138.72, 138.47, 138.21, 136.58, 132.71, 132.50, 132.38, 131.62, 131.55, 
131.45, 131.36, 131.32, 130.97, 129.01, 128.89, 128.81, 128.57, 128.39, 128.22, 
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128.16, 128.02, 127.97, 127.64, 127.34, 127.25, 126.44, 125.83, 125.65, 125.56, 
125.40, 124.94, 121.46, 109.83, 109.43, 109.13, 106.06, 90.38, 88.01, 87.53, 53.87, 
53.63, 48.24, 47.68, 46.43, 46.23, 45.80, 40.90, 40.75, 39.80, 39.66, 36.12, 35.73, 
35.14, 35.02, 34.94, 34.70, 33.49, 33.02, 29.98, 29.94, 29.07, 28.73, 28.54, 28.16, 
28.02, 27.89, 27.76, 27.58, 27.53, 27.47, 27.37, 27.28, 27.20, 27.15, 26.90, 26.70, 
26.62, 26.53, 26.48, 26.42, 26.35, 26.32, 26.19, 26.07, 25.89, 25.07, 24.85, 22.97, 
14.39. 
Cyoct=
N N
Cyoct
Cyoct
Pd
Cl
Ph
Cyoct
Cyoct
anti-D
syn-(2,7)-(ICyoctNap)Pd(cin)Cl  
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][1,3-bis(2,7-dicyclooctylnaphthalen-1-yl)-
imidazol-2-ylidene] palladium(II) (anti-D). 1,3-Bis(2,7-dicyclooctylnaphthalen-1-
yl)imidazolium chloride (288 mg, 0.36 mmol), KOtBu (40 mg, 0.36 mmol) and dry 
THF (20 ml) were stirred for 20 min in a round flask in the glovebox. Then 
[Pd(cinnamyl)Cl]2 (93 mg, 0.18 mmol) was added and the mixture was stirred at room 
temperature for 16 h. The solvent was removed in vacuo, and the residue was 
separated by flash chromatography on siliga gel (n-hexane:EtOAc 5:1) to afford only 
one atropisomer (200 mg, 56%). Elemental analysis (%): calcd for C64H81ClN2Pd: C, 
75.35; H, 8.00; N, 2.75. Found: C, 75.52; H, 8.07; N, 2.71.   HRMS (ESI): m/z : calcd 
for C64H81N2Pd [M-Cl]+: 983.54345; found: 983.54573. 1H NMR (CDCl3, 500 MHz): 
δ = 7.91-7.79 (m, 4H), 7.57-7.28 (m, 8H), 7.00-6.86 (m, 5H), 4.75-3.94 (m, 1H), 3.11 
(br, 2H), 2.87 (br, 2H),  2.67-2.55 (m, 1H), 2.34-1.12 (m, 58H). 13C {1H} NMR 
(CDCl3, 125 MHz): 186.18, 185.97, 185.23, 149.40, 149.16, 149.14, 148.42, 148.31, 
145.88, 145.82, 144.54, 138.81, 138.58, 138.33, 136.60, 134.74, 134.62, 132.26, 
132.18, 132.08, 131.96, 131.44, 131.29, 131.17, 131.09, 131.03, 130.99, 130.93, 
130.89, 130.80, 129.70, 129.44, 128.63, 128.48, 128.37, 128.26, 128.24, 128.17, 
128.06, 127.99, 127.68, 127.36, 127.27, 126.38, 125.94, 125.86, 125.83, 125.81, 
125.64, 125.19, 124.87, 124.79, 124.46, 121.34, 121.20, 120.41, 120.15, 109.41, 
109.04, 108.63, 105.49, 89.46, 88.97, 87.20, 86.88, 68.24, 60.66, 48.06, 47.61, 46.57, 
46.41, 46.26, 46.12, 45.68, 41.14, 40.48, 40.26, 39.52, 39.48, 35.78, 35.00, 34.93, 
34.45, 34.03, 33.92, 33.76, 33.59, 33.56, 32.98, 32.36, 32.15, 31.86, 29.30, 28.60, 
33 
28.25, 28.02, 27.95, 27.66, 27.64, 27.58, 27.47, 27.38, 27.33, 27.15, 27.12, 26.98, 
26.94, 26.60, 26.56, 26.40, 26.34, 26.30, 26.25, 26.21, 26.16, 26.08, 26.02, 25.89, 
25.88, 25.84, 25.45, 25.12, 24.77, 22.97, 22.93, 14.41.  
 
2-Methyl-1-naphthylboronicacid. 1-Bromo-2-methylnaphthalene (2.81 g, 12.7 
mmol), magnesium (338 mg, 13.9 mmol) and one crystal of I2 were 
refluxed in 20 ml THF for 2 h. Upon cooling to room temperature, the 
generated grinard reagent was added dropwise into the solution of B(OMe)3 (2.2 ml, 
19.1 mmol) in 8 ml THF under 0 °C. The mixture was stirred for another 1 h under 0 
°C and then overnight at room temperature. The reaction was quenched with 5 ml 
water and the whole mixture was concentrated by evaporation. To the residue was 
added 40 ml HCl aqueous solution (1 mol/L) and the mixture was stirred for 30 min 
to get the precipitate. The yellow precipitate was stirred in 50 ml n-hexane for 2 h. 
After filtration, the title compound was obtained as a white solid (1.60 g, 68% yield). 
1H NMR (CDCl3, 500 MHz): δ = 7.80 (d, J = 8.2 Hz, 1H), 7.78 (d, J = 7.9 Hz, 1H), 
7.74 (d, J = 8.4 Hz, 1H), 7.45 (td, J = 6.9, 1.3 Hz, 1H), 7.29 (d, J = 8.4 Hz, 1H), 4.78 
(s, 2H), 2.56 (s, 3H). 
 
1-Chloro-4-methoxy-2,6-dimethylbenzene. 4-Chloro-3,5-dimethylphenol (1.88 g, 
12.0 mmol) was treated with anhydrous K2CO3 (5.0 g, 36.0 mmol) and 
iodomethane (6.8 g, 48.0 mmol) in refluxing acetone for 3 h. To the 
residue after evaporation was added 50 ml water and 50 ml CH2Cl2. The 
organic phase was washed with 30 ml NaOH solution (2 mol/L) and then with water. 
After drying over anhydrous MgSO4, the solvent was removed in vacuo and the title 
compound was obtained as a colorless oil (1.72 g, 84% yield). %).1H NMR (CDCl3, 
400 MHz): δ = 6.63 (s, 2H), 3.75 (s, 3H), 2.35 (s, 6H). 13C {1H} NMR (CDCl3, 100 
MHz): 157.68, 137.32, 126.46, 114.16, 55.57, 21.19. 
 
4-Chloro-3,5-dimethylacetophenone. In a 100 ml schlenk flask was charged with 
dry chloroform (30 ml), 2-chloro-1,3-dimethylbenzene (7 g, 50 mmol). 
The mixture was cooled to 0 °C  and then a pre-mixed solution of 
aluminum trichloride (6.3 g, 47.5 mmol) and acetyl chloride (3.2 ml, 45 
mmol) was added to this chloroform solution in 1h via addition funnel. 
The reaction was gradually warmed to room temperature and stirred for another 1h 
B(OH)2
OMe
Cl
Cl
O
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and then quenched with ice (50 g). The aqueous was extracted with 50 ml chloroform 
and the combined organic phase was washed with 50 ml saturated K2CO3 until 
slightly basic. The organic layer was further washed with water (50 ml) and brine (50 
ml) and then dried over anhydrous MgSO4. After rotary evaporation, the mixture was 
purified with flash chromatography on silica gel (n-hexane:EtOAc 10:1) to get the 
title compound as a colorless solid (5.0 g, 61% yield). HRMS (EI): m/z : calcd for 
C10H11ClO [M]+: 182.0498; found: 182.0498. 1H NMR (CDCl3, 400 MHz): δ = 7.64 
(s, 2H), 2.55 (s, 3H), 2.41 (s, 6H). 13C {1H} NMR (CDCl3, 100 MHz): 197.82, 
140.27, 136.98, 135.10, 128.47, 26.86, 21.09. 
 
2-(4-chloro-3,5-dimethylphenyl)-2-methyl-1,3-Dioxolane. To a solution of 4-
Chloro-3,5-dimethylacetophenone (1.0 g, 5.5 mmol) in toluene (10 ml) 
was added ethylene glycol (1.02 g, 16.5 mmol) and a catalytic amount of 
p-toluene sulfonic acid. The mixture was refluxed for 12h with a Dean-
Stark trap. Upon cooling to room temperature, the solution was extracted 
with 50 ml EtOAc. The organic phase was washed with water (50 ml) and brine (50 
ml) and then dried over anhydrous MgSO4. After removing the solvent by evaporation, 
the residue was purified by flash chromotagraphy on siliga gel (n-hexane:CH2Cl2  2:1) 
to get the product as a colorless oil (686 mg, 55% yield). HRMS (ESI): m/z : calcd for 
C10H11ClNaO [M-C2H4O+Na]+: 205.03906; found: 205.03901. 1H NMR (CDCl3, 400 
MHz): δ = 7.18 (s, 2H), 4.02-3.99 (m, 2H), 3.78-3.74 (m, 2H), 2.36 (s, 6H), 1.61 (s, 
3H). 13C {1H} NMR (CDCl3, 100 MHz): 141.38, 136.31, 134.35, 108.75, 64.74, 
27.88, 21.07. 
 
1,3-Dimethyl-2-chloro-5-(1-methylethenyl)-benzene. To a suspension of  
methyltriphenylphosphonium bromide (1.17 g, 3.27 mmol) in 30 ml THF 
was added NaOtBu as a solid in small portions. The obtained bright 
yellow mixture was stirred for 1 h at room temperature under N2 and then 
cooled to -78 °C. To this mixture 4-chloro-3,5-dimethylacetophenone 
solution in 5 ml THF was added. The reaction was allowed to gradually warm to 
room temperature before quenching with water. The organic layer was washed with 
water (30 ml), brine (30 ml) and then dried over anhydrous MgSO4 and concentrated 
in vacuo. To the residue n-hexane (20 ml) was added and the immediate formation of 
the precipitate was observed. After filtration, the solid was washed with 20 ml n-
Cl
O
O
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hexane and the combined n-hexane solution was dried. The crude product was 
purified by flash chromatography on siliga gel (n-hexane) to afford the title 
compound as a colorless oil (392 mg, 80% yield). HRMS (ESI): m/z : calcd for 
C11H13Cl [M]+: 180.0706; found: 180.0706. 1H NMR (CDCl3, 400 MHz): δ = 7.16 (s, 
2H), 5.31 (s, 1H), 5.05 (s, 1H), 2.37 (s, 6H), 2.11 (s, 3H). 13C {1H} NMR (CDCl3, 100 
MHz): 142.86, 139.37, 136.12, 134.00, 125.89, 112.79, 22.12, 21.10. 
 
1-Chloro-2-methylnaphthalene. The suspension of 1-bromo-2-methylnaphthalene 
(2.0 g, 9.0 mmol) and CuCl (960 mg, 9.7 mmol) in 30 ml DMF was 
refluxed for 7 h. Upon cooling to room temperature, the mixture was 
filtered through a plug silica gel with n-hexane as eluent. After 
evaporation of the solvent, the residue was purified by flash chromatography on siliga 
gel(n-hexane) to afford the title compound as a colorless oil (1.34 g, 84% yield). 
HRMS (EI): m/z : calcd for C11H9Cl [M]+: 176.0393; found: 176.0394. 1H NMR 
(CDCl3, 400 MHz): 8.29 (d, J = 8.3 Hz, 1H), 7.80 (d, J = 8.1 Hz, 1H), 7.66 (d, J = 8.4 
Hz, 1H), 7.56 (td, J = 8.4,1.3 Hz, 1H), 7.46 (td, J = 8.0,1.0 Hz, 1H), 7.33 (d, J = 8.4 
Hz, 1H), 2.58 (s, 3H). 13C {1H} NMR (CDCl3, 100 MHz):133.73, 133.32, 131.45, 
130.94, 128.98, 128.25, 127.25, 126.71, 125.89, 124.42, 21.09. 
 
1-Chloro-2,6-dimethoxybenzene. The suspension of 1-bromo-2,6-
dimethoxybenzene (500 mg, 2.3 mmol) and CuCl (250 mg, 2.5 mmol) 
in 15 ml DMF was refluxed overnight. Upon cooling to room 
temperature, the mixture was filtered through a plug silica gel with n-hexane as 
eluent. After evaporation of the solvent, the residue was purified by flash 
chromatography on siliga gel (n-hexane/ether 10:1) to afford the title compound as a 
white solid (370 mg, 93% yield). HRMS (EI): m/z : calcd for C8H9O2Cl [M]+: 
172.0291; found: 172.0291. 1H NMR (CDCl3, 400 MHz): 7.16 (t, J = 8.4 Hz, 1H), 
6.59 (d, J = 8.4 Hz, 2H), 3.88 (s, 6H). 13C {1H} NMR (CDCl3, 100 MHz): 156.58, 
127.42, 105.01, 105.00, 56.64. 
 
1-Chloro-2-methoxynaphthalene. The suspension of 1-bromo-2-
methoxynaphthalene (1.0 g, 4.2 mmol) and CuCl (459 mg, 4.6 
mmol) in 25 ml DMF was refluxed overnight. Upon cooling to 
room temperature, the mixture was filtered through a plug silica gel with n-hexane as 
Cl
OO
Cl
O
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eluent. After evaporation of the solvent, the residue was purified by flash 
chromatography on siliga gel (n-hexane/ether 10:1) to afford the title compound as a 
white solid (370 mg, 93% yield). HRMS (EI): m/z : calcd for C11H9OCl [M]+: 
192.0342; found: 192.0340. 1H NMR (CDCl3, 400 MHz): 8.20 (d, J = 8.6 Hz, 1H), 
7.77 (t, J = 8.6 Hz, 2H), 7.55 (t, J = 8.2 Hz, 1H), 7.39 (t, J = 7.8 Hz, 1H), 7.29 (d, J = 
9.0 Hz, 1H). 13C {1H} NMR (CDCl3, 100 MHz): 152.86, 132.19, 129.83, 128.28, 
128.25, 127.74, 124.61, 123.77, 57.29. 
 
2.5.2 General Suzuki-coupling procedure. In the glovebox, a vial (10 mL screw-cap 
threaded) equipped with a stir-bar was  charged with arylhalide (0.40 mmol), boronic 
acid (0.60 mmol for bromides or 0.80 mmol for chlorides), potassium tert-butoxide 
(112 mg, 1.0 mmol), then the Pd-complex anti-C (8.2 mg, 0.0080 mmol) and toluene 
(3.2 ml) were added. The mixture was stirred at room temperature for indicated period 
of time before being quenched with water (10 ml) outside the golvbox (the reaction 
mixture turned into a red and homogeneous solution before it completed). 
Alternatively, if heating was needed, the vial was sealed a Teflon®-lined screw cap 
and the mixture was stirred at 65 °C for indicated period of time before being 
quenched with water (10 ml). The mixture was extracted with ethylacetate (15 ml × 2) 
and the combined organic layers were dried with anhydrous MgSO4 , the solvent was 
removed in vacuo and the residue was purified by flash chromatography. 
 
2,6-Dimethoxy-2',6'-dimethylbiphenyl (Table 4, Entry 1): The general Suzuki 
coupling procedure was followed, using anti-C (8.2 mg, 0.0080 
mmol). After 12 h at room temperature,93.0 mg (96% yield) of the 
product was isolated by flash chromatography (n-N-hexane/Ether = 
20/1 ) as a white solid. The spectral data were in accordance with 
those reported in the literature.20b  
 
2,6-Dimethoxy-2',3',5',6'-tetramethylbiphenyl (Table 4, Entry 2): The general 
Suzuki coupling procedure was followed, using anti-C (8.2 mg, 
0.0080 mmol). After 72 h at room temperature, 86 mg (80% yield) of 
the product was isolated by flash chromatography (n-Hexane/Ether = 
20/1 ) as a white solid. HRMS (EI): m/z : calcd for C18H22O2 [M]+: 
270.1620; found: 270.1622. 1H NMR (CDCl3, 500 MHz): 7.30 (t, J = 8.3 Hz, 1H), 
O
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6.97 (s, 1H), 6.65 (d, J = 8.3 Hz, 1H), 3.70 (s, 6H), 2.26 (s, 6H), 1.86 (s, 6H). 13C 
{1H} NMR (CDCl3, 125 MHz): 157.92, 134.05, 133.12, 133.03, 131.14, 128.58, 
119.20, 104.18, 56.07, 20.59, 16.67. 
 
2,6-Dimethoxy-2',3',5',6'-tetramethylbiphenyl (Table 4, Entry 3): 
The general Suzuki coupling procedure was followed, using anti-C 
(4.1 mg, 0.004 mmol). After 2 h at 65 °C, 104 mg (96% yield) of the 
product was isolated. The spectral data were identical with those in 
Table 4, Entry 2. 
 
2,6-Dimethoxy-2',3',5',6'-tetramethylbiphenyl (Table 4, Entry 4): 
The general Suzuki coupling procedure was followed, using anti-C 
(2.0 mg, 0.002 mmol) and 2 ml Toluene. After 3 h at 65 °C, 99 mg 
(92% yield) of the product was isolated. The spectral data were 
identical with those in Table 2, Entry 2. 
 
2,6-Dimethoxy-2',3',5',6'-tetramethylbiphenyl (Table 4, Entry 5): 
The general Suzuki coupling procedure was followed, using anti-C 
(0.82 mg, 0.0008 mmol) and 2 ml Toluene. After 12 h at 65 °C, 105 
mg (97% yield) of the product was isolated. The spectral data were 
identical with those in Table 4, Entry 2. 
 
1-(2´,6´-dimethylphenyl)-2,7-dimethylnaphthalene (Table 4, Entry 6): The 
general Suzuki coupling procedure was followed, using anti-C (8.2 
mg, 0.0080 mmol). After 15 h at room temperature, 96 mg (92% 
yield) of the product was isolated by flash chromatography (n-
Hexane) as a colorless oil. HRMS (EI): m/z : calcd for C20H20 [M]+: 
260.1565; found: 260.1567. 1H NMR (CDCl3, 400 MHz): 7.79-7.76 (m, 2H), 7.40 (d, 
J = 8.4 Hz, 1H), 7.32-7.26 (m, 4H), 7.00 (s, 1H), 2.38 (s, 3H), 2.12 (s, 3H), 1.88 (s, 
6H). 13C {1H} NMR (CDCl3, 100 MHz): 139.04, 136.98, 136.17, 135.96, 133.15, 
132.40. 130.78, 128.12, 128.02, 127.71, 127.39, 127.02, 124.10, 22.22, 20.21, 20.12. 
 
 
 
O
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2-Methyl-1-(2´,6´-dimethylphenyl)-naphthalene (Table 4, Entry 7): The general 
Suzuki coupling procedure was followed, using anti-C (8.2 mg, 
0.0080 mmol). After 12 h at room temperature, 84 mg (85% yield) of 
the product was isolated by flash chromatography (n-hexane) as a 
colorless oil. The spectral data were in accordance with those reported in the 
literature.18a 
 
2-methoxy-2'-methyl-1,1'-binaphthyl (Table 4, Entry 8): The general Suzuki 
coupling procedure was followed, using anti-C (4.1 mg, 0.0040 
mmol). After 16 h at room temperature, 113 mg (95% yield) of the 
product was isolated by flash chromatography (n-hexane:ether 20:1) 
as a white solid. The spectral data were in accordance with those 
reported in the literature.30 
 
2-Methoxy-1-(2´,3´,5´,6´-tetramethylphenyl)-naphthalene (Table 4, Entry 9): The 
general Suzuki coupling procedure was followed, using anti-C (8.2 
mg, 0.0080 mmol). After 10 h at room temperature, 106 mg (91% 
yield) of the product was isolated by flash chromatography (n-hexane: 
CH2Cl2 10:1) as a white solid. HRMS (EI): m/z : calcd for C21H22O 
[M]+: 290.1671; found: 290.1671. 1H NMR (CDCl3, 400 MHz): 7.91 (d, J = 9.0 Hz, 
1H), 7.86 (d, J = 9.0 Hz, 1H), 7.41 (d, J = 9.0 Hz, 1H), 7.37-7.28 (m, 2H), 7.16 (d, J = 
8.2 Hz, 1H), 7.09 (s, 1H), 3.86 (s, 3H), 2.33 (s, 6H), 1.78 (s, 6H). 13C {1H} NMR 
(CDCl3, 100 MHz): 153.85, 135.84, 133.56, 133.52, 133.35, 131.11, 129.37, 128.86, 
128.14, 126.58, 125.14, 124.94, 123.71, 113.85, 56.68, 20.54, 16.71. 
 
2,6,-Diethyl-2',6',-dimethylbiphenyl (Table 4, Entry 10): The general Suzuki 
coupling procedure was followed, using anti-C (8.2 mg, 0.0080 
mmol). After 18 h at room temperature, 64 mg (67% yield) of the 
product was isolated by flash chromatography (n-hexane) as a 
colorless oil. The spectral data were in accordance with those reported 
in the literature.18a 
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4-(2´,6´-dimethylphenyl)-3,5-dimethylisoxazole (Table 4, Entry 
11): The general Suzuki coupling procedure was followed, using anti-
C (8.2 mg, 0.0080 mmol). After 20 h at room temperature,  56 mg 
(70% yield) of the product was isolated by flash chromatography (n-hexane:EtOAc 
20:1) as a white solid. The spectral data were in accordance with those reported in the 
literature.16a 
 
4-mesityl-1,3,5-trimethyl-1H-pyrazoleThe (Table 4, Entry 12):  The general 
Suzuki coupling procedure was followed, using anti-C (8.2 mg, 
0.0080 mmol). After 20 h at room temperature, 80 mg (88% yield) 
of the product was isolated by flash chromatography (n-
hexane:EtOAc 3:2) as a colorless oil. The spectral data were in accordance with those 
reported in the literature.31 
 
2,2',4,6,6'-Pentamethylbiphenyl (Table 5, entry 1):  The general Suzuki coupling 
procedure was followed, using anti-C (8.2 mg, 0.0080 mmol). After 
8 h at room temperature, 70 mg (78% yield) of the product was 
isolated by flash chromatography (n-hexane) as a colorless oil. The 
spectral data were in accordance with those reported in the literature.18a 
 
2,6-Dimethoxy-2',6'-dimethylbiphenyl (Table 5, Entry 2): The general Suzuki 
coupling procedure was followed, using anti-C (4.1 mg, 0.0040 
mmol). After 8 h at 65 °C, 78 mg (80% yield) of the product was 
isolated by flash chromatography (n-hexane:ether 20/1 ) as a white 
solid. The spectral data were identical with those in Table 4, Entry 1. 
 
4-Methoxy-2,2',6,6'-tetramethyl-biphenyl (Table 5, entry 3): The general Suzuki 
coupling procedure was followed, using anti-C (8.2 mg, 0.0080 
mmol). After 2 h at 65 °C, 69 mg (72% yield) of the product was 
isolated by flash chromatography (n-hexane:EtOAc 30:1) as a 
colorless oil. The spectral data were in accordance with those reported in the 
literature.18a 
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9-(2´-methylnaphthalen-1-yl)anthracene (Table 5, entry 4): The 
general Suzuki coupling procedure was followed, using anti-C (8.2 
mg, 0.0080 mmol). After 20 h at room temperature, 117 mg (92% 
yield) of the product was isolated by flash chromatography (n-hexane) 
as a white solid. The spectral data were in accordance with those reported in the 
literature.19 
 
9-(2´,6´-Dimethylphenyl)anthracene (Table 5, entry 6) : The general Suzuki 
coupling procedure was followed, using anti-C (8.2 mg, 0.0080 
mmol). After 20 h at room temperature, 97 mg (86% yield) of the 
product was isolated by flash chromatography (n-hexane) as a white 
solid. The spectral data were in accordance with those reported in the 
literature.16a 
 
2-Methyl-1-(2´,6´-dimethylphenyl)-naphthalene (Table 5, Entry 7): The general 
Suzuki coupling procedure was followed, using anti-C (8.2 mg, 
0.0080 mmol). After 8 h at room temperature, 88 mg (89% yield) of 
the product was isolated by flash chromatography (n-hexane) as a 
colorless oil. The spectral data were identical with Table 4, Entry 7. 
 
2-Methyl-1-(2´,6´-dimethylphenyl)-naphthalene (Table 5, Entry 8): The general 
Suzuki coupling procedure was followed, using anti-C (2.0 mg, 0.002 
mmol) and 2 ml of Toluene. After 1.5 h 65 °C, 84 mg (85% yield) of 
the product was isolated by flash chromatography (n-hexane) as a 
colorless oil. The spectral data were identical with Table 4, Entry 7. 
 
2,2´-dimethyl-1,1´-binaphthalene (Table 5, Entry 9): The general 
Suzuki coupling procedure was followed, using anti-C (8.2 mg, 
0.0080 mmol). After 16 h at room temperature, 93 mg (82% yield) of 
the product was isolated by flash chromatography (n-hexane) as a 
colorless oil. The spectral data were in accordance with those reported in the 
literature.31 
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1-(2´,6´-dimethylphenyl)-2-methoxynaphthalene (Table 5, Entry 10): The general 
Suzuki coupling procedure was followed, using anti-C (4.1 mg, 
0.0040 mmol). After 10 h at room temperature,   95 mg (90% yield) 
of the product was isolated by flash chromatography (n-
hexane:EtOAc 30:1) as a white solid. The spectral data were in 
accordance with those reported in the literature.16a 
 
1-(2´,6´-dimethylphenyl)-2-methoxynaphthalene (Table 5, Entry 
11): The general Suzuki coupling procedure was followed, using anti-
C (4.1 mg, 0.0040 mmol). After 10 h at 65 °C, 96 mg (91% yield) of 
the product was isolated by flash chromatography (n-hexane:EtOAc 
30:1) as a white solid. The spectral data were indentical with Table 5, Entry 10. 
 
1-(2´,6´-dimethylphenyl)-2-methoxynaphthalene (Table 5, Entry 12): The general 
Suzuki coupling procedure was followed, using anti-C (2.0 mg, 
0.0020 mmol, from stock solution) and 2 ml of toluene. After 1.5 h at 
65 °C, 92 mg (88% yield) of the product was isolated by flash 
chromatography (n-hexane:EtOAc 30:1) as a white solid. The spectral 
data were indentical with Table 5, Entry 10. 
 
1-(2´,6´-dimethylphenyl)-2-methoxynaphthalene (Table 5, Entry 13): The general 
Suzuki coupling procedure was followed, using anti-C (0.8 mg, 
0.00080 mmol, from stock solution) and 2 ml of toluene. After 7 h at 
65 °C, 84 mg (80% yield) of the product was isolated by flash 
chromatography (n-hexane:EtOAc 30:1) as a white solid. The spectral 
data were indentical with Table 5, Entry 10. 
 
 
2-[3,5-Dimethyl-4-(2-methyl-naphathalen-1-yl)phenyl]-2-methyl-[1,3]dioxolane 
(Table 5, entry 14): The general Suzuki coupling procedure was 
followed, using anti-C (8.2 mg, 0.0080 mmol). After 20 h at 
room temperature, 104 mg (78% yield) of the product was 
O
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O
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isolated by flash chromatography (n-hexane:EtOAc  5:1) as a colorless oil. The 
spectral data were in accordance with those reported in the literature.18a 
 
2,2´,4´,6,6´-pentmethyl-4-(1-methylethenyl)biphenyl (Table 5, Entry 15): The 
general Suzuki coupling procedure was followed, using anti-C 
(8.2 mg, 0.0080 mmol). After 20 h at room temperature, 75 mg 
(71% yield) of the product was isolated by flash 
chromatography (n-hexane) as a colorless solid. HRMS (EI): m/z : calcd for C20H24 
[M]+: 264.1878; found: 264.1874. 1H NMR (CDCl3, 400 MHz): 7.22 (s, 2H), 6.93 (s, 
2H), 5.41 (s, 1H), 5.06 (s, 1H), 2.32 (s, 3H), 2.17 (s, 3H), 1.90 (s, 6H), 1.86 (s, 6H). 
13C {1H} NMR (CDCl3, 100 MHz): 143.22, 139.41, 139.25, 136.83, 136.17, 135.53, 
135.34, 128.23, 124.58, 111.53, 21.85, 21.12, 20.06, 19.79. 
 
2,2´,3´,5´ ,6,6´-hexamethyl-4-(1-methylethenyl)biphenyl (Table 
5, Entry 16): The general Suzuki coupling procedure was 
followed, using anti-C (8.2 mg, 0.0080 mmol). After 24 h at room 
temperature, 80 mg (72% yield) of the product was isolated by flash chromatography 
(n-hexane) as a white solid. HRMS (EI): m/z : calcd for C21H26 [M]+: 278.2035; 
found: 278.2034. 1H NMR (CDCl3, 400 MHz): 7.24 (s, 2H), 6.97 (s, 1H), 5.43 (s, 
1H), 5.07 (s, 1H), 2.26 (s, 6H), 2.19 (s, 3H), 1.88 (s, 6H), 1.78 (s, 6H). 13C {1H} NMR 
(CDCl3, 100 MHz): 143.52, 141.00, 140.04, 139.35, 135.89, 133.83, 131.46, 130.35, 
124.76, 111.74, 22.13, 20.48, 20.46, 16.21. 
 
2-Methyl-1-(2´,6´-dimethylphenyl)-naphthalene (Table 5, Entry 17): The general 
Suzuki coupling procedure was followed, using anti-C (8.2 mg, 0.0080 
mmol). After 12 h at room temperature, 90 mg (91% yield) of the 
product was isolated by flash chromatography (n-hexane) as a colorless 
oil. The spectral data were identical with Table 4, Entry 7. 
 
1-(2´,6´-dimethylphenyl)-naphthalene (Table 5, Entry 18): In the glovebox, a vial 
(4 mL screw-cap threaded) equipped with a stir-bar was  charged with 
2,6-dimethylphenylchloride (70 mg, 0.5 mmol), 1-naphthylboronic 
acid (95 mg, 0.55 mmol), potassium tert-butoxide (73 mg, 0.65 
mmol), then the Pd-complex anti-C (0.255 mg, 2.50 x 10-4 mmol, from the prepared 
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stock solution)  was added. Outside of the glovebox, 0.5 ml of technical grade 
isopropanol was added. The mixture was stirred at room temperature 15h before being 
quenched with water (2 ml). The mixture was extracted with MTBE (15 ml × 2) and 
the combined organic layers were dried with anhydrous MgSO4 , the solvent was 
removed in vacuo and the residue was purified by flash chromatography (n-hexane). 
93 mg (80% yield) of the product was isolated as a colorless oil. The spectral data 
were in accordance with those reported in the literature.32 
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Chapter 3 
 
Synthesis of 3-Allyl/Fluoro-3-Aryl Oxindoles via the Direct 
Enantioselective Catalytic α-Arylation of Amides 
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3.1 Abstract 
A new NHC•Pd-catalyzed asymmetric α-arylation of amides is reported giving 
direct access to synthetically valuable, 3-allyl/fluoro oxindoles with quaternary 
carbon centers. Based on the chiral regime of C2-symmetric starting diamines, the 
naphthyl-based chiral NHC ligands were readily prepared. When the 2-positions of 
the naphthyl side chains were substituted with 3-pentyl groups, three diastereomers 
were present in the corresponding salt. The palladium complex of one of the isomer 
(Ra,Ra) showed high chemo- and enantioselectivity for the synthesis of chiral 3-allyl 
oxindoles. When the 2-positions of the naphthyl side chains were substituted with 
cyclooctyl groups, only one diastereomer exsits in the corresponding salt. The 
enantiopure NHC ligand was then used to form precatalyst, which was tested in the 
asymmetric synthesis of 3-aryl-3-fluoro oxindoles. The biologically important 
oxindoles could be obtained with good yields (up to 94%) and excellent 
enantioselectivities (up to >99% ee). DFT calculations are offered to rationalize the 
excellent selectivity. 
 
3.2 Introduction 
As part of our ongoing research on employing chiral monodentate N-heterocyclic 
carbene (NHC) ligands for metal-catalyzed asymmetric catalysis, we reported the 
synthesis of diastereomerically pure palladium complexes incorporating new chiral 
NHC ligands and their successful application in the Pd-catalyzed intramolecular α-
arylation of amides to obtain enantiomerically enriched 3-aryl-3-methyl oxindoles.1 
While elegant as a methodology to obtain chiral quaternary carbon centers, the 
intramolecular α-arylation at present has the drawback of providing oxindoles that are 
difficult to functionalize further. We therefore wondered whether 3-allyl-3-aryl 
oxindoles, previously only accessible via a two-step procedure involving a Pd-
catalyzed intramolecular α-arylation followed by an asymmetric Pd-catalyzed allylic 
alkylation,2 could be obtained directly. Herein we report the successful achievement 
of this strategy by using a newly designed NHC ligand. 
Monodentate N-heterocyclic carbene (NHC) ligands have become ubiquitous in 
organometallic chemistry and catalysis.3 Conversely, development of chiral 
monodentate NHC ligands that induce high selectivity in asymmetric metal catalysis 
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is still at an early stage with relatively few reports detailing enantioselectivities of 
90% ee and higher.4-8 The main difficulties in designing efficient ligands of this type 
reside in placing stereocontrol elements at positions near the metal center without 
affecting the overall reactivity of the catalysts. Scheme 1 shows some of the most 
promising ligand designs to date and highlights the fact that the inherent flexibility of 
the N-substituents has to be restricted to afford ligands that efficiently transfer their 
chiral information. This can be done by fusing these wingtips onto the N-heterocycle, 
a design motif pioneered by Glorius et al.,4 and more recently developed further by 
Murakami et al.5 Decreasing the rotation of the N-substituents is also key in the 
successful C2-symmetric ligand design reported by Kündig et al.,6 who have been able 
to show that such ligands can be used very effectively in palladium chemistry. 
Probably the most versatile ligand system developed so far was first reported by 
Grubbs et al.,7,8 and relies on transferring chirality from a chiral N-heterocyclic 
backbone onto unsymmetrically substituted aryl side chains and ultimately onto the 
metal coordination sphere. While the design permits easy access to the precursor 
imidazolinium salts, such side chains will in principle create three diastereomers that 
would have to be separated for optimal use in catalysis. Our own efforts,9 have indeed 
highlighted the pivotal role the respective orientation of naphthyl wingtips can have 
on enantioselectivity and, contrary to what other groups have proposed or found, the 
best ligands with 2-alkyl-substituted naphthyl side chains position their alkyl 
substituents directly below the corresponding phenyl group of the backbone [(Ra,Ra)-
isomer]. Herein we report the successful access to this diastereomer using a newly 
designed NHC ligand which showed excellent selectivities for synthesis of chiral 3-
fluoro-3-aryl oxindoles.  
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Scheme 1. Examples of chiral, monodentate NHC ligands 
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3.3 Results and Discussion 
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Scheme 2. Palladium complexes used as the catalysts 
 
Our investigation commenced by examining the ability of NHC•Pd complexes 1a-
c (Scheme 2), previously developed in our laboratories,1 to promote the 
intramolecular α-arylation of the model substrate 2a (Table 1). At the outset of the 
study and under the reaction conditions used, it was not clear whether such α-
arylations would be preferred over a reaction scenario involving Heck cyclizations 
giving rise to 7-exo-trig (or 8-endo-trig) products. The catalytic results reported in 
Table 1 indeed indicate that Heck cyclization is competitive and product 4a was 
formed in noticeable amounts (15-20%) with all diastereomers of precatalysts 1a-c. 
Trends in enantioselectivity though were immediately apparent. Somewhat surprising 
was the fact that the diastereomers of catalyst 1a, which performed best in our 
previous investigation, gave erratic results with inconsistent absolute configurations 
of product 3a. In fact, omitting the R2-isopropyl group on the naphthyl wingtips of the 
NHC (precatalysts 2b) gave more usable results (entries 4, 5). Furthermore, 
precatalyst 1c that incorporates a slightly bulkier R2-cyclohexyl group resulted in 
better enantioselection (entries 6, 7).  
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Table 1. Initial screening of Pd-complexes 1a-c 
 
Br
N
O
Ph
1 (5 mol %)
1.5 eq. NaOtBu
DME, 16h
N
O
Ph
N
O
Ph+
2a 3a 4a  
 
Entry NHC•Pd T (°C) Conv [%][a] 3a/4a[b] ee [%][c,d] 
1 (Ra,Ra)-1a 23 >99 5:1 -24 (S) 
2 (Ra,Sa)-1a 23 >99 4:1  56 (R) 
3 (Sa,Sa)-1a 23 >99 5:1  34 (R) 
4 (Ra,Ra)-1b 50 >99 4:1  39 (R) 
5 (Ra,Sa)-1b 50 >99 4:1  58 (R) 
6 (Ra,Ra)-1c 50 >99 6:1  46 (R) 
7 (Ra,Sa)-1c 50 >99 4:1  66 (R) 
8 (Ra,Ra)-1d 23 >99 1:0  81 (R) 
9 (Ra,Sa)-1d 23 >99 16:1  81 (R) 
10 (Sa,Sa)-1d 23 >99 1:0  52 (R) 
[a] Determined by GC-MS. [b] Determined by analysis of 1H NMR spectra of 
product mixtures prior to purification. [c] Determined by chiral HPLC for 3a. [d] 
The absolute configuration of 3a was assigned according to ref 10. 
The tendencies in selectivity observed in Table 1 were subsequently implemented 
in the design of a modified chiral NHC structure that lacks the R2 wingtip group and 
incorporates a bulkier, unstrained 3-pentyl moiety on the 2-position of the naphthyl 
side chains. We were hoping that the bulkier group would help transfer the chiral 
information more effectively from the NHC backbone to the side chains, and hence 
induce higher enantioselectivity. Thus, three separable diastereomers [(Ra,Ra)-1d, 
(Ra,Sa)-1d and (Sa,Sa-1d)] were prepared relatively easily. These new catalysts were 
subjected to our standard substrate 2a (Table 2, entries 8-10). The results were very 
encouraging and all three diastereomeric precatalysts 1d proved superior to their 
congeners 1a-c both in terms of their higher reactivity (room temperature) and their 
enhanced selectivity. As an unexpected and very welcome side effect, incorporation 
of the new NHC ligand also greatly enhanced the chemoselectivity of the 
transformation with generation of only trace amounts (if any) of Heck byproduct 4a. 
As a consequence, treatment of 2a in the presence of 5 mol % RaRa-1d gave rise to 
oxindole 3a in 96% isolated yield and 81% ee. Because catalyst RaRa-1d showed the 
best result in terms of chemoselectivity and enantioselectivity, we examined this 
complex with other substrates (Scheme 3). Thus, an important number of different 
amides were synthesized and subjected to the standard reaction conditions [5 mol % 
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(Ra,Ra)-1d, 1.5 eq. NaOtBu, DME, 23°C, 16h]. Results in Scheme 3 show that broad 
structural variations in the amide system can be accommodated. In nearly all cases, 
excellent yields, virtually complete chemoselectivities and good-to-excellent 
enantioselectivities were obtained. For example, ortho-substituted aromatic groups 
are tolerated, and the sterically demanding products were obtained with selectivities 
of up to 91 % ee (3f). The method is compatible with both electron-rich and electron-
poor aromatic groups, and ortho-, meta-, as well as para-positions could be varied. 
We also examined two substrates containing a 5-methoxy group, a motif commonly 
found in bioactive oxindole-based compounds, with equally satisfying results (3q, 
3r). Furthermore, the remarkable reactivity of catalyst (Ra,Ra)-1d allows the reaction 
with less reactive aryl chlorides to proceed at room temperature with high yield and 
ee (3f).10 Limitations became only apparent when the sterically highly congested 
substrate 2s was tested. Here, a complete loss of enantioselectivity was accompanied 
with lower than normal reactivity. Nevertheless, the simple fact that catalyst RaSa-1d 
could promote such a difficult C–C coupling at room temperature is noteworthy. 
Substrate 2t containing a heteroaromatic N-Me-3-indolyl moiety also undergoes 
smooth cyclization to give oxindole 3t (94% yield, 86% ee). Contrary to what has 
been described,11 the possible indolo-benzazepine byproduct arising from competitive 
Heck cyclization of the indolyl group was not observed. The framework of 3t is of 
particular synthetic interest as it is widely found in natural products, and a range of 
total syntheses have been carried out based on this type of core structure.12 We found 
that the selectivities of substrates which contain meta-substituted aromatic moieties 
could be further enhanced when (Ra,Sa)-1d was used as the precatalyst (3c, 3h-3j).  
To exemplify the generality of the present protocol and highlight catalyst 1d’s 
excellent performance, substrate 2u with two alkyl substituents at the α-position of 
the carbonyl moiety was also tested. The reaction with this more challenging substrate 
once again proceeded smoothly at ambient temperature to give oxindole 3u with 
acceptable levels of enantioselectivity and excellent chemoselectivity (>20:1). To our 
knowledge, this is the first successful example of preparing enantiomerically enriched 
3,3'-dialkyl oxindoles via a Pd-catalyzed α-arylation protocol.13 Indeed, 3u is a key 
intermediate for the synthesis (-)-physostigmine.14 
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Scheme 3. Scope of asymmetric synthesis of oxindoles with (Ra,Ra)-1d. a (Ra,Sa)-1d was used as the 
catalyst. b chloride used as the substrate. 
 
Encouraged by these results, we became interested in ways of exclusively 
accessing the particularly useful diastereomer (Ra,Ra), as it would undoubtedly allow 
a more straightforward synthesis and use of these ligands. After testing several 
substitution patterns, we were pleased to find that placing a relatively rigid cyclooctyl 
group at the 2-position of the naphthyl moieties and ring closing the corresponding 
chiral diamine A at 120 °C for 2 hours (Scheme 4) generated virtually pure NHC salt 
(Ra,Ra)-B. The salt showed one set of signals and a diagnostic single peak for the C2 
proton of the imidazolinium ring in the 1H NMR spectrum. 
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Scheme 4. Synthesis of the Chiral NHC Complex 
 
This salt was then used to synthesize the palladium cinnamyl complex (Ra,Ra)-C 
in high yield, the structure of which was unambiguously confirmed by single-crystal 
X-ray crystallography. Qualitative assessment of the structure shows both the relative 
bulk and the C2-symmetry of the ligand. The overall steric demand of the ligand was 
then quantified via its buried volume %VBur, a parameter describing the amount of 
volume in the first coordination sphere of a metal occupied by a given ligand and its 
topographic steric map.15,16 To understand how the C2-symmetry of the ligand affects 
the environment around the metal, we evaluated the %VBur in the four single 
quadrants of (Ra,Ra)-C and plotted the steric contour map highlighting zones of 
different steric pressures as shown in Figure 1.16,17 This analysis was performed on 
the geometry of the (Ra,Ra)-C obtained from its crystal structure without further 
modifications. This analysis shows that the two quadrants where the 2-cyclooctyl 
groups are located are heavily hindered (bottom left and top right quadrants, %VBur 
~46%), while the other two quadrants are clearly more open (bottom right and top left 
quadrants, %VBur ~35%). The map therefore demonstrates that the NHC ligand wraps 
around the metal center with almost perfect C2-symmetry, a result that boded well for 
its application as an effective ancillary ligand in asymmetric transformations. 
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Figure 1. Steric contour maps of the NHC ligand in (Ra,Ra)-C. The complex is oriented as shown in 
the sketch. The number close to each quadrant is the %Vur of this quadrant. 
 
In earlier work, we had shown that relatives of (Ra,Ra)-C can be used as 
precatalysts in the α-arylation of amides to give enantioenriched oxindoles with 
quaternary carbon centers.1 In this context, an attractive transformation involving 
such an α-arylation reaction would see the introduction of a fluorine atom onto the 
oxindole moiety, effectively resulting in the direct formation of enantioenriched 3-
fluoro-3-aryl oxindoles. Owing to the often attractive properties of such fluorinated 
compounds for pharmaceutical applications,18 incorporation of fluorine into organic 
molecules via enantioselective catalytic processes has been extensively investigated in 
the past decade. Up to now, such products are typically obtained via direct catalytic 
enantioselective fluorinations employing an electrophilic source of fluorine,19 and no 
attempts at using enantioselective a-arylation reactions to gain access to these 
compounds have been documented (Scheme 5).20 
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Scheme 5. Catalytic enantioselective synthesis of 3-fluoro-3-aryl oxindoles 
 
We began our study by screening the protecting group at the N-substituent. The 
results in Table 2 reveal that when toluene was used as the solvent and NaOtBu as the 
base, methyl protected starting product gave good yield (83%) and excellent 
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enantioselectivity (97% ee, entry 1). Using benzyl moiety retained the reactivity while 
decreasing the selectivity (entry 2). Tert-butoxycarbonyl (Boc) or 2-
methoxyethoxymethyl (MEM) protected starting product did not show any reactivity 
(entries 3,4). The solvent study showed that toluene and benzene gave the best result 
in terms of yield and ee (entries 1, 6) while dioxane gave poor yield (entry 5) and 
tBuOH did not gave any product (entry 7). We also found out that it was crucial not to 
use excess of the base (NaOtBu) to get high yield of the prodcut, as the substrate 
would otherwise decompose. 
 
Table 2. Screening of protecting group and solvent 
 
Br
N
PG F
O (Ra,Ra)-C (5 mol%)
1.1 eq. NaOtBu
RT, 16 h
Solvent (0.10 M)
N
!
O
PG
F
Entry PG Yield(%)a ee(%)b
1
2
3
4
Me
Bn
MEM
Boc
0
0
----
----
67
9783
88
Solvent
Toluene
Toluene
Toluene
Toluene
5 Me Dioxane 35 88
6 Me Benzene 82 95
7 Me tBuOH 0 -----
 
                                                        a Isolated yields; b Determined by chiral HPLC 
 
Under optimized reaction conditions, different substrates were tested in the 
asymmetric α-arylation. As evidenced from data collected in Table 3, a variety of 
substrates are tolerated in this reaction. For instance, the introduction of electron-
donating and electron-withdrawing groups (methoxy, methyl, phenyl, chloro, fluoro 
and trifluoromethyl) on the ortho-, meta-, or  para-positions  of   the  3-phenyl  
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Table 3. Substrate Scope for the NHC-Pd Catalyzed α-Arylation.[a] 
 
 
Br
N
F
O
(Ra,Ra)-C (5 mol%)
1.1 eq. NaOtBu
Temperature, 16 h
Toluene (0.10 M)
N
!
O
R
F
R
R'
R'
5 6
Entry Substr. R[b] Prod. Yield (%) ee (%)
1 5a H H 6a
T (°C)
RT 83 97
2 5b 5-Me 2-F RT 6b 62 >99
3 5c 5-Me 4-Me RT 6c 70 99
4 5d 5-MeO 1-Nap 50 6d 58 94
5 5e 5-MeO H RT 6e 82 99
6[c] 5e 5-MeO H RT 6e 89 91
7 5f 5-MeO 2-F 50 6f 82 99
8 5g 5-MeO 2-CF3 50 6g 85 98
9 5h 5-F H RT 6h 70 96
10 5i 5-F 2-F RT 6i 76 >99
11 5j 6-CF3 H RT 6j 81 94
12 5k 6-Me 2-Cl 60 6k 86 82
13 5l H 2-Me RT 6l 59 96
14 5m H 2-F RT 6m 65 >99
15[c] 5m H 2-F RT 6m 94 95
16 5n H 3-MeO RT 6n 50 95
17 5o H 3-F RT 6o 80 96
18 5p H 4-Ph RT 6p 61 94
R'
[a] Conditions: 5 (0.20 mmol, 1.0 equiv), (Ra,Ra)-C (5.0 mol%), NaOtBu (1.1 
equiv), toluene (2.0 ml), RT or 50 °C, 16 h. We assume that all substrates follow 
the same reaction pathway to get the same relative configuration; [b] Numbering 
based on the oxindole product. [c] DME as solvent.  
 
groups lead to excellent enantioselectivities and good yields within 16h at room 
temperature or 50 °C. Selected examples with substituents at the 5- and 6- position of 
the oxindole core lead to equally satisfying results. When DME is used as a solvent 
(entries 6, 15), reactivity increases while the selectivity is slightly lower. In several 
cases, virtually enantiopure products were obtained (6b, 6f, 6i and 6m), a rather 
unique result when employing chiral, monodentate NHC ligands.21 
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The absolute stereochemistry of the products was deduced from an X-ray 
crystallographic analysis of compound 6o, the stereogenic carbon center of which had 
the S-configuration. 
 
 
 
Figure 2. Optimized structure of the key intermediate before reductive elimination. The intermediates 
leading to the major S and minor R products are shown in parts a and b, respectively. C atoms of the 
NHC are colored in grey, C and H atoms of the substrate are colored in green. 
 
To further support the assigned stereochemistry of the products and to gain first 
insights into the reaction mechanism, we performed a DFT study of the key 
intermediates in the case of the prototype substrate 5a, corresponding to the expected 
compounds before final reductive elimination and release of product 6a. The 
optimized geometries are reported in Figure 2. Structural analysis indicates that in the 
most stable intermediate of Figure 2a, leading to the experimentally favored S 
enantiomer, the aromatic ring that will form the skeleton of the oxindole product, and 
the Ph substituent on the final chiral C atom of the product are placed below the 
naphthyl ring, which is in the less buried quadrants highlighted by the steric map of 
Figure 1. By contrast, in the key intermediate of Figure 2b, leading to the 
experimentally less favored R enantiomer, the Ph substituent on the final chiral C 
atom of the product is placed below the cyclooctyl ring, which is in a buried quadrant 
highlighted by the steric contour map of Figure 1. According to calculations, the 
intermediate of Figure 2a is favored by 4.4 kcal/mol in toluene, a value correctly 
reflecting the high enantioselectivity observed. 
 
3.4 Conclusion 
 
In conclusion, we have developed a new catalytic method for the enantioselective 
construction of carbon-fluorine bonds that relies on an asymmetric α-arylation 
protocol and have demonstrated its efficacy for the direct synthesis of 3-fluoro-3-aryl 
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oxindoles. These target molecules were obtained in good yields and with excellent 
enantioselectivities when employing a new NHC ligand with a chiral N-heterocycle 
and naphthyl side chains that is easily accessed in virtually enantiopure form as a 
single diastereomer. Detailed mechanistic studies are in progress to shed light on the 
whole reaction pathway connecting reactants and products. Ongoing research aims to 
broaden the scope of this promising new way of enantioselective incorporation of 
fluorine into organic molecules and to test ligand (Ra,Ra)-B in other transformations. 
 
3.5 Experimental Part 
 General: All reactions were carried out using standard Schlenk or glovebox 
(Mecaplex or Innovative Technology) techniques under nitrogen. KOtBu was used 
after sublimation. 1-Bromo-2-cyclooctyl was prepared according to our previous 
report.9e α-Fluoro-α-arylcarboxylic acids were prepare according to reported 
procedure.22 All other reagents were used as received unless otherwise noted. 
Solvents were purchased in the best quality available, degassed by purging thoroughly 
with nitrogen and dried over molecular sieves of appropriate size. Alternatively, they 
were purged with argon and passed through alumina columns in a solvent purification 
system (Innovative Technology). Solvents for NMR spectroscopy were degassed with 
nitrogen and dried over molecular sieves. NMR spectra were collected on AV2 400 or 
AV2 500 MHz Bruker spectrometers. Chemical shifts are given in ppm. The spectra 
were calibrated to the residual 1H and 13C of the solvent. Multiplicities are 
abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), doublet-doublet 
(dd), quintet (quint), septet (sept), multiplet (m), and broad (br).  High-resolution 
electrospray ionization mass spectrometry was performed on a FinniganMAT 900 
(Finnigan MAT95, San Jose, CA; USA) double-focusing magnetic sector mass 
spectrometer (geometry BE). GC analysis was done on a ThermoQuest 
TraceGC2000. GC-MS analysis was done on a Finnigan Voyager GC8000 Top. X-ray 
crystallography was made on an Agilent Technologies SuperNova area-detector 
diffractometer using Mo Kα radiation (λ = 0.71073 Å) from a micro-focus X-ray 
source and an Oxford Instruments Cryojet XL cooler. 
 
 
61 
1S,2S-N,N'-Bis(2-cyclooctylnaphthalen-1-yl)-1,2-
diphenylethane-1,2-diamine. A 250 mL schlenk flask was 
charged with Pd(dba)2 (862 mg, 1.50 mmol), (±)-BINAP 1.12 
g, 1.80 mmol), NaOtBu (5.76 g, 60.0 mmol) and toluene (160 
mL) and stirred for 5 min. 1-Bromo-2-cyclooctylnaphthalene 
(9.50 g, 30.0 mmol) and (1S,2S)-(-)-1,2-diphenylethylenediamine (3.10 g, 15.0 mmol) 
were then added and the solution was heated to 120 °C for 60 h. After cooling to 
room temperature, the resulting mixture was filtered through a celite and siliga filter 
and washed with CH2Cl2. The filtrate was concentrated and the residue was purified 
by flash chromatography (SiO2, 1:3 CH2Cl2/n-hexane) to afford 1S,2S-N,N′- bis(2-
cyclooctylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine as a white solid (4.50 g, 
44%). 1H NMR (CDCl3, 400 MHz): δ = 8.64 (d, J = 8.3, 2H), 7.74 (d, J = 8.2, 2H), 
7.50 (d, J = 8.6, 2H), 7.42-7.35 (m, 4H), 7.24 (d, J = 8.6 Hz, 2H), 6.96-6.90 (m, 10H), 
5.10 (s, 2H), 4.87 (s, 2H), 3.08 (br, 2H), 1.84-0.97 (m, 28H). 13C {1H} NMR (CDCl3, 
100 MHz):  140.94, 140.46, 138.20, 133.38, 130.14, 128.68, 128.49, 128.26, 127.28, 
125.62, 125.37, 124.95, 124.69, 124.35, 68.80, 38.70, 35.39, 34.19, 27.32, 27.04, 
27.01, 26.38, 26.15. HRMS (ESI): m/z : calcd for C50H57N 2[M+1]+: 685.45163; 
found: 685.45156. 
 
 
4S,5S-1,3-Bis(2-cyclooctylnaphthalen-1-yl)-4,5-diphenyl-
4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate ((2)-
DiPhSICyoctNap·HBF4). 1S,2S-N,N'-Bis(2-
cyclooctylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine 
(4.20 g, 6.13 mmol), ammonium tetrafluoroborate (1.29 g, 
12.3 mmol), triethyl orthoformate (20 ml) and formic acid (0.2 
ml) were heated to 120 °C and stirred for 2 h. The resulting suspension was filtered, 
and the residue was washed with ether (50 ml) to get a white powder (3.46 g, 72%). 
[α]25D = -198.8 (c = 0.65, CH2Cl2). 1H NMR (DMSO-d6, 400 MHz): δ = 9.92 (s, 1H), 
8.18-8.06 (m, 6H), 7.90 (t, J = 7.5 Hz, 2H), 7.75 (t, J = 7.5 Hz, 2H),  7.57 (d, J = 7.2 
Hz, 4H), 7.46 (d, J = 8.7 Hz, 2H), 7.34-7.28 (m, 6H), 7.03 (s, 2H), 2.97 (br, 2H), 
1.75-1.59 (m, 26H), 0.47 (br, 2H). 13C {1H} NMR (DMSO-d6, 125 MHz):  160.71, 
147.96, 132.70, 131. 99, 130.89, 130.18, 129.82, 129.59, 129.49, 129.26, 129.20, 
127.26, 125.59, 124.29, 122.32, 71.97, 41.04, 34.78, 32.46, 27.32, 26.53, 26.30, 
NH HN
Ph Ph
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25.61, 25.18. 19F NMR (DMSO-d6, 376 MHz): 148.33. HRMS (ESI): m/z : calcd for 
C51H55N2 [M-BF4]+: 695.4360; found: 695.4356. 
 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis(2-cycoctyl-naphthalen-1-
yl)-4,5-dihydro-4,5-diphenyl imidazol-2-ylidene] 
palladium(II) [((2)-DiPhSICyoctNap)Pd(cin)Cl]. (2)-
DiPhSICyoctNap·HBF4 (400 mg, 0.51 mmol), KOtBu (57 
mg, 0.51 mmol) and [Pd(cinnamyl)Cl]2 (132 mg, 0.26 
mmol) were mixed together in a round flask in the glovebox. 
Dry THF (45 mL) was added and the mixture was stirred at 
room temperature for 16 h. The solvent was removed in vacuo, and the residue was 
separated by flash chromatography on siliga gel (n-hexane:ether 2:1→1:1) to afford 
the title product as a yellow solid (390 mg, 80%). Elemental analysis: calcd for 
C60H63ClN2Pd : C, 75.54; H, 6.66; N, 2.94. Found: C, 75.29; H, 6.50; N, 2.90. 1H 
NMR (CDCl3, 400 MHz): δ = 8.44 (br, 2H), 7.83-7.71 (m, 6H), 7.52 (s, 2H), 7.26-
6.98 (m, 17H), 6.04 (s, 2H), 4.97 (br, 0.6H), 4.43-4.17 (m, 1H), 3.24 (br, 1.9H), 2.47-
2.11 (m, 2.5H), 1.67-1.27 (m, 25H), 0.34-0.13 (m, 3H). 13C {1H} NMR (CDCl3, 125 
MHz): 193.82, 192.47, 191.13, 180.58, 152.89, 147.78, 147.64, 142.58, 140.23, 
137.72, 137.28, 134.51, 134.33, 134.17, 134.02, 133.04, 132.89, 132.79, 132.73, 
132.70, 132.39, 131.33, 130.76, 130.29, 129.80, 129.29, 129.21, 129.15, 129.12, 
129.03, 129.00, 128.93, 128.88, 128.85, 128.79, 128.75, 128.74, 128.66, 128.63, 
128.60, 128.58, 128.54, 128.48, 128.22, 127.80, 127.28, 127.22, 126.34, 126.07, 
125.82, 125.63, 125.44, 125.34, 125.23, 125.01, 124.52, 115.18, 75.40, 73.91, 72.92, 
41.98, 41.64, 41.28, 34.80, 34.58, 32.36, 31.61, 28.86, 28.44, 28.14, 27.96, 27.55, 
26.69, 26.36, 26.27, 25.63, 25.25, 23.64, 23.06. HRMS (ESI): m/z : calcd for 
C60H63N2Pd [M-Cl]+: 917.4041; found: 917.4051. 
 
N-(2-Bromophenyl)-N-(tert-butoxycarbonyl)-2-fluoro-2-phenylacetamide. The 
mixture of amide (see bellow for synthesis of amide, 200 mg, 
0.65 mmol), di-tert-butyl dicarbonate (176 mg, 0.81 mmol) and 
4-dimethylaminopyridine (8.0 mg, 0.65 mmol) was stirred in 10 
ml of CH2Cl2 for 20 h. Then the solved was removed under vacuum and the residue 
was purified by flash chromatography (Hexane/EtOAc) to afford the title as colorless 
oil. 1H NMR (CDCl3, 400 MHz): δ = 7.62-7.53 (m, 3H), 7.43-7.26 (m, 4H), 7.21-7.17 
N N
Ph Ph
Pd
Cl
Br
N
O
FBoc
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(m, 1.5H), 7.11 (d, J = 10.6 Hz, 0.5H), 6.98 (d, J = 10.6 Hz, 0.5H), 6.86 (dd, J = 7.8, 
1.6 Hz, 0.5H), 1.27 (s, 4.5H), 1.25 (s, 4.5H). 13C {1H} NMR (CDCl3, 100 MHz):  
170.70, 170.44, 170.31, 170.05, 150.93, 150.88, 137.19, 136.71, 134.55, 134.04, 
133.84, 133.10, 133.04, 130.32, 129.85, 129.81, 129.78, 129.66, 129.63, 129.39, 
129.05, 129.00, 128.73, 128.71, 128.61, 128.57, 128.32, 128.30, 128.14, 123.21, 
122.79, 91.35, 89.56, 84.27, 84.24, 27.53, 27.50. HRMS (ESI): m/z : calcd for 
C19H19BrFNNaO3 [M+Na]+: 430.04246; found: 430.04268. 
 
Synthesis of the benzyl, 2-methoxyethoxymethyl and methyl protected substrates 
 
F
COOH
Br
NH2
R1 R2
DCC (1.2 eq)
DMAP (0.2 eq)
DCM
Br
N
H
O
F
R2 R1
Br
N
O
F
R2 R1
PG
NaH
MeI (BnBr or MEMCl)
 
 
α-Fluoro-α-arylcarboxylic acid (2.0 mmol) , aniline (2.0 mmol) and DMAP (4-
dimethylaminopyridine, 0.40 mmol) were dissolved in 10 ml of CH2Cl2. Upon 
cooling to 0 °C, DCC (N,N'-Dicyclohexylcarbodiimide, 2.4 mmol) in 10 ml CH2Cl2 
was added in 5 min. The mixture was gradually warmed to RT and then leave 
overnight. The suspension was filtered and the filtrate was dried and then purified by 
flash chromatography (EtOAc/Hexane) to get the unprotected amide.  
    To a solution of the corresponding amide (1.0 mmol, 1.0 eq) in 10 ml of THF, 1.1 
eq. NaH (60% in mineral oil) was added in small portions at 0 °C, and the resulting 
mixture was stirred for 30 min. Subsequently, 1.1 eq. MeI (or BnBr, or MEMCl) in 
THF was added dropwise at 0 °C, and the resulting mixture was stirred overnight at 
RT. The reaction mixture was then filtered through a pad of silica/celite, washed with 
CH2Cl2, and dried in vacuo. The residue was then purified by flash chromatography 
(EtOAc/Hexane) to afford the corresponding substrate.  
 
N-(2-Bromophenyl)-N-benzyl-2-fluoro-2-phenylacetamide. 1H NMR (CDCl3, 
400 MHz): δ = 7.67 (d, J = 8.0 Hz, 0.6H), 7.53-7.51 (m, 0.4H), 
7.32-7.05 (m, 11.4H), 6.87 (t, J = 7.7 Hz, 0.6H), 6.80-6.77 (m, 
0.4H), 6.04 (d, J = 7.8 Hz, 0.6H), 5.74-5.35 (m, 2H), 4.12 (d, J = 
14.3 Hz, 0.6H), 3.94 (d, J = 14.2 Hz, 0.4H). 13C {1H} NMR (CDCl3, 100 MHz):  
168.42, 168.16, 167.94, 167.68, 138.84, 138.81, 136.64, 136.56, 134.77, 134.57, 
Br
N
O
F
Ph
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134.50, 134.22, 134.11, 133.91, 132.60, 130.82, 130.77, 130.29, 130.26, 130.13, 
130.10, 130.06, 129.79, 129.09, 129.08, 128.95, 128.91, 128.68, 128.64, 128.40, 
128.36, 128.32, 128.22, 125.20, 124.50, 90.78, 90.32, 88.99, 88.54, 52.70, 52.19. 
HRMS (ESI): m/z : calcd for C21H17BrFNNaO [M+Na]+: 420.03698; found: 
420.03663. 
 
N-(2-Bromophenyl)-N-methoxyethoxymethyl-2-fluoro-2-phenylacetamide. 1H 
NMR (CDCl3, 400 MHz): δ = 7.65 (dd, J = 8.1, 1.2Hz, 0.6H), 
7.46-6.98 (m, 7.8H), 6.56 (dd, J = 7.8, 1.4 Hz, 0.6H), 5.74-5.36 
(m, 2H), 4.59 (d, J = 10.7 Hz, 0.6H), 4.49 (d, J = 10.7 Hz, 0.4H), 
3.88-3.66 (m, 2H), 3.52-3.38 (m, 2H), 3.31 (s, 1.2 H), 3.24 (s, 1.8H). 13C {1H} NMR 
(CDCl3, 125 MHz):  169.25, 169.04, 168.83, 168.63, 137.74, 137.62, 133.95, 133.92, 
133.79, 133.65, 133.11, 133.02, 132.95, 132.40, 130.78, 130.67, 130.11, 130.09, 
129.93, 129.90, 128.80, 128.79, 128.76, 128.63, 128.62, 128.53, 128.27, 128.24, 
128.12, 128.08, 124.62, 123.74, 90.22, 89.61, 88.78, 88.18, 77.85, 77.84, 77.56, 
71.75, 71.63, 69.08, 68.84, 59.12, 59.01. HRMS (ESI): m/z : calcd for 
C18H19BrFNNaO3 [M+Na]+: 418.04246; found: 418.04269. 
 
N-(2-Bromophenyl)-N-methyl-2-fluoro-2-phenylacetamide (5a). 1H NMR 
(CDCl3, 500 MHz): δ = 7.69 (dd, J = 8.0, 1.3 Hz, 0.6H), 7.52 (dd, 
J = 8.1, 1.3 Hz, 0.4H), 7.42-7.04 (m, 7.4H), 6.59 (dd, J = 7.8, 1.6 
Hz, 0.6H), 5.66 (d, J = 47.2 Hz, 0.4H), 5.41 (d, J = 47.2 Hz, 
0.6H), 3.22 (s, 1.2H), 3.20 (s, 1.8H). 13C {1H} NMR (CDCl3, 100MHz): 167.66, 
140.36, 134.17, 134.09, 133.84, 133.55, 131.29, 130.31, 130.18, 129.75, 129.72, 
129.54, 129.51, 128.84, 128.60, 128.59, 128.57, 128.44, 128.43, 128.11, 128.06, 
127.75, 127.69, 124.34, 123.47, 90.12, 89.69, 88.33, 87.90, 36.51, 36.50, 36.49. 
HRMS (ESI): m/z : calcd for C15H13BrFNNaO [M+Na]+: 344.00568; found: 
344.00577. 
 
N-(2-Bromo-4-methylphenyl)-N-methyl-2-fluoro-2-(2-fluorophenyl)acetamide 
(5b). 1H NMR (CDCl3, 400 MHz): δ = 7.55-7.50 (m, 1.6H), 
7.34-7.28 (m, 1.8 H), 7.26-7.23 (m, 0.4H), 7.16-7.10 (m, 1H), 
6.92-6.86 (m, 1.6H), 6.46 (d, J = 8.0 Hz, 0.6H), 6.03 (d, J = 
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47.1 Hz, 0.4H), 6.03 (d, J = 47.1 Hz, 0.6H), 3.22 (s, 1.2H), 3.20 (s, 1.8H), 2.38 (s, 1.2 
H), 2.36 (s, 1.8H). 13C {1H} NMR (CDCl3, 125 MHz):  167.55, 167.34, 161.22, 
159.23, 141.05, 141.04, 127.34, 137.03, 134.31, 131.80, 131.77, 131.73, 131.70, 
131.60, 131.57, 131.53, 131.51, 130.05, 129.99, 129.97, 129.96, 129.94, 129.79, 
129.59, 129.46, 129.44, 129.42, 124.61, 124.59, 124.58, 124.56, 124.46, 124.45, 
124.44, 124.42, 123.22, 122.80, 122.10, 121.99, 121.93, 121.82, 115.44, 115.43, 
115.32, 115.31, 115.27, 115.26, 115.15, 115.14, 82.66, 82.62, 82.31, 82.27, 81.24, 
81.21, 80.90, 80.86, 36.56, 36.55, 36.54, 36.53, 20.84, 20.83. HRMS (ESI): m/z : 
calcd for C16H14BrF2NNaO [M+Na]+: 376.0119; found: 376.0115. 
 
N-(2-Bromo-5-methylphenyl)-N-methyl-2-fluoro-2-(4-methylphenyl)acetamide 
(5c). 1H NMR (CDCl3, 400 MHz): δ = 7.49 (s, 0.6H), 7.33 (s, 
0.4H), 7.19-7.18(m, 0.8H), 7.05-7.03(m, 2H), 6.99-6.95 (m, 
2H), 6.90-6.88 (m, 0.6H), 6.46 (d, J = 7.9 Hz, 0.6H), 5.60 (d, 
J = 47.6 Hz, 0.4H), 5.36 (d, J = 48.1 Hz, 0.6H), 3.17 (s, 1.2H), 3.15 (s, 1.8H), 2.35 (s, 
1.2H), 2.33 (s, 1.8H), 2.30-2.29 (m, 3H). 13C {1H} NMR (CDCl3, 125MHz): 168.29, 
168.08, 167.96, 167.75, 140.93, 140.88, 139.81, 139.78, 139.50, 139.47, 138.03, 
137.63, 134.35, 134.12, 131.45, 131.29, 130.83, 130.78, 130.66, 129.63, 129.59, 
129.30, 129.25, 129.24, 129.09, 129.08, 128.17, 128.14, 127.85, 127.81, 123.82, 
122.93, 89.59, 89.19, 88.17, 87.77, 36.48, 21.34, 20.90, 20.88.   HRMS (ESI): m/z : 
calcd for C17H17BrFNNaO [M+Na]+: 372.03698; found: 372.03651. 
 
N-(2-Bromo-4-methoxyphenyl)-N-methyl-2-fluoro-2-(1-naphthyl)acetamide 
(5d). 1H NMR (CDCl3, 500 MHz): δ = 7.86-7.67 (m, 3H), 
7.42-6.68 (m, 6H), 6.33 (d, J = 47.0 Hz, 0.4H), 6.15 (d, J = 
47.0 Hz, 0.6H), 6.07 (d, J =8.8 Hz, 0.5H), 6.97 (d, J = 8.8 
Hz, 0.5H), 3.77 (s, 0.3H), 3.72 (s, 0.9H), 3.63 (s, 1.8H), 3.18 (s, 1.2H), 3.16 (s, 1.8H).  
13C {1H} NMR (CDCl3, 125 MHz): 171.44, 168,96, 168.75, 168.52, 168.32, 160.23, 
159.98, 133.94, 133.80, 133.32, 132.79, 131.64, 131.44, 131.23, 130.70, 130.63, 
130.60, 130.55, 130.43, 129.31, 128.77, 128.73, 128.14, 128.09, 127.83, 127.78, 
127.75, 127.02, 126.73, 126.22, 126.17, 125.94, 125.71, 124.32, 123.69, 123.60, 
123.28, 118.96, 118.91, 118.80, 114.96, 114.82, 114.08, 88.73, 88.64, 87.30, 87.22, 
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56.05, 55.95, 37.14. HRMS (ESI): m/z : calcd for C20H17BrFNNaO2 [M+Na]+: 
424.03189; found: 424.03189. 
 
N-(2-Bromo-4-methoxyphenyl)-N-methyl-2-fluoro-2-phenylacetamide (5e). 1H 
NMR (CDCl3, 400 MHz): δ = 7.22-7.18 (m, 4H), 7.10-7.06 
(m, 2H), 7.01 (d, J = 2.8 Hz, 0.4H), 6.90 (dd, J = 8.7, 2.8 Hz, 
0.4H), 6.58 (dd, J = 8.8, 2.8 Hz, 0.6H), 6.44 (d, J = 8.7 Hz, 
0.6H), 5.64 (d, J = 47.7 Hz, 0.4H), 5.42 (d, J = 47.7 Hz, 0.6H), 3.80 (s, 1.2H), 3.78 (s, 
1.8H), 3.17 (s, 1.2H), 3.14 (s, 1.8H).  13C {1H} NMR (CDCl3, 100 MHz): 168.56, 
168.30, 168.21, 167.95, 160.38, 160.31, 134.69, 134.49, 134.07, 133.87, 133.49, 
133.10, 131.79, 130.66, 129.95, 129.92, 129.73, 129.71, 128.80, 128.78, 128.64, 
128.63, 128.35, 128.31, 128.04, 127.99, 125.04, 119.15, 118.70, 114.64, 114.61, 
90.28, 89.81, 88.50, 88.04, 56.10, 56.07, 36.88, 36.87. HRMS (ESI): m/z : calcd for 
C16H15BrFNNaO2 [M+Na]+: 374.01624; found: 374.01642. 
 
N-(2-Bromo-4-methoxyphenyl)-N-methyl-2-fluoro-2-(2-fluorophenyl)acetamide 
(5f). 1H NMR (CDCl3, 400 MHz): δ = 7.52-7.48 (m, 1H), 
7.31-7.08 (m, 3H), 7.01 (d, J = 2.8 Hz, 0.4H), 6.92-6.84 (m, 
1.4H),  6.56 (dd, J = 8.8, 2.8 Hz, 0.6H), 6.41 (d, J = 8.8 Hz, 
0.6H), 6.00 (d, J = 47.1 Hz, 0.4H), 5.80 (d, J = 47.1 Hz, 0.6H), 3.79 (s, 1.2H), 3.77 (s, 
1.8H), 3.18 (s, 1.2H), 3.16 (s, 1.8H).  13C {1H} NMR (CDCl3, 100 MHz): 160.48, 
160.39, 133.03, 132.70, 131.95, 131.92, 131.87, 131.84, 131.79, 131.76, 131.71, 
131.68, 131.13, 130.69, 130.28, 130.25, 129.73, 129.70, 124.87, 124.84, 124.83, 
124.81, 124.74, 124.72, 124.50, 124.08, 119.24, 118.72, 115.71, 115.69, 115.58, 
115.50, 115.48, 115.37, 114.87, 114.83, 83.09, 83.05, 82.72, 82.68, 81.32, 81.27, 
80.96, 80.92, 56.11, 36.96, 36.95. HRMS (ESI): m/z : calcd for C16H14BrF2NNaO2 
[M+Na]+: 392.00734; found: 392.00746. 
 
N-(2-Bromo-4-methoxyphenyl)-N-methyl-2-fluoro-2-(2-trifluoromethylphenyl) 
acetamide (5g). 1H NMR (CDCl3, 400 MHz): δ = 7.90-6.94 
(m, 6H), 6.57-6.54 (m, 0.5H), 6.39 (d, J = 8.8 Hz, 0.5H), 
6.10 (d, J = 47.4 Hz, 0.4H), 5.90 (d, J = 47.4 Hz, 0.6H), 3.82 
(s, 1.2H), 3.79 (s, 1.8H), 3.27 (s, 1.2H), 3.25 (s, 1.8H).  13C {1H} NMR (CDCl3, 125 
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MHz):  170.31, 167.61, 167.41, 167.29, 167.09, 160.29, 160.23, 159.88, 134.94, 
132.73, 132.71, 132.56, 132.55, 132.41, 132.40, 132.35, 132.34, 131.69, 131.68, 
130.92, 130.87, 130.72, 130.26, 130.02, 129.99, 129.96, 129.92, 129.87, 129.84, 
126.91, 126.20, 126.18, 126.15, 126.14, 125.93, 125.92, 125.89, 125.88, 125.84, 
124.13, 123.80, 123.29, 118.94, , 118.76, 118.60, 114.88, 114.71, 114.56, 85.40, 
85.38, 84.68, 83.97, 83.96, 55.87, 57.14, 36.93,36.27. HRMS (ESI): m/z : calcd for 
C17H14BrF4NNaO2 [M+Na]+: 442.00417; found: 442.00426 
 
N-(2-Bromo-4-fluorophenyl)-N-methyl-2-fluoro-2-phenylacetamide (5h). 1H 
NMR (CDCl3, 400 MHz): δ = 7.47-7.09 (m, 6.8H), 6.83 (td, J 
= 7.7, 2.8 Hz, 0.6H), 6.58-6.56 (m, 0.6H), 5.68 (d, J = 47,6 Hz, 
0.4H), 5.43 (d, J = 47,6 Hz, 0.6H), 3.22 (s, 1.2H), 3.21 (s, 
1.8H). 13C {1H} NMR (CDCl3, 125 MHz):  168.14, 167.93, 167.84, 167.64, 163.14, 
163.05, 161.12, 161.03, 137.16, 137.13, 136.80, 136.77, 134.31, 134.15, 133.72, 
133.55, 132.57, 132.49, 131.39, 131.32, 130.14, 130.11, 129.89, 129.86, 128.94, 
128.92, 128.77, 128.76, 128.26, 128.22, 127.86, 127.82, 125.32, 125.24, 124.32, 
124.24, 121.49, 121.29, 121.26, 121.06, 116.24, 116.07, 116.05, 115.87, 90.24, 89.88, 
88.81, 88.44, 36.83. HRMS (ESI): m/z : calcd for C15H12BrF2NNaO [M+Na]+: 
361.9968; found: 361.9965. 
 
N-(2-Bromo-4-fluorophenyl)-N-methyl-2-fluoro-2-(2-fluorophenyl)acetamide 
(5i). 1H NMR (CDCl3, 300 MHz): δ = 7.56-7.12 (m, 5H), 6.96-
6.79 (m, 1.6 H), 6.59-6.54 (m, 0.4H), 6.02 (d, J = 47.0 Hz, 
0.4H), 5.80 (d, J = 47.0 Hz, 0.6H), 3.23 (s, 1.2H), 3.19 (s, 
1.8H). 13C {1H} NMR (CDCl3, 75 MHz): 167.50, 167.15, 166.80, 163.70, 163.61, 
161.91, 161.85, 161.79, 160.33, 160.24, 158.60, 158.53, 158.47, 136.48, 136.43, 
136.20, 136.15, 131.96, 131.92, 131.85, 131.81, 131.75, 131.71, 131.64, 131.59, 
131.28, 131.16, 129.95, 129.90, 129.86, 129.40, 129.36, 129.32, 124.79, 124.76, 
124.71, 124.65, 124.60, 124.57, 124.42, 124.15, 124.02, 121.34, 121.26, 121.01, 
120.92, 116.38, 116.09, 116.00, 115.70, 115.56, 115.54, 115.43, 115.28, 115.26, 
115.14, 83.11, 83.05, 82.82, 82.76, 80.73, 80.67, 80.46, 80.40, 36.63. HRMS (ESI): 
m/z : calcd for C15H11BrF3NNaO [M+Na]+: 379.98683; found: 379.98682. 
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N-(2-Bromo-5-trifluoromethyl-phenyl)-N-methyl-2-fluoro-2-phenylacetamide 
(5j). 1H NMR (CDCl3, 400 MHz): δ = 7.78 (d, J = 8.4 Hz, 
0.6H), 7.63 (d, J = 8.3 Hz, 0.4H), 7.45-7.18 (m, 3.4H), 7.02-
6.95 (m, 2H), 6.70 (s, 0.6H), 5.64 (d, J = 47.8 Hz, 0.4H), 
5.30 (d, J = 47.8 Hz, 0.6H), 3.18 (s, 1.2H), 3.16 (s, 1.8H). 13C {1H} NMR (CDCl3, 
100 MHz):  167.82, 167.59, 167.56, 167.35, 141.71, 141.19, 134.93, 134.80, 134.03, 
133.90, 133.93, 133.69, 131.70, 131.36, 130.38, 130.35, 129.11, 129.09, 128.92, 
128.89, 128.84, 128.12, 128.10, 128.09, 128.01, 127.43, 127.40, 127.22, 127.18, 
127.14, 127.13, 127.11, 127.02, 126.99, 126.95, 124.58, 124.24, 121.88, 121.53, 
118.83, 90.93, 90.72, 89.10, 88.92, 36.92, 36.67. HRMS (ESI): m/z : calcd for 
C16H12BrF4NNaO [M+Na]+: 411.99306; found: 411.99346. 
 
N-(2-Bromo-5-methylphenyl)-N-methyl-2-fluoro-2-(2-chlorophenyl)acetamide 
(5k). 1H NMR (CDCl3, 400 MHz): δ = 7.59-7.52 (m, 1H), 7.43 
(d, J = 8.2 Hz, 0.67H), 7.30-7.11 (m, 3.67H), 6.96-6.90 (m, 1H), 
6.12 (d, J = 47.3 Hz, 0.33H), 6.10 (s, 0.67H), 5.84 (d, J = 47.3 
Hz, 0.67H), 3.15 (s, 1H), 3.12 (s, 2H), 2.27 (s, 1H), 1.93 (s, 2H). 13C {1H} NMR 
(CDCl3, 100 MHz): 168.02, 167.76, 167.62, 167.36, 140.28, 140.10, 139.79, 139.65, 
135.41, 135.37, 134.43, 134.38, 134.35, 134.02, 132.93, 132.73, 132.01, 131.93, 
131.81, 131.75, 131.69, 131.53, 131.50, 131.34, 131.31, 131.22, 130.76, 130.71, 
130.39, 130.35, 129.79, 129.77, 129.73, 129.71, 127.91, 127.88, 127.74, 127.72, 
120.40, 120.20, 86.79, 86.01, 85.01, 84.25, 37.04, 36.88, 36.87, 21.29, 21.07. HRMS 
(ESI): m/z : calcd for C16H14BrClFNNaO [M+Na]+: 391.98235; found: 391.98270. 
 
N-(2-Bromophenyl)-N-methyl-2-fluoro-2-(2-methylphenyl)acetamide (5l). 1H 
NMR (CDCl3, 400 MHz): δ = 7.64 (d, J = 8.1 Hz, 0.6H), 7.46-
6.94 (m, 6.8H), 6.34 (d, J = 8.2 Hz, 0.6H), 5.91 (d, J = 47.6 Hz, 
0.4H), 5.65 (d, J = 47.6 Hz, 0.6H), 3.22 (s, 1.2H), 3.19 (s, 1.8H), 
1.84 (s, 1.2H), 1.70 (s, 1.8H). 13C {1H} NMR (CDCl3, 125MHz): 170.71, 168.36, 
168.16, 167.96, 167.76, 142.53, 140.57, 140.02, 137.66, 137.63, 137.35, 137.32, 
136.82, 134.25, 133.95, 133.74, 133.71, 132.47, 132.33, 131.44, 131.29, 131.26, 
130.61, 130.59, 130.55, 130.53, 130.24, 130.22, 130.09, 129.98, 129.95, 129.91, 
129.84, 129.65, 129.63, 129.19, 129.15, 129.03, 129.01, 128.67, 128.51, 128.50, 
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128.49, 126.89, 126.48, 126.45, 126.22, 126.20, 125.85, 124.19, 123.56, 123.45, 
87.27, 85.85, 39.08, 36.61, 36.48, 36.12, 19.66, 18.37, 18.08.   HRMS (ESI): m/z : 
calcd for C16H15BrFNNaO [M+Na]+: 358.02133; found: 358.02162. 
 
N-(2-Bromo-phenyl)-N-methyl-2-fluoro-2-(2-fluorophenyl) acetamide (5m). 1H 
NMR (CDCl3, 500 MHz): δ = 7.67-7.07 (m, 6.4 H), 6.86 (br, 1H), 
6.55 (s, 0.6H), 6.01 (d, J = 47.1 Hz, 0.4H), 5.78 (d, J = 47.1 Hz, 
0.6H), 3.23 (s, 1.2H), 3.21 (s, 1.8H).  13C {1H} NMR (CDCl3, 
125 MHz): 167.41, 167.20, 167.05, 166.85, 161.33, 161.27, 161.23, 159.34, 159.30, 
159.27, 159.24, 140.07, 139.80, 134.09, 133.94, 131.83, 131.81, 131.76, 131.74, 
131.68, 131.65, 131.61, 131.59, 130.61, 130.47, 130.45, 130.15, 130.01, 129.50, 
129.47, 129.45, 129.12, 128.73, 124.66, 124.54, 123.76, 123.38, 122.04, 121.93, 
121.87, 121.76, 121.12, 121.02, 120.95, 120.85, 115.46, 115.35, 115.29, 115.17, 
82.69, 82.66, 82.33, 82.30, 81.28, 81.24, 80.92, 80.89, 36.55, 36.53 HRMS (ESI): 
m/z : calcd for C15H12BrF2NNaO [M+Na]+: 361.99625; found: 361.99622. 
 
N-(2-Bromophenyl)-N-methyl-2-fluoro-2-(3-methoxyphenyl)acetamide (5n). 1H 
NMR (CDCl3, 500 MHz): δ = 7.74-7.15 (m, 4.4H), 6.90-6.88 
(m, 1H), 6.71-6.61 (m, 2.6H), 5.68 (d, J = 47.6 Hz, 0.4H), 5.42 
(d, J = 47.6 Hz, 0.6H), 3.76 (s, 3H), 3.25 (s, 1.2H), 3.23 (s, 
1.8H). 13C {1H} NMR (CDCl3, 100 MHz): 168.02, 167.76, 167.49, 159.92, 159.90, 
159.79, 140.87, 140.53, 135.88, 135.68, 135.26, 135.05, 134.27, 134.03, 131.57, 
130.56, 130.55, 130.37, 129.79, 129.78, 129.67, 129.08, 128.85, 124.54, 123.63, 
120.60, 120.56, 120.28, 120.22, 116.16, 116.14, 116.13, 116.01, 115.98, 113.05, 
113.00, 112.72, 112.67, 90.23, 89.80, 88.44, 88.01, 55.49, 55.48, 36.72, 36.70. 
HRMS (ESI): m/z : calcd for C16H15BrFNNaO2 [M+Na]+: 374.01679; found: 
374.01668. 
 
N-(2-Bromophenyl)-N-methyl-2-fluoro-2-(3-fluorophenyl)acetamide (5o). 1H 
NMR (CDCl3, 500 MHz): δ = 7.74-7.18 (m, 4.5H), 7.06-7.01 (m, 
1H), 6.86-6.82 (m, 1H), 6.72 (d, J = 8.8 Hz, 0.5 H), 5.67 (d, J = 
47.4 Hz, 0.5H), 5.45 (d, J = 47.4 Hz, 0.5H), 3.24 (s, 1.5H), 3.23 
(s, 1.5H). 13C {1H} NMR (CDCl3, 125 MHz): 167.35, 167.14, 167.02, 166.82, 163.54, 
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163.51, 161.55, 140.40, 140.11, 136.56, 136.50, 136.39, 136.34, 134.14, 133.97, 
131.11, 130.59, 130.58, 130.27, 130.26, 130.20, 130.19, 130.15, 130.11, 130.05, 
129.02, 128.76, 124.13, 123.63, 123.60, 123.59, 123.57, 123.40, 123.36, 123.34, 
123.32, 123.29, 116.85, 116.83, 116.68, 116.66, 116.61, 116.59, 116.44, 116.42, 
114.98, 114.94, 114.80, 114.77, 114.72, 119.59, 114.54, 89.08, 89.07, 88.66, 88.64, 
87.65, 87.63, 87.22, 87.20, 36.60, 36.59, 36.54. HRMS (ESI): m/z : calcd for 
C15H12BrF2NNaO [M+Na]+: 361.99625; found: 361.99611. 
 
N-(2-Bromo-phenyl)-N-methyl-2-fluoro-2-(4-biphenyl) acetamide (5p). 1H NMR 
(CDCl3, 400 MHz): δ = 7.38-7.18 (m, 10H), 7.12-7.07 (m, 
2.4H), 6.64 (d, J = 7.8 Hz, 0.6H), 5.66 (d, J = 47.5 Hz, 
0.4H), 5.43 (d, J = 47.5 Hz, 0.6H), 3.20 (s, 1.2H), 3.19 (s, 
1.8H).  13C {1H} NMR (CDCl3, 125 MHz): 168.16, 167.90, 167.86, 167.61, 142.87, 
142.84, 142.69, 142.66, 140.98, 140.79, 140.64, 140.47, 140.46, 134.38, 134.14, 
133.51, 133.31, 132.93, 132.72, 131.56, 130.62, 130.45, 129.15, 129.06, 128.91, 
128.78, 128.74, 128.45, 128.39, 128.02, 127.85, 127.52, 127.50, 127.42, 127.36, 
124.58, 123.73, 90.07, 89.71, 88.28, 87.92, 36.77, 36.76. HRMS (ESI): m/z : calcd for 
C21H17BrFNNaO [M+Na]+: 420.03698; found: 420.03657. 
 
Catalyzed α-arylation 
General catalysis procedure: In the glovebox, a vial (10 mL screw-cap threaded) 
equipped with a stir-bar was charged with palladium catalyst (9.5 mg, 5.0 mol%), 
sodium tert-butoxide (21.1 mg, 0.22 mmol), then the substrate (0.20 mmol) and 
toluene (2 ml) were added. The mixture was stirred at room temperature for 16 h 
before flitering throuth celite. Alternatively, if heating was needed, the vial was sealed 
a Teflon®-lined screw cap and the mixture was stirred at 50 °C for 16 h before 
filtering through celite. The solvent was removed in vacuo and the residue was 
purified by flash chromatography. The product was analyzed by chiral HPLC 
analysis. 
 
(S)- 1-Benzyl-3-fluoro-3-phenylindolin-2-one. Room temperature, white solid, 88% 
yield. [α]25D = 77.8 (c = 0.69, CHCl3), 67% ee [Chiralcel OJ-H column, n-hexane/i-
PrOH =90:10, 1.0 mL/min, tR = 36.0 min (minor) and 62.6 min (major)]. 1H NMR 
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(CDCl3, 400 MHz): δ = 7.41-7.26 (m, 12H), 7.08 (t, J = 7.6 Hz, 1H), 
6.77 (d, J = 7.9 Hz, 1H), 4.96 (d, J = 15.7 Hz, 1H), 4.83 (d, J = 15.7 
Hz, 1H). 13C {1H} NMR (CDCl3, 100 MHz): 172.96, 172.72, 144.09, 
144.04, 136.43, 136.16, 135.40, 131.72, 131.68, 129.55, 129.53, 
129.21, 128.93, 128.16, 127.54, 127.53, 127.35, 127.17, 126.53, 126.52, 126.20, 
126.13, 123.87, 123.85, 110.22, 110.20, 44.31. 19F NMR (CDCl3, 376 MHz): -152.90.  
HRMS (ESI): m/z : calcd for C21H16FNNaO [M+Na]+: 340.11081; found: 340.11049. 
 
(S)-3-Fluoro-1-methyl-3-phenylindolin-2-one (6a). Room temperature, colorless 
oil, 83% yield. [α]25D = 110.7 (c = 1.9, CH2Cl2), 97% ee [Chiralcel 
OD-H column, n-hexane/i-PrOH =90:10, 1.0 mL/min, tR = 7.47 min 
(minor) and 9.11 min (major)]. 1H NMR (CDCl3, 400 MHz): δ = 
7.45-7.31 (m, 7H), 7.13 (t, J = 7.6 Hz, 1H), 6.90 (d, J = 7.8 Hz, 1H), 3.21 (s, 3H). 13C 
{1H} NMR (CDCl3, 125 MHz): 172.56, 172.36, 144.69, 144.65, 135.99, 135.77, 
131.57, 131.54, 129.26, 128.58, 126.92, 126.78, 126.20, 126.00, 125.95, 123.58, 
108.85, 93.97, 92.47, 26.52. 19F NMR (CDCl3, 376 MHz): -152.90.  HRMS (ESI): 
m/z : calcd for C15H12FNNaO [M+Na]+: 264.07951; found: 264.07945. 
 
(R)-3-Fluoro-1,5-dimethyl-3-(2-fluorophenyl)-indolin-2-one (6b). Room 
temperature, colorless oil, 62% yield. [α]25D = -45.3 (c = 0.38, 
CH2Cl2), 99.5% ee [Chiralcel OD-H column, n-hexane/i-PrOH 
=90:10, 1.0 mL/min, tR = 6.44 min (minor) and 7.81 min (major)]. 
1H NMR (CDCl3, 400 MHz): δ = 7.75 (t, J = 7.7 Hz, 1H), 7.33-7.13 
(m, 3H), 6.94-6.89 (m, 2H), 6.74 (d, J = 7.0 Hz, 1H), 3.22 (s, 3H), 2.21 (s, 3H).  13C 
{1H} NMR (CDCl3, 125 MHz): 171.46, 171.29, 159.50, 159.46, 157.53, 157.49, 
142.17, 142.13, 133.13, 133.10, 131.87, 131.84, 130.61, 130.55, 127.02, 127.00, 
126.93, 126.91, 126.47, 126.32, 126.00, 124.66, 124.56, 124.42, 124.41, 124.39, 
124.38, 115.90, 115.89, 115.74, 115.72, 108.60, 108.58, 92.06, 90.57, 26.59, 20.96. 
19F NMR (CDCl3, 376 MHz): -114.44, -159.26. HRMS (ESI): m/z : calcd for 
C16H13F2NNaO [M+Na]+: 296.08574; found: 296.08557. 
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(S)-3-Fluoro-1,5-dimethyl-3-(4-methylphenyl)-indolin-2-one (6c). Room 
temperature, white solid, 70% yield. [α]27D = 131.2 (c = 0.45, 
CH2Cl2), 99% ee [Chiralcel OD-H column, n-hexane/i-PrOH 
=90:10, 1.0 mL/min, tR = 12.83 min (minor) and 13.76 min 
(major)]. 1H NMR (CDCl3, 400 MHz): δ = 7.18 (d, J = 8.1 Hz, 2H), 7.13-7.04 (m, 
4H), 6.69 (d, J = 8.0 Hz, 1H), 3.08 (s, 3H), 2.24 (s, 3H), 2.23 (s, 3H). 13C {1H} NMR 
(CDCl3, 125 MHz): 172.69, 172.49, 142.24, 142.19, 139.18, 139.17, 133.24, 133.22, 
133.20, 132.98, 131.67, 131.64, 130.70, 129.25, 129.21, 127.44, 127.03, 126.89, 
126.81, 125.95, 125.90, 108.58, 108.57, 94.17, 92.68, 26.51, 21.26, 21.05. 19F NMR 
(CDCl3, 376 MHz): -152.29. HRMS (ESI): m/z : calcd for C17H16FNNaO [M+Na]+: 
292.11081; found: 292.11092. 
 
(S)-3-Fluoro-5-methoxy-1-methyl-3-(1-naphthyl)-indolin-2-one (6d). 50 °C, 
white solid, 58% yield. [α]25D = 56.5 (c = 0.92, CH2Cl2), 94% ee 
[Chiralcel OD-H column, n-hexane/i-PrOH =90:10, 1.0 mL/min, 
tR = 12.75 min (minor) and 17.92 min (major)]. )]. 1H NMR 
(CDCl3, 500 MHz): δ = 7.88-7.70 (m, 4H), 7.48-7.38 (m, 3H), 
6.97-6.84 (m, 3H), 3.68 (s, 3H), 3.31 (s, 3H).  13C {1H} NMR (CDCl3, 125 MHz): 
172.15, 171.97, 156.62, 156.59, 137.61, 137.57, 134.27, 130.40, 129.01, 128.77, 
128.62, 126.65, 125.86, 124.86, 116.25, 116.22, 112.82, 109.66, 109.65, 55.80, 26.75. 
19F NMR (CDCl3, 376 MHz): -147.83. HRMS (ESI): m/z : calcd for C20H16FNNaO2 
[M+Na]+: 344.10573; found: 344.10538. 
 
(S)-3-Fluoro-5-methoxy-1-methyl-3-phenyl-indolin-2-one (6e). Room 
temperature, white solid, 82% yield. [α]27D = 181.6 (c = 1.40, 
CH2Cl2), 99% ee [Chiralcel OD-H column, n-hexane/i-PrOH 
=90:10, 1.0 mL/min, tR = 9.05 min (minor) and 11.62 min 
(major)]. 1H NMR (CDCl3, 400 MHz): δ = 7.36 (br, 5H), 6.96-6.92 (m, 2H), 6.81 (d, J 
= 8.4 Hz, 1H), 3.76 (s, 3H), 3.18 (s, 3H).  13C {1H} NMR (CDCl3, 100 MHz): 156.90, 
156.87, 138.23, 138.18, 136.37, 129.50, 129.48, 128.85, 128.14, 126.21, 126.15, 
116.53, 116.51, 113.19, 109.68, 109.66, 94.76, 92.89, 56.18, 26.85. 19F NMR (CDCl3, 
376 MHz): -153.48. HRMS (ESI): m/z : calcd for C16H14FNNaO2 [M+Na]+: 
294.09008; found: 294.08991. 
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(R)-3-Fluoro-5-methoxy-1-methyl-3-(2-fluorophenyl)-indolin-2-one (6f). 50 °C, 
yellow oil, 82% yield. [α]27D = -29.9 (c = 1.05, CH2Cl2), 99% ee 
[Chiralcel OD-H column, n-hexane/i-PrOH =90:10, 1.0 mL/min, 
tR = 8.64 min (minor) and 10.76 min (major)]. 1H NMR (CDCl3, 
400 MHz): δ =7.74 (t, J = 7.5 Hz, 1H), 7.32-7.27 (m, 1H), 7.21 (d, J = 5.8 Hz, 1H), 
6.94-6.85 (m, 2H), 6.77-6.74 (m, 2H), 3.67 (s, 3H), 3.21 (s, 3H).  13C {1H} NMR 
(CDCl3, 100 MHz): 171.64, 160.38, 157.92, 156.99, 138.35, 131.21, 131.13, 127.55, 
127.52, 127.44, 127.41, 124.89, 116.53, 116.50, 116.44, 116.24, 112.89, 109.81, 
92.91, 90.97, 56.34, 27.11. 19F NMR (CDCl3, 376 MHz): -114.33, -159.50. HRMS 
(ESI): m/z : calcd for C16H13F2NNaO2 [M+Na]+: 312.08066; found: 312.08061. 
 
(S)-3-Fluoro-5-methoxy-1-methyl-3-(2-trifluoromethylphenyl)-indolin-2-one 
(6g). 50 °C, colorless oil, 85% yield. [α]27D = -13.65 (c = 1.65, 
CH2Cl2), 98% ee [Chiralcel OD-H column, n-hexane/i-PrOH 
=90:10, 1.0 mL/min, tR = 8.07 min (minor) and 9.71 min 
(major)]. 1H NMR (CDCl3, 400 MHz): δ = 7.82-7.72 (m, 2H), 
7.62 (t, J = 7.8 Hz, 1H), 7.50 (t, J = 7.6 Hz, 1H), 6.93-6.90 (m, 1H), 6.80 (d, J = 8.5 
Hz, 1H), 6.70 (s, 1H), 3.70 (s, 3H), 3.23 (s, 3H).  13C {1H} NMR (CDCl3, 125 MHz): 
171.51, 171.33, 156.42, 156.40, 132.10, 129.16, 128.12, 127.98, 127.80, 127.75, 
124.74, 122.48, 116.28, 116.25, 112.91, 109.40, 109.38, 94.26, 92.79, 55.88, 26.58. 
19F NMR (CDCl3, 376 MHz): -57.74, -168.74. HRMS (ESI): m/z : calcd for 
C17H13F4NNaO2 [M+Na]+: 362.07746; found: 362.07727. 
 
(S)-3,5-difluoro-1-methyl-3-phenyl-indolin-2-one (6h). Room temperature, white 
solid, 70% yield. [α]27D = 111.8 (c = 1.25, CH2Cl2), 96% ee 
[Chiralcel OD-H column, n-hexane/i-PrOH =90:10, 0.7 mL/min, tR 
= 11.09 min (minor) and 14.93 min (major)]. )]. 1H NMR (CDCl3, 
400 MHz): δ = 7.36 (br, 5H), 7.15-7.05 (m, 2H), 6.84 (dd, J = 8.5, 2.9 Hz, 1H), 3.19 
(s, 3H).  13C {1H} NMR (CDCl3, 125 MHz): 172.51, 172.32, 160.71, 160.69, 158.78, 
158.76, 140.80, 140.79, 140.76, 140.74, 135.67, 135.45, 129.73, 129.72, 128.95, 
128.57, 128.51, 128.43, 128.37, 126.02, 125.97, 118.23, 118.21, 118.04, 118.02, 
114.58, 114.38, 109.92, 109.91, 109.85, 94.07, 94.06, 92.57, 92.56, 26.91. 19F NMR 
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(CDCl3, 376 MHz): -118.73, -153.62. HRMS (ESI): m/z : calcd for C15H11F2NNaO 
[M+Na]+: 282.07009; found: 282.07005. 
 
(R)-3,5-difluoro-1-methyl-3-(2-fluorophenyl)-indolin-2-one (6i). Room 
temperature, colorless oil, 76% yield. [α]27D = -119.84 (c = 1.90, 
CH2Cl2), 99.9% ee [Chiralcel OD-H column, n-hexane/i-PrOH 
=90:10, 1.0 mL/min, tR = 9.21 min (major) and 11.17 min 
(minor)]. 1H NMR (CDCl3, 500 MHz): δ = 7.78 (td, J = 7.7, 1.6 Hz, 1H), 7.39-7.34 
(m, 1H), 7.29-7.25 (m, 1H), 7.09 (tt, J = 8.8, 2.3 Hz, 1H), 6.99-6.92 (m, 2H), 6.85-
6.82 (m, 1H), 3.27 (s, 3H).  13C {1H} NMR (CDCl3, 125 MHz): 171.73, 171.56, 
160.99, 160.10, 160.06, 159.06, 159.03, 158.13, 158.09, 141.11, 131.58, 131.52, 
128.42, 128.35, 128.27, 128.21, 127.57, 127.55, 127.48, 127.46, 125.16, 125.15, 
125.13, 124.51, 124.41, 124.28, 124.18, 118.60, 118.57, 118.41, 118.38, 116.55, 
116.53, 116.38, 116.37, 114.12, 113.92, 110.19, 110.13, 92.26, 90.76, 27.26. 19F 
NMR (CDCl3, 376 MHz): -114.51, -119.16, -160.07. HRMS (ESI): m/z : calcd for 
C15H10F3NNaO [M+Na]+: 300.06067; found: 300.06069. 
 
(R)-3-fluoro-1-methyl-6-trifluoromethyl-3-phenyl-indolin-2-one (6j). Room 
temperature, white solid, 81% yield. [α]27D = 108.1 (c = 2.05, 
CH2Cl2), 94% ee [Chiralcel OD-H column, n-hexane/i-PrOH 
=90:10, 1.0 mL/min, tR = 7.04 min (minor) and 10.56 min 
(major)]. 1H NMR (400 MHz, CDCl3): δ = 7.45-7.34 (m, 7H), 7.12 (s, 1H), 3.25 (s, 
3H). 13C {1H} NMR (CDCl3, 125 MHz): 172.39, 172.20, 145.57, 145.53, 135.31, 
135.10, 134.16, 134.14, 133.90, 133.88, 130.78, 130.77, 130.63, 130.62, 129.91, 
129.89, 129.03, 126.77, 126.76, 126.04, 125.99, 124.88, 122.72, 122.71, 120.91, 
120.89, 120.87, 120.85, 106.01, 106.00, 105.98, 105.97, 93.52, 92.02, 26.96. 19F 
NMR (CDCl3, 376 MHz): -62.92, -154.29. HRMS (ESI): m/z : calcd for 
C16H11F4NNaO [M+Na]+: 332.06690; found: 332.06707. 
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(R)-3-fluoro-1,6-dimethyl-3-(2-chlorophenyl)-indolin-2-one 
(6k). 60 °C, white solid, 86% yield. [α]25D = -96.8 (c = 1.45, 
CH2Cl2), 82% ee [Chiralcel OD-H column, n-hexane/i-PrOH 
=90:10, 1.0 mL/min, tR = 7.45 min (minor) and 9.22 min (major)]. 
1H NMR (400 MHz, CDCl3): δ = 7.90 (d, J = 7.9 Hz, 1H), 7.37 (t, J = 7.5 Hz, 1H), 
7.29-7.20 (m, 2H), 6.87 (dd, J = 7.5, 2.7 Hz, 1H), 6.78 (d, J = 7.6 Hz, 1H), 6.67 (s, 
1H), 3.22 (s, 3H), 2.35 (s, 3H). 13C {1H} NMR (CDCl3, 125 MHz): 171.89, 171.67, 
146.18, 146.12, 142.98, 142.94, 135.15, 134.87, 130.77, 130.75, 130.54, 128.16, 
128.01, 127.48, 127.46, 125.48, 125.46, 124.27, 124.23, 123.57, 123.39, 110.22, 
110.20, 94.01, 92.20, 27.04, 22.65, 22.63. 19F NMR (CDCl3, 376 MHz): -152.35. 
HRMS (ESI): m/z : calcd for C16H13ClFNNaO [M+Na]+: 312.05619; found: 
305.05614. 
 
(S)-3-fluoro-1-methyl-3-(2-methylphenyl)-indolin-2-one (6l). Room temperature, 
white solid, 59% yield. [α]27D = -23.8 (c = 1.20, CH2Cl2), 96% ee 
[Chiralcel OD-H column, n-hexane/i-PrOH =90:10, 1.0 mL/min, tR = 
7.35 min (minor) and 8.94 min (major)]. 1H NMR (500 MHz, 
CDCl3): δ = 7.69 (d, J = 7.1 Hz, 1H), 7.45 (tt, J = 7.8, 1.4 Hz, 1H), 7.34-7.28 (m, 2H), 
7.18-7.14 (m, 2H), 7.09 (t, J = 7.5 Hz, 1H), 6.94 (d, J = 7.9 Hz, 1H), 3.31 (s, 3H), 
1.98 (s, 3H). 13C {1H} NMR (CDCl3, 125 MHz): 172.01, 171.83, 144.77, 144.73, 
134.59, 134.56, 134.31, 134.12, 131.67, 131.65, 131.63, 131.60, 128.91, 128.90, 
126.76, 126.61, 126.02, 126.00, 125.94, 125.83, 125.77, 125.75, 123.65, 123.63, 
108.76, 108.74, 94.46, 93.01, 26.47, 19.43. 19F NMR (CDCl3, 376 MHz): -151.65. 
HRMS (ESI): m/z : calcd for C16H14FNNaO [M+Na]+: 278.09516; found: 278.09497. 
 
(R)-3-fluoro-1-methyl-3-(2-fluorophenyl)-indolin-2-one (6m). Room temperature, 
white solid, 65% yield. [α]27D = -101.5 (c = 0.85, CH2Cl2), 99.3% ee 
[Chiralcel OD-H column, n-hexane/i-PrOH =90:10, 1.0 mL/min, tR = 
7.72 min (minor) and 9.16 min (major)]. 1H NMR (CDCl3, 400 
MHz): δ =7.74 (td, J = 7.6, 1.6 Hz, 1H), 7.41-7.31 (m, 2H), 7.27 (dd, J = 7.6, 1.0 Hz, 
1H), 7.18 (d, 7.8 Hz, 1H), 7.03 (t, 7.6 Hz, 1H), 6.97-6.88 (m, 2H), 3.27 (s, 3H).  13C 
{1H} NMR (CDCl3, 100 MHz): 171.49, 171.28, 159.79, 159.73, 157.33, 157.27, 
144.60, 144.55, 131.65, 131.62, 130.68, 130.60, 127.07, 127.04, 126.96, 126.93, 
N
O
F
Cl
N
O
F
N
O
F
F
76 
126.57, 126.38, 125.27, 124.56, 124.43, 124.40, 123.38, 123.35, 115.91, 115.89, 
115.70, 108.82, 92.05, 90.19, 26.54. 19F NMR (CDCl3, 376 MHz): -114.47, -159.50. 
HRMS (ESI): m/z : calcd for C15H11F2NNaO [M+Na]+: 282.07099; found: 282.07042. 
 
(S)-3-fluoro-1-methyl-3-(3-methoxyphenyl)-indolin-2-one (6n). Room 
temperature, colorless oil, 50% yield. [α]27D = 94.7 (c = 0.95, 
CH2Cl2), 95% ee [Chiralcel OD-H column, n-hexane/i-PrOH 
=90:10, 1.0 mL/min, tR = 8.74 min (minor) and 9.40 min (major)]. 
1H NMR (400 MHz, CDCl3): δ = 7.38 (tt, J = 7.8, 1.6 Hz, 1H), 7.28 
(d, J = 7.4 Hz, 1H), 7.21 (t, J = 8.2 Hz, 1H), 7.08 (t, J = 7.6 Hz, 1H), 6.96 (t, J = 1.9 
Hz, 1H), 6.86-6.81 (m, 3H), 3.75 (s, 3H), 3.16 (s, 3H). 13C {1H} NMR (CDCl3, 125 
MHz): 172.67, 172.48, 159.97, 144.88, 144.84, 137.74, 137.53, 131.82, 131.80, 
128.89, 127.15, 127.01, 126.36, 123.84, 123.82, 118.39, 118.35, 115.03, 111.93, 
111.88, 109.10, 94.16, 92.66, 55.60, 26.77. 19F NMR (CDCl3, 376 MHz): -153.42. 
HRMS (ESI): m/z : calcd for C16H14FNNaO2 [M+Na]+: 294.09008; found: 294.09014. 
 
(S)-3-fluoro-1-methyl-3-(3-fluorophenyl)-indolin-2-one (6o). Room temperature, 
white solid, 80% yield. [α]25D = 106.1 (c = 1.85, CH2Cl2), 96% ee 
[Chiralcel OD-H column, n-hexane/i-PrOH =90:10, 1.0 mL/min, tR = 
6.62 min (minor) and 7.24 min (major)]. 1H NMR (500 MHz, 
CDCl3): δ = 7.45 (t, J = 7.8 Hz, 1H), 7.34-7.30 (m, 2H), 7.15-7.03 (m, 
4H), 6.92 (d, J = 7.9 Hz, 1H), 3.21 (s, 3H). 13C {1H} NMR (CDCl3, 125 MHz): 
172.24, 172.05, 163.99, 162.03, 144.91, 144.87, 138.73, 138.67, 138.51, 138.45, 
132.12, 132.10, 130.56, 130.50, 126.67, 126.52, 126.39, 126.38, 124.01, 123.99, 
121.91, 121.89, 121.87, 121.84, 116.62, 116.61, 116.45, 116.44, 113.77, 113.71, 
113.58, 113.52, 109.28, 109.27, 93.73, 93.71, 92.22, 92.21, 26.84. 19F NMR (CDCl3, 
376 MHz): -111.93, -153.07. HRMS (ESI): m/z : calcd for C15H11F2NNaO [M+Na]+: 
282.07009; found: 282.06984. 
 
(S)-3-fluoro-1-methyl-3-(4-biphenyl)-indolin-2-one (6p). Room temperature, 
white solid, 61% yield. [α]27D = 116.6 (c = 0.90, CH2Cl2), 94% ee [Chiralcel OJ-H 
column, n-hexane/i-PrOH =80:20, 1.0 mL/min, tR = 27.34 min (minor) and 30.65 min 
(major)]. 1H NMR (400 MHz, CDCl3): δ = 7.59-7.54 (m, 4H), 7.47-7.32 (m, 7H), 
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7.16 (t, J = 7.5 Hz, 1H), 6.93 (d, J = 7.9 Hz, 1H), 3.23 (s, 3H). 13C 
{1H} NMR (CDCl3, 125 MHz): 172.79, 172.60, 144.96, 144.91, 
142.52, 142.50, 140.71, 135.10, 134.89, 131.90, 131.87, 129.10, 
127.89, 127.64, 127.63, 127.46, 127.05, 126.90, 126.80, 126.75, 
126.49, 123.89, 123.87, 109.18, 109.17, 94.16, 92.67, 26.81. 19F NMR (CDCl3, 376 
MHz): -152.25. HRMS (ESI): m/z : calcd for C21H16FNNaO [M+Na]+: 340.11081; 
found: 340.11090. 
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4.1 Abstract 
A new NHC·Cu catalyzed asymmetric ring-opening of oxabicyclic alkenes with 
Grignard reagents is reported. Based on the chiral regime of C2-symmetric starting 
diamines, the naphthyl-based chiral NHC ligands were readily prepared (Chapter 3). 
When the 2-positions of the naphthyl side chains were substituted with cyclooctyl 
groups, only one diastereomer was generated in the corresponding NHC salt. The 
enantiopure NHC ligand was then transferred onto a copper complex, which was 
tested in the asymmetric ring-opening of oxabicyclic alkenes with Grignard reagents. 
The ring-opened products were obtained in high yields, high enantioselectivities and 
excellent trans diastereoselectivities. When phenyl or allyl Grignard reagents were 
used, high yields and moderate selectivities were observed. 
 
4.2 Introduction 
Transition-metal-catalyzed asymmetric C-C bond-formation reactions which 
employ organometallic reagents are of the most useful and practical methods in 
organic synthesis. The enantioselective ring opening of meso-oxabicyclic alkenes 
with organometallic reagents is an efficient method to construct cyclic compounds 
with multiple chiral centers while simultaneously generating a new C-C bond.1 
Following the pioneering work of Lautens et al., this asymmetric transformation has 
been accomplished successfully with various organometallic reagents, such as 
organozinc,2 organoaluminum,3 organoboron,4 Grignard reagent,3c, 5 and recently 
organolithium6 in the presence of palladium, nickel, rhodium and copper catalysts. In 
all of these cases, enantioselectivity arrises by choosing the appropriate chiral 
phosphine or phosphoramidite ligands. Chiral N-heterocyclic carbenes as ancillary 
ligands  have so far not been reported in these reaction schemes. 
Due to their versatility, tunable steric and electronic properties, and ease of 
formation of stable metal complexes, NHCs have found extensive utility in transition 
metal catalysed,7 and organocatalytic,8 reactions. Chiral NHC ligands are slow to 
make their way into the realm of asymmetric catalytic reactions that provide products 
with high asymmetric induction. Moreover, development of chiral monodentate NHC 
ligands that induce high selectivity in asymmetric organometallic catalysis is still at 
an early stage with relatively few reports detailing high enantioselectivities.9 The 
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main difficulties in designing efficient ligands of this type reside in placing 
stereocontrol elements at positions close to the metal center without affecting the 
overall reactivity of the catalysts. Our group has reported the synthesis of new NHC 
ligands with a chiral N-heterocycle and naphthyl side chains. In principle, three 
different isomers exist in such monodentate chiral imidazolinium salts.10 Recently, we 
were able to exclusively access one of these diastereomers in pure form (salt A, 
Scheme 1) by introducing cyclooctyl groups to the 2-positions of the naphthyl side 
chains. Its palladium complex  showed excellent enantioinduction in the α-arylation 
of amides forming 3-fluoro-3-aryl oxindoles.9r 
The nearly perfect C2-symmetry of this ligand creates a remarkable chiral 
environment around the metal center and we therefore envisioned that this particular 
ligand would have potential applications in other transition metal catalyzed reactions. 
Here, we report the synthesis of a copper complex of this ligand (B) and its 
application in asymmetric ring opening of oxabicyclic alkenes with Grignard reagents. 
Good reactivities (up to 92% yield) and high enantioselectivities (up to 92% ee) were 
obtained. 
 
4.3 Results and Discussion 
NH HN
Ph PhCyoct Cyoct
N N
Ph Ph
Cyoct
Cyoct
BF4
HC(OEt)3
NH4BF4
HCO2H (cat.)
120 °C, 2 h
N N
Ph Ph
Cyoct
Cyoct
Cu
KOtBu
CuCl
Cl
A B
 
Scheme 1. Synthesis of a copper-NHC* complex (B) and its solid state structure 
 
The NHC salt A was obtained as a single diastereomer according to our previously 
reported procedure.9r Copper complex B was subsequently synthesized by 
deprotonation of salt A followed by complexation with CuCl. Appropriate workup 
gave compound B as a bench-stable white solid whose structure was unambiguously 
confirmed by single-crystal X-ray crystallography (Scheme 1). As can be seen from 
the crystal structure, the backbone atoms deviate measurably from the plane of three 
ring atoms. The NHC ligand shows perfect C2-symmetry and the ligand-Cu-Cl 
adopted a linear conformation.  
With precatalyst B  in hand, we started our investigation by optimizing different 
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reaction conditions. Without any additives, 5 mol% of complex promoted this 
transformation with high conversion at -20 °C after 3 days by using dichloroethane 
(DCE) as the solvent. However, the diastereoselectivity and enantioselectivity were 
moderate (Table 1, entry 1). Fortunately, the addition of NaBArF (tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate) significantly enhanced the enantioselectivity to 
83% ee and the anti isomer was highly favored (entry 2), although the conversion was 
sluggish after 12 h. Adding silver salts had a negative effect on the reactivity and only 
trace product was observed (entries 3 and 4). Interestingly, increasing the temperature 
will enhance both the enantioselectivity and reactivity while  
 
Table 1. Optimization of the reaction conditions. 
 
entry X additive (Y) T (°C)solvent conv. (%)
a anti/synb ee (%)c
1d 5 ---- -20 95 5:1 47
2e 5 NaBArF (10) -20 50 >99:1 83
3 5 AgPF6 (10) -20 10 ---- ----
4 5 AgBF4 (10) -20 5 ---- ----
7 5 NaBArF (10) 0 100 >99:1 88
8 5 NaBArF (10) RT 100 >99:1 92
9e,g 1 NaBArF (2) RT 100 5:1 84
10e,g 0.5 NaBArF (1) RT 100 1.2:1 81
11e,g 0.2 NaBArF (0.4) RT 100 1:3 80
12h 0.005 NaBArF (0.01) 70 100 1:35 36
13 5 NaBArF (7) RT 100 >99:1 92
14e 5 NaBArF (7) RT 100 >99:1 83
DCE
DCE
DCE
DCE
DCE
DCE
DCE
DCE
DCE
DCE
DCE
Benzene
15 5 NaBArF (7) RT 5 ---- ----THF
16 5 NaBArF (7) RT 100 60:1 83DCM
5 NaBArF (7) RT 100 >99:1 90Hexane17
i
5f
6
5
5 NaBPh4
NaBF4 DCE
DCE
RT
RT
100
100 >99:1 71
---- ----
O + EtMgBr
B (X mol%)
Additive (Y mol%)
3 eq.
solvent (0.10 M)
temperature, 12h
OH
Et
OH
Et
+
anti syn
 
a determined by 1H NMR and/or GC-MS. b Determined by 1H NMR. c Determined by chiral HPLC. Isolated cis 
isomer is racemic. d 72h. e 15-20% of dehydroxylation product 2-ethylnaphthalene was observed. f full conversion 
to 2-ethylnaphthalene g 60h. h 90% of naphthalene was observed. 
 
maintaining the diastereoselectivity. Moreover, 92% ee could be obtained at room 
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temperature using DCE as the solvent (entry 8). Using NaBF4 as the additive at room 
temperature led to full conversion to the by-product 2-ethylnaphthalene (entry 5). 
NaBPh4, the non-fluorinated analogue of NaBArF, promoted the reaction efficiently 
but with lower enantioselectivity (entry 6). When we tried to decrease the catalyst 
loading, the syn-product was found to be preferable and the enantioselectivity 
decreased along with decomposition of either the product (entries 9-11) or the starting 
material (entry 12). The amount of  NaBArF additive could be lowered to 7% without 
affecting the selectivity and reactivity (entry 13). Switching to THF as the reaction 
solvent will completely shut down the reaction (entry 15). Interestingly, using hexane 
as the solvent will give a clean outcome with excellent selectivities and reactivity 
(entry 17).  
To evaluate the scope of this reaction, various oxabenzonorbornadienes and 
Grignard reagents were studied and are listed in Table 2. In most cases, full 
conversion was achieved after stirring the reaction mixture for 12 h at room 
temperature or 50 °C and the anti products were formed exclusively. A broad range of 
primary Grignard reagents reacted with oxabenzonorbornadiene forming the products 
with good reactivities and enantioselectivies (entries 1-7). The bromo Grignard 
reagent is superior to the chloro counterpart in terms of enantioselectivity (entries 3 
and 4). Furthermore, the use of secondary Grignard reagent isopropylmagnesium 
bromide leads to good yields, although the selectivity is moderate (entry 8). 
Performing the reaction of 6,7-dibromo-substituted oxabenzonorbornadiene (2) and 
isobutylmagnesium bromide at room temperature afforded good reactivity and 
selectivity (entry 9). With slight heating, the yield of the product could be improved 
to 91% and the enantioselectivity decreased only slightly (entry 10). The reaction of 
bulky substrate 3, which contains methoxy groups at the 5,8-positions, gave moderate 
selectivity (entry 11). Substrate 4, which bears two methyl groups at the 1,4-positions, 
reacts with different primary Grignard reagents efficiently at room temperature 
affording the products with good selectivities (entries 12-14). For unsymmetrical 
oxabenzonorbornadiene 5 bearing a methyl substituent at the bridgehead position, the 
expected kinetic resolution of the racemic substrate with EtMgBr was not observed 
and the anti ring opened product 6l was obtained with only 9% ee in a yield of 65% 
(entry 15). The reaction proceeded with complete regioselectivity by attack of the 
ethyl Grignard reagent onto the olefinic terminus distant to the methyl group.  
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Table 2. Asymmetric ring opening of oxabenzonorbornadienes with alkyl Grignard reagentsa 
 
O
R2
+ R1MgBr
OH
R1R
2B (5 mol%)
NaBArF (7 mol%)
Temperature
hexane,12h
anti:syn >99:1  
entry substrate productR1 yield (%)
b ee (%)c
1d O
OH
R1Et 85 92
2
T (°C)
RT
RT nBu 90 87
50
3
nBu 92 744
e
50 iBu 92 885
RT iBu 30 916
d
RT Me 76 75
7 RT nC12H25 71 74
8 50 iPr 92 52
9
O
Br
Br
RT iBu 83 85
50 iBu 91 8010
11 O
OMe
OMe
RT Et 81 47
12
O
RT Et 88 84
OH
R1Br
Br
OH
R1
OMe
OMe
R1
OH
13
14
RT
RT
nPent 86 77
iBu 86 88
15 O RT Et 65 9
R1
OH
1
2
3
4
5
6a
6b
6c
6c
6d
6d
6e
6f
6g
6g
6h
6i
6j
6k
6l
 
a reaction conditions: oxabenzonorbornadiene (0.2 mmol), R1MgBr (3.0 eq.), B (5 mol%), NaBArF (7 mol%). b  
Isolated yield. In all cases anti/syn are >99/1. c ee of trans product and determined by chiral HPLC. d DCE (3 ml) 
was used as solvent e nBuMgCl was used as the Grignard reagent.  
 
 
To the best of our knowledge, there is only one report to date describing the 
asymmetric desymmetrization of oxabenzonorbornadienes with aryl groups giving the 
anti product. In 2009, Alexakis et al. used PhAlEt2 as the arylation agent to get the 
corrresponding product 7 with 84% ee. However, due to the competing reaction 
87 
between phenyl and ethyl groups of PhAlEt2, the yield was low (40%). In our 
preliminary trial, we were delighted to find that our catalyst promotes the reaction 
between oxabenzonorbornadiene and phenylmagnesium bromide smoothly, providing 
the product with 70% yield albeit with moderate selectivity (Scheme 2). Further 
studies are in progress towards the improvement of enantioselectivity in this 
asymmetric transformation.  
 
O + PhMgBr
B (5 mol%)
NaBArF (7 mol%)
DCE/Hexane (2ml/2ml)
50 °C, 12h
OH
Ph anti/syn 98:2
70% yield, 52% ee
71  
 
Scheme 2. Ring opening of oxabenzonorbornadiene with phenylmagnesium bromide 
 
Allyl magnesium halides are another class of nucleophiles that in general do not 
show any reactivity in these transformations.5b We found that, by using copper 
complex B as the precatalyst, the asymmetric ring-opening of oxabenzonorbornadiene 
with allyl magnesium chloride leads to the anti product in a good 73% yield although 
with only very moderate enantioselectivity (35% ee, Scheme 3).  
 
O + AllylMgCl
B (5 mol%)
NaBArF (7 mol%)
DCE(0.10 M)
RT, 48h
OH
anti/syn >99:1
73% yield, 35% ee  
Scheme 3. Ring opening of oxabenzonorbornadiene with allylmagnesium chloride 
 
Finally, the less reactive non-aromatic oxabicyclic alkene, 5,6-bismethoxymethyl-
7-oxa-bicyclo[2.2.1]-2-heptene, was also examined in the reaction with ethyl 
magnesium bromide. Only the starting material was recovered under our reaction 
conditions (50 °C, one day) (Scheme 4).  
 
O
OMe
OMe
+ EtMgBr
3.0 eq.
B (5 mol%)
NaBArF (7 mol%)
DCE, 50 °C
24h
No reaction
8  
 
Scheme 4. Trial of ring-opening of oxabicyclic alkene 8 
 
4.4 Conclusion 
 
In summary, we have developed the first chiral NHC-copper catalyst that effects 
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the enantioselective ring-opening of oxabicyclic alkenes with Grignard reagents. The 
ring-opened products were obtained in high yields, high enantioselectivities and 
excellent trans diastereoselectivities. Other asymmetric transformations using this 
catalyst are underway. 
 
Acknowledgment. Support for this work was provided by the SNF (grant to L. Wu), 
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4.5 Experimental Part 
General: All reactions were carried out using standard Schlenk or glovebox 
(Mecaplex or Innovative Technology) techniques under nitrogen. All reagents were 
used as received unless otherwise noted. Solvents were purchased in the best quality 
available, degassed by purging thoroughly with nitrogen and dried over molecular 
sieves of appropriate size. Alternatively, they were purged with argon and passed 
through alumina columns in a solvent purification system (Innovative Technology). 
Solvents for NMR spectroscopy were degassed with nitrogen and dried over 
molecular sieves. NMR spectra were collected on AV2 400 or AV2 500 MHz Bruker 
spectrometers. Chemical shifts are given in ppm. The spectra were calibrated to the 
residual 1H and 13C of the solvent. Multiplicities are abbreviated as follows: singlet 
(s), doublet (d), triplet (t), quartet (q), doublet-doublet (dd), quintet (quint), septet 
(sept), multiplet (m), and broad (br).  High-resolution electrospray ionization mass 
spectrometry was performed on a FinniganMAT 900 (Finnigan MAT95, San Jose, 
CA; USA) double-focusing magnetic sector mass spectrometer (geometry BE). GC-
MS analysis was done on a Finnigan Voyager GC8000 Top. X-ray crystallography 
was performed on an Agilent Technologies SuperNova area-detector diffractometer 
using Mo Kα radiation (λ = 0.71073 Å) from a micro-focus X-ray source and an 
Oxford Instruments Cryojet XL cooler. 
 
Chiral NHC salt A was prepared according to our previous report. 9r 
Oxabenzonorbornadienes 2,11 3,12 4,13 5,14 and 83b were prepared according to 
literature.  
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Synthesis of Cu complex B: 
 
Chloro [4S,5S-1,3-Bis(2-cycoctyl-naphthalen-1-yl)-4,5-dihydro-
4,5-diphenyl imidazol-2-ylidene] copper (I) [((2)-
DiPhSICyoctNap)CuCl]. A (1.50 g, 1.92 mmol), KOtBu (279 mg, 
2.49 mmol) and CuCl (247 mg, 2.49 mmol) were mixed together in 
a round flask in the glovebox. Dry THF (30 mL) was added and the mixture was 
stirred at room temperature for 4 h. The resulting mixture was filtered through celite 
and dried under vacuum, and the residue was further purified by flash 
chromatography on siliga gel (DCM:ethanol  100:1) to afford the title product as a 
white solid (900 mg, 59%). Elemental analysis: calcd for C51H54ClN2Cu : C, 77.15; 
H, 6.86; N, 3.53. Found: C, 76.80; H, 6.81; N, 3.22. [α]25D = -144.5 (c = 0.77, 
CH2Cl2). 1H NMR (CDCl3, 500 MHz): δ = 8.13 (d, J = 8.0 Hz, 2H), 7.88 (d, J = 8.1 
Hz, 2H), 7.76-7.72 (m, 4H), 7.53 (t, J = 7.5 Hz, 2H), 7.23-7.07 (m, 12H), 6.12 (s, 
2H), 3.12 (br, 2H), 2.06-2.05 (m, 2H), 1.72-1.60(m, 24H), 0.32-0.28 (m, 2H). 13C 
{1H} NMR (CDCl3, 125 MHz): 203.78, 148.67, 134.06, 133.72, 131.22, 130.52, 
130.02, 129.95, 129.75, 129.50, 129.30, 128.08, 126.34, 125.96, 122.79, 73.49, 40.33, 
36.74, 34.20, 28.21, 27.85, 27.00, 26.60, 26.26. HRMS (ESI): m/z : calcd for 
C51H54ClN2CuNa [M+Na]+: 815.31637; found: 815.31582. 
 
Catalytic ring-opening reaction:  
 
O
R2
+ R1MgBr
OH
R1R
2B (5 mol%)
NaBArF (7 mol%)
Temperature
hexane,12h
anti:syn >99:1  
General catalysis procedure: A solution of copper complex B (7.9 mg, 0.010 mmol), 
and NaBArF (12.8 mg, 0.014 mmol) in anhydrous hexane (6 mL) or DCE (3 ml) was 
stirred at room temperature for 15 min. Oxabenzonorbornadiene  (0.20 mmol) was 
added to this colorless solution followed by the addition of the Grignard reagent in 
diethyl ether. The solution was stirred at the corresponding temperature for 12h. After 
quenching with an aqueous solution of Na2CO3 (1.0 M, 1 mL) at -20 degree, the 
reaction mixture was extracted with ether (3 X 10 mL). The organic phase was dried 
over anhydrous MgSO4, filtered, and concentrated to give a crude product, which was 
N N
Ph Ph
Cu
Cl
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subjected to flash chromatography on silica gel with n-hexane/ethyl acetate/triethyl 
amine (100:15:1) to afford the product. The enantiomeric excess of the product was 
analyzed by HPLC. 
 
(-)-trans-2-Ethyl-1,2-dihydronaphth-1-ol (6a, Table 2, entry 1)  
85% yield, colorless oil, the spectral data were in accordance with 
those reported in the literature.2c 92% ee [Chiralcel OD-H column, 
n-hexane/i-PrOH =98:2, 1.0 mL/min; t = 18.1 min (major) and 21.2 min (minor)]. 
 
(-)-trans-2-Methyl-1,2-dihydronaphth-1-ol (6b, Table 2, entry 2)  
76% yield, white solid, the spectral data were in accordance with those 
reported in the literature. 2c 75% ee [Chiralcel OD-H column, n-
hexane/i-PrOH =99:1, 1.0 mL/min; t = 33.2 min (major) and 37.8 min 
(minor)]. 
 
(-)-trans-2-n-Butyl-1,2-dihydronaphth-1-ol (6c, Table 2, entry 3)  
90% yield, white solid, the spectral data were in accordance with 
those reported in the literature. 2c 87% ee [Chiralcel OD-H 
column, n-hexane/i-PrOH =99:1, 1.0 mL/min; t = 26.9 min (major) and 34.1 min 
(minor)]. 
 
(-)-trans-2-iso-Butyl-1,2-dihydronaphth-1-ol (6d, Table 2, entry 5)  
92% yield, white solid, the spectral data were in accordance with 
those reported in the literature. 15 88% ee [Chiralcel OD-H column, 
n-hexane/i-PrOH =99:1, 1.0 mL/min; t = 25.2 min (major) and 31.7 min (minor)]. 
 
(-)-trans-2-n-Dodecyl-1,2-dihydronaphth-1-ol (6e, Table 2, entry 7)  
71% yield, white solid. 1H NMR (CDCl3, 400 MHz): δ = 7.27 (d, J = 
7.1 Hz, 1H), 7.19-7.14 (m, 2H), 7.02 (d, J = 7.2 Hz, 1H), 6.40 (d, J = 
10,6 Hz, 1H), 5.93 (t, J = 5.1 Hz, 1H), 4.43 (s, 1H), 2.47 (br, 1H), 1.31-1.67 (m, 22H), 
0.81-0.79 (m, 3H). 13C {1H} NMR (CDCl3, 100 MHz): 136.32, 132.97, 131.70, 
129.08, 128.46, 128.20, 127.08, 126.46, 73.05, 43.13, 32.52, 32.22, 30.40, 30.27, 
OH
OH
OH
OH
OH
11
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30.24, 30.21, 30.13, 29.95, 27.71, 23.29, 14.71. HRMS (EI): m/z : calcd for C22H34O 
[M]+: 314.26042; found: 314.26092. [α]25D = -163.4 (c = 0.97, CH2Cl2), 74% ee 
[Chiralcel OD-H column, n-hexane/i-PrOH =99:1, 1.0 mL/min; t = 19.2 min (major) 
and 24.8 min (minor)]. 
 
(-)-trans-2-iso-Propyl-1,2-dihydronaphth-1-ol (6f, Table 2, entry 8)  
92% yield, white solid, the spectral data were in accordance with 
those reported in the literature. 2c 52% ee [Chiralcel OD-H column, n-
hexane/i-PrOH =99:1, 1.0 mL/min; t = 27.6 min (major) and 37.8 min (minor)]. 
 
(-)-trans-2-iso-Butyl-6,7-dibromo-1,2-dihydronaphth-1-ol (6g, Table 2, entry 10)  
91% yield, colorless oil, the spectral data were in accordance 
with those reported in the literature. 5b 80% ee [Chiralcel OD-H 
column, n-hexane/i-PrOH =99:1, 1.0 mL/min; t = 31.6 min (major) and 39.2 min 
(minor)]. 
 
(-)-trans-2-Ethyl-5,8-dimethoxy-1,2-dihydronaphth-1-ol (6h, Table 2, entry 11)  
81% yield, colorless oil, the spectral data were in accordance with 
those reported in the literature. 2c 47% ee [Chiralcel OD-H column, n-
hexane/i-PrOH =90:10, 1.0 mL/min; t = 14.0 min (minor) and 27.1 min 
(major)]. 
 
(-)-trans-2-Ethyl-1,4-dimethyl-1,2-dihydronaphth-1-ol (6i, Table 2, entry 12) 
88% yield, colorless oil, the spectral data were in accordance with 
those reported in the literature. 2c 84% ee [Chiralpak AD-H column, n-
hexane/i-PrOH =99:1, 1.0 mL/min; t = 19.2 min (major) and 30.4 min 
(minor)]. 
 
(-)-trans-2-n-Pentyl-1,4-dimethyl-1,2-dihydronaphth-1-ol (6j, Table 2, entry 13) 
86% yield, colorless oil. 1H NMR (CDCl3, 400 MHz): δ = 7.60-7.58 (m, 1H), 7.26-
7.22 (m, 3H), 5.71 (dd, J = 2.9, 1.5Hz, 1H), 2.34-2.32 (m, 1H), 2.06 (t, J = 1.8 Hz, 
OH
OH
Br
Br
OHOMe
OMe
OH
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3H), 1.75-1.71 (m, 1H), 1.51-1.20 (m, 11H), 0.89 (t, J = 7.0 Hz, 
3H). 13C {1H} NMR (CDCl3, 100 MHz):  144.31, 134.63, 
131.96, 129.01, 128.30, 127.83, 123.85, 123.73, 75.28, 47.30, 
32.68, 28.73, 27.93, 23.26, 23.07, 19.73, 14.69. HRMS (ESI): m/z : calcd for C17H24O 
[M]+: 244.18217; found: 244.18230. [α]25D = -47.60 (c = 1.37, CH2Cl2), 77% ee 
[Chiralpak AD-H column, n-hexane/i-PrOH =99:1, 1.0 mL/min; t = 15.3 min (major) 
and 23.8 min (minor)]. 
 
(-)-trans-2-iso-Butyl-1,4-dimethyl-1,2-dihydronaphth-1-ol (6k, Table 2, entry 14) 
86% yield, colorless oil, the spectral data were in accordance with 
those reported in the literature.5b 88% ee [Chiralpak AD-H column, 
n-hexane/i-PrOH =99:1, 1.0 mL/min; t = 13.4 min (major) and 15.9 
min (minor)]. 
 
(-)-trans-2-Ethyl-4-methyl-1,2-dihydronaphth-1-ol (6l, Table 2, entry 15) 
65% yield, colorless oil, the spectral data were in accordance with those 
reported in the literature. 2c 9% ee [Chiralcel OD-H column, n-hexane/i-
PrOH =99:1, 0.5 mL/min; t = 55.3 min (major) and 59.1 min (minor)]. 
 
(-)-trans-2-Phenyl-1,2-dihydronaphth-1-ol (6m, Scheme 2) 
70% yield, white solid, the spectral data were in accordance with 
those reported in the literature.15 7.45 (dd, J = 7.2, 0.8 Hz, 1H), 
7.35-7.29 (m, 7H), 7.22 (dd, J = 7.0, 1.7 Hz, 1H), 6.70 (dd, J = 9.6, 2.0 Hz, 1H), 6.08 
(dd, J = 9.6, 3.8 Hz, 1H), 4.88 (dd, J = 7.7, 5.2 Hz, 1H), 3.86-3.83 (m, 1H), 1.99 (d, J 
= 5.3 Hz, 1H). 13C NMR 140.87, 135.60, 132.59, 129.82, 128.79, 128.42, 128.25, 
128.10, 127.65, 127.21, 126.41, 74.36, 50.16. [α]25D = -144.4 (c = 0.93, CH2Cl2), 52% 
ee [Chiralcel OJ-H column, n-hexane/i-PrOH =90:10, 1.0 mL/min; t = 12.7 min (major) 
and 22.2 min (minor)]. 
 
 
 
OH
OH
OH
OH
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(-)-trans-2-Allyl-1,2-dihydronaphth-1-ol (6n, Scheme 3) 
73% yield, colorless oil. 1H NMR (CDCl3, 400 MHz): δ = 7.38-7.27 
(m, 3H), 7.17 (dd, J = 7.1, 1.2 Hz, 1H), 6.07-5.98 (m, 1H), 5.88 (dd, 
J = 8.1, 1.5 Hz, 1H), 5.25-5.15 (m, 2H), 4.64 (s, 1H), 2.63-2.59 (m, 2H), 2.45-2.36 (m, 
1H), 1.64 (d, J = 6.5 Hz, 1H). 13C {1H} NMR (CDCl3, 100 MHz):  136.66, 136.59, 
132.64, 130.29, 128.61, 127.70, 127.61, 127.03, 126.59, 116.88, 70.26, 40.31, 33.62. 
HRMS (EI): m/z : calcd for C13H14O [M]+: 186.10392; found: 186.10378. [α]25D = -
55.64 (c = 0.63, CH2Cl2), 35% ee [Chiralcel OD-H column, n-hexane/i-PrOH =99:1, 
1.0 mL/min; t = 24.3 min (major) and 27.6 min (minor)]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OH
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Chapter 5 
 
Monodentate Chiral N-Heterocyclic Carbene Palladium 
Catalyzed Asymmetric Suzuki-Miyaura and Kumada 
Couplings 
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5.1 Abstract 
N-Heterocyclic carbene ligands derived from C2-symmetric diamine with naphthyl 
side chains are introduced as chiral monodentate ligands, and their palladium 
complexes (NHC)Pd(cin)Cl are prepared. At the 2-position of the naphthyl moiety, a 
4-heptyl group is introduced. These compounds exist as a mixture of diastereomers, 
and the palladium complexes can be successfully separated. When one of the pure 
palladium diastereomers (Sa,Sa) is used in the asymmetric Suzuki-Miyaura and 
Kumada coupling, chiral biaryls can be obtained in high yield and moderate 
selectivity. 
 
5.2 Introduction 
Axially chiral biaryls are common and decisive structure motifs in bioactive 
compounds1 and are the fundamental basis for most effective chiral ligands, such as 
the well-known BINAP2 and BINOL3 ligands. Cross-coupling reactions4 (i.e. Suzuki-
Miyaura coupling and Kumada coupling) have opened a direct and convenient route 
to such unsymmetric axially chiral molecules like biaryls, which cannot be readily 
obtained by other catalytic asymmetric reactions. The first successful atroposelective 
cross-coupling was reported by Hayashi in the late 1980s using aryl halides and aryl 
Grignard reagents as the coupling partners (Kumada coupling) and chiral 
ferrocenylphosphine/Ni as the catalyst.5 Following this seminal work, several 
phosphine ligands were examined in the Kumada coupling but only low to moderate 
enantioselectivities have been achieved to date.6 To date, several reports of 
asymmetric Suzuki-Miyaura and Kumada coupling using chiral phosphine ligands 
have appeared.7 The earliest reports of asymmetric cross-coupling of aryl halides and 
aryl boron reagents were disclosed by Cammidge8 and Buchwald9 using ferrocene and 
binaphthyl derived phosphines respectively. Since then, a variety of chiral ligands 
have been examined for the asymmetric Pd-catalyzed Suzuki-Miyaura coupling 
reaction.10 Moreover, it is noteworthy that Uozumi reported a chiral resin-supported 
phosphine ligand that efficiently catalyzes the synthesis of axially chiral biaryl 
compounds via Suzuki-Miyaura coupling with excellent selectivities (up to 94% ee) 
in water.10f More recently, in 2008 Lassaletta et al. disclosed a new class of chiral bis-
hydrazone ligands derived from C2-symmetric hydrazines for the asymmetric Suzuki-
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Miyaura coupling, providing the biaryls in high selectivity (up to 98% ee).10e In 
addition, Suginome showed that helically chiral poly(quinoxaline-2,3-diyl)-based 
phosphines serve as highly enantioselective ligand ( up to 95% ee) in the Suzuki–
Miyaura coupling reaction to form axially chiral biarylphosphinic esters.10i  
N-heterocyclic carbenes (NHCs) have received a great deal of attention in the past 
decade and are now considered as ligands of choice for various (asymmetric) catalytic 
reactions.11 The use of NHCs as ligands in cross-coupling has been intensively 
studied by different research groups and they have demonstrated remarkably high 
activity promoting this kind of transformation.11c,12 The capacity of NHCs has been 
illustrated not only in cross-coupling reactions but also in different asymmetric 
transformations.13 However, little attention has been given to the asymmetric cross-
coupling using chiral NHCs as the ligands. To the best of our knowledge, there are 
only two reports to date on using chiral NHC ligands to promote asymmetric cross-
coupling reactions. In 2010, Labande disclosed the first example of asymmetric 
Suzuki-Miyaura coupling with palladium complexes bearing chelating, planar chiral 
ferrocenyl phosphine-NHC ligands.14 However, only low enantioselectivities were 
achieved (less than 40% ee) in this transformation using aryl bromides as the 
electrophiles. Recently, Zhang et al. prepared two palladium complexes of bis-NHC 
ligands derived from 1,2-cyclohexanediamine and employed them to catalyze the 
asymmetric Suzuki-Miyaura couplings of aryl bromides with arylboronic acids in 
good yields and moderate enantioselectivities (up to 61% ee).15 As far as we are 
aware, there are no reports on asymmetric cross-coupling using chiral monodentate 
NHCs as the stereocontrolling ligand. Moreover, no chiral (monodentate or chelate) 
NHC ligands have been disclosed for the asymmetric Kumada cross-coupling 
reaction.  
X
R2R1
+
B(OH)2
R3 R4 Pd/chiral monodentate NHC R
1 R2
R3 R4
No reports:
X
R2R1
+
MgBr
R3 R4 Pd/chiral NHC R
1 R2
R3 R4
X = Cl, Br  
Scheme 1. Asymmetric Suzuki-Miyaura and Kumada coupling 
 
99 
5.3 Results and Discussion 
Our group has developed a new type of monodentate NHC ligand with a chiral N-
heterocycle and naphthyl side chains. These compounds exist as a mixture of 
diastereomers and their palladium complexes showed different selectivity asymmetric 
intramolecular α-arylation.16 Recently, we have gained access to only one 
diastereomer by introdution of bulky cyclooctyl groups to the 2-position of the 
naphthyl side chain. The palladium cinnamyl complex (Scheme 1, A) thereof allowed 
the direct synthesis of 3-aryl-3-fluoro-oxindoles via an α-arylation protocol in good 
yields and with excellent enantioselectivities (up to >99% ee).17  
When this complex was used to catalyze the coupling between 1-bromo-2-
methoxynaphthalene and 1-naphthylboronic acid (asymmetric Suzuki-Miyaura 
coupling), a high yield of the product was obtained. However, only low 
enantioselectivity (25%) was observed (entry 1, Table 1). When the bulky and acyclic 
4-heptyl moiety was introduced to the 2-position of the naphthyl group, a new NHC 
salt (Scheme 2, B) was generated and a mixture of three diastereomers was observed 
with the ratio of 38:28:34 [(Sa,Sa):(Ra,Ra):(Ra,Sa)]. While the separation of these 
three diastereomeric salts turned out to be impossible, we successfully separated the 
corresponding palladium cinnamyl complexes via simple column chromatography. 
The structure of one of the isomers [(Ra,Sa)-C] was unambiguously confirmed by 
single-crystal X-ray crystallography. All of these three complexes were independently 
tested in the asymmetric Suzuki-Miyaura coupling. To our surprise, the (Ra,Ra) 
isomer, which showed the best enantiomeric discrimination in asymmetric α-
arylations, gave low reactivity and selectivity (entry 2). In contrast, isomer (Ra,Sa)-C 
showed excellent reactivity in this tranformation while giving the racemic product 
(entry 3). Conversely, the (Sa,Sa)-C diastereomer, which possesses the alkyl chains 
opposite to the phenyl groups, promoted this reaction efficiently affording the tri-
ortho-substituted biaryl in excellent yield (91%) and moderate enantioselecvitity 
(60% ee, entry 4). When 1-bromo-2-methylnaphthalene instead of 1-bromo-2-
methoxynaphthalene was used, a slightly lower ee was observed (entry 5). Screening 
of the solvent revealed that toluene is the best choice and that ethereal solvents and 
dichloromethane gave lower enantioselectivities (entries 6-9). The catalyst showed 
little reactivity in hexane (entry 10). Optimization of the base revealed that NaOtBu 
gave much lower yield and enantioselectivity compared to KOtBu (entry 11), while 
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the use of LiOtBu and KHMDS led to the recovery of the starting material (entries 12 
and 13). 
 
N N
Ph Ph
Cyoct
Cyoct
Pd
Cl
Ph
A
N N
Ph Ph
4-Hep
N N
Ph Ph
4-Hep 4-Hep
N N
Ph Ph
4-Hep
4-Hep
RaSa-CSaSa-C RaRa-C
4-Hep
Pd
Cl
Ph
Pd
Cl
Ph
Pd
Cl
Ph
N N
Ph Ph4-Hep4-Hep
BF4
SaSa:RaRa:RaSa = 38:28:34
KOtBu, 
[Pd(cinnamyl)Cl]2
THF, RT
B
B
Cyoct =
4-Hept =
 
Scheme 1. NHC-Pd complexes tested in this study 
 
Table 1. Optimization of the Suzuki-Miyaura reaction condition.a 
 
R
Br B(OH)2
Pd complex (2 mol%)
Base, Solvent (0.125 M)
RT, 16h
R
Entry R
R = OMe, Me
Base Solvent Yieldb e.e.
c
Pd complex
SaSa-C OMe KOtBu Toluene 6091
2
OMe KOtBu Toluene 933
OMe KOtBu Toluene 55
8
4
22
5
Me THF 92 40
DME 83 50
Dioxane 94 37
DCM 92 35
7
8
9
Me
Me
Me
KOtBu
KOtBu
KOtBu
KOtBu
Me KOtBu Toluene 94 51
OMe KOtBu Toluene 2590A
RaRa-C
RaSa-C
1
6
SaSa-C
SaSa-C
SaSa-C
SaSa-C
SaSa-C
Me Hexane <20 N.D.
Toluene 43 35
Toluene <15 N.D.
Toluene <10 N.D.
11
12
13
Me
Me
Me
KOtBu
NaOtBu
LiOtBu
KHMDS
10 SaSa-C
SaSa-C
SaSa-C
SaSa-C
1.5 eq.
 
a Conditions: bromide (0.125 mmol, 1eq), 2-naphthylboronic acid (1.5 eq), base (2.5 eq), Pd complex 
(2 mol%), solvent (1 ml), 250C, 16 h; b Isolated yield; c Determined by HPLC.  
 
With the optimized condition in hand [2 mol% of the catalyst (Sa,Sa)-C, toluene as 
solvent and KOtBu as base], different substrates were tested and the results are 
summarized in Table 2. In most of the cases, excellent yields could be obtained by 
using 2 mol% of the (Sa,Sa)-C.  The coupling of 1-bromo-2-methylnaphthalene and 
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1-naphthylboronic acid afforded the product in excellent yield and 51% ee (entry 1). 
Increasing the amount of boronic acid, base and the catalyst decreased the reactivity 
and selectivity (entry 2). The use of the (Ra,Ra)-C isomer or the in situ generated  
 
Table 2. Substrate scope of asymmetric Suzuki-Miyaura couplingsa 
 
ArX + ArB(OH)2
Ar-Ar
SaSa-C (2 mol%)
KOtBu, Toluene
RT, 16h  
Entry ArX ArB(OH)2 Ar-Ar Yieldb ee
c
1
Br B(OH)2
Me Me
94 51 (S)
2 90 43 (S)d
85 30 (S)e3
4 95 27 (S)f
Br
OMe
5
B(OH)2
OMe
91
6
Br
OMeMeO
B(OH)2
OMeMeO
86 12
Cl
OMe
B(OH)2
OMe
70
7
8
Br B(OH)2
93 46 (S)
Me
Me
Br
Me
B(OH)2
Me 83
28
9
Me
Me
Cl
Me
B(OH)2
Me
66 33 (S)
10
60 (R)
50 (R)
 
a Conditions: ArX (0.125 mmol, 1eq), ArB(OH)2 (1.5 eq), KOtBu (2.5 eq), (Sa,Sa)-C (2 mol%), 
Toluene (1 ml), 25 0C, 16h; b Isolated yield; c Determined by HPLC. The absolute configuration was 
assigned by comparison with literature; d ArB(OH)2 (2.5 eq), KOtBu (3.5 eq), (Sa,Sa)-C (5 mol%); e 
(Ra,Ra)-C (2 mol%), 50 0C; f B (5 mol%), [Pd(cinnamyl)Cl]2 (2.5 mol%). 
102 
 
catalyst (employing the diastereomeric mixture of B) lowered the enantioselectivity 
(entries 3 and 4) as well. The aryl chloride analogue could serve as an effective 
electrophile, although the yields and enantioselectivities decreased compared to the 
bromides (entry 1 vs 5, 7 vs 8). Interchanging the electrophile and nucleophile of 
entry 1 (see entry 6) did not affect the yield, but the ee decreased slightly from 51% to 
46%. Interestingly, the configuration of the product was retained (both S) which is  
consistant with Lassaletta’s result.10e Introduction of the substitution to the 7- position 
of the electrophile seems to be very deleterious to the selectivity (entry 7 vs 9). One 
example of ortho-substituted phenylbromide was examined, and the product 2-
methyl-1-(2- methylphenyl)naphthalene was obtained in good yield (83%) and 
relatively low ee (28%, entry 10). 
With the promising results from asymmetric Suzuki-Miyaura coupling in hand, we 
turned our attention to another versatile coupling — the Kumada coupling. We were 
delighted to find that our catalyst (Sa,Sa)-C could promote the asymmetric Kumada 
coupling smoothly giving the chiral biaryls in good yields, albeit in very moderate 
selectivities (Table 3). For instance, the in situ generated 2-
methoxynaphthylmagnesium bromide can couple with 1-bromonaphthalene at room 
temperature affording the chiral binaphthyl product in 81% yield and 48% ee (entry 1). 
In this case, switching the nucleophile and electrophile to each other reduced both 
reactivity and selectivity, but not the configuration of the product (entry 2). Using aryl 
chloride retained the selectivity, although the yield of the product decreased 
dramatically from 81% to 40% (entry 3 vs 1). Replacement of 1-bromonaphthalene 
with 2-methylphenylbromide lowered both the yield and enantioselectivity (entry 4 vs 
1). The yield was improved by heating (50 °C), but at the expense of further eroding 
the enantioselectivity (31% ee, entry 5). Using the aryl chloride did not change the 
outcome in terms of reactivity and selectivity (entry 6). Changing the nucleophile to a 
more sterically hindered compound (2-methylnaphthylmagnesium bromide) 
decreased the enantioselectivity (27% ee, entry 7 vs 1). 
 
5.4 Conclusion 
 
In conclusion, we report the synthesis of a new NHC ligand with a chiral N-
heterocycle and naphthyl side chains having 4-heptyl groups in the 2-position. The 
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imidazolinium salts showed the existence of three different isomers in such NHC 
structures. Diastereomerically pure palladium complexes incorporating these ligands 
were obtained after simple chromatography. One of the resulting compounds (Sa,Sa-
C) was tested in the asymmetric Suzuki-Miyaura and Kumada coupling that formed 
chiral biaryls in high yields and moderate enantioselectivities. This represents the first 
example of asymmetric C-C couplings giving chiral biaryls using a monodentate 
chiral NHC ligand. 
 
Table 3. Substrate scope of asymmetric Kumada couplinga 
 
ArMgBr + ArX Ar-Ar
(Sa,Sa)-C (2 mol%)
Toluene
Temperature, 16h  
Entry ArMgBr Ar'X Ar-Ar' Yieldb ee
c
1
MgBr
OMe
OMe 81
MgBr
Me
3
Br
Me 78 27 (S)
4
MgBr
OMe
Br
OMe 71 31
7
5d
MgBr Br
51 39
Me
Me
6d
MgBr Cl
40
2d
RT
OMe
OMe
OMe
OMe
Me
Me
MgBr
OMe
Cl
OMe 77
31Me
Me
MgBr Br
72
OMe
OMe
Br
Temp.(°C)
50
50
RT
50
50
RT
48 (R)
37(R)
41 (R)
 
a Conditions: ArMgBr (0.25 mmol, 1 eq), Ar’X (1.0 or 2.0 eq), (Sa,Sa)-C (2 mol%), THF (2 ml), 16h; b 
Isolated yield; c Determined by HPLC. The absolute configuration was assigned by comparison with 
literature; d 2.0 equivalents of halide was used. 
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5.5 Experimental Part 
General: All reactions were carried out using standard Schlenk or glovebox 
(Mecaplex or Innovative Technology) techniques under nitrogen. KOtBu was used 
after sublimation. All other reagents were used as received unless otherwise noted. 
Solvents were purchased in the best quality available, degassed by purging thoroughly 
with nitrogen and dried over molecular sieves of appropriate size. Alternatively, they 
were purged with argon and passed through alumina columns in a solvent purification 
system (Innovative Technology). Solvents for NMR spectroscopy were degassed with 
nitrogen and dried over molecular sieves. NMR spectra were collected on AV2 400 or 
AV2 500 MHz Bruker spectrometers. Chemical shifts are given in ppm. The spectra 
were calibrated to the residual 1H and 13C of the solvent. Multiplicities are 
abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), doublet-doublet 
(dd), quintet (quint), septet (sept), multiplet (m), and broad (br).  High-resolution 
electrospray ionization mass spectrometry was performed on a FinniganMAT 900 
(Finnigan MAT95, San Jose, CA; USA) double-focusing magnetic sector mass 
spectrometer (geometry BE). Crystallographic data for the structure were collected at 
100(2) K on an Oxford Diffraction Gemini diffractometer fitted with Mo Kα 
radiation. 
 
Synthesis of the Pd complex:  
2-(4-heptyl)naphthalene. In a 250 mL 3-necked flask, equipped with condenser, 
addition funnel and N2 inlet, were added magnesium (1.18 g, 48.3 
mmol) and I2 (one crystal) under N2. In the addition funnel were 
charged 2-bromonaphthalene (10.00 g, 48.3 mmol) and THF (70 
ml). A small amount of this solution was added to the flask and warmed with the heat 
gun until the color became light brown. The reaction mixture was then heated to 60˚C 
(oil bath) and the remaining 2-bromonaphthalene solution was added dropwise. At the 
end of the addition, the mixture was further refluxed for 1h. In the meanwhile, in a 250 
ml Schlenk flask containing 60 ml of dry THF where charged 4-bromoheptane (6.66 g, 
37.2 mmol) and (FeCl3)2(TMEDA)3 (0.75 g, 1.12 mmol). To this flask was then 
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added dropwise the Grignard reagent previously generated; the resulting black mixture 
was stirred for 30 min at room temperature. The reaction was quenched with aqueous 
HCl (1 M solution) and extracted with Et2O (2x150 ml). After evaporation of the 
solvent, the crude product was heated at 90 °C under high vacuum to eliminate the 
excess of alkyl bromide and naphthalene. The desired product was isolated after flash 
chromatography (eluent: hexane) as colorless oil (7.3 g, 92 % yield). 1H NMR (CDCl3, 
400 MHz): δ 7.83 (m, 3H), 7.61 (s, 1H), 7.52-7.42 (m, 2H), 7.37 (m, 1H), 2.76 (m, 
1H), 1.77-1.64 (m, 4H), 1.30-1.15 (m, 4H), 0.91 (t, J = 7.3 Hz, 6H). 13C NMR 
(CDCl3, 100 MHz): δ 144.0, 133.9, 132.5, 128.1, 127.9, 127.8, 126.6, 126.3, 126.0, 
125.2, 45.9, 39.4, 21.1, 14.4. HRMS (ESI) m/z calcd for C17H22: 226.1722. Found: 
226.1722. 
 
1-bromo-2-(4-heptyl)naphthalene. 2-(4-heptyl)naphthalene (5.00 g, 23.55 mmol) 
was dissolved in 100 ml of dry CH2Cl2 in a Schlenk flask and the 
solution was cooled to -78°C. At this temperature a solution of Br2 
(3.76 g, 23.55 mmol) in CH2Cl2 (50 ml) was slowly added. The 
reaction was left stirring at the same temperature for 5 hours and was subsequently 
quenched with aqueous NaOH (1M solution, 100 ml). The organic phase was 
separated, washed with 200 ml of water, dried with MgSO4, filtered and concentrated 
under vacuum to afford a orange oil. After purification on a silica gel pad (eluent: 
hexane) to eliminate residual Br2, the desired product was obtained as a colorless oil 
(6.80 g, 99 % yield). 1H NMR (CDCl3, 400 MHz): δ 8.35 (d, J = 8.5 Hz, 1H), 7.78 (m, 
2H), 7.57 (t, J = 8.3 Hz, 1H), 7.47 (t, J = 8.0 Hz, 1H), 7.33 (d, J = 8.5 Hz, 1H), 3.63 
(m, 1H), 1.77-1.51 (m, 4H), 1.34-1.08 (m, 4H), 0.85 (t, J = 7.4 Hz, 6H). 13C NMR 
(CDCl3, 100 MHz): δ 143.5, 133.5, 132.8, 128.3, 128.2, 128.0, 127.4, 126.0, 125.3, 
125.2, 44.2, 39.1, 20.7, 14.5. HRMS (EI) m/z calcd for C17H21Br 304.0827. Found: 
304.0830. 
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4S,5S-1,3-Bis[2-(4-heptyl)]-4,5-diphenyl-4,5-dihydro-1H-imidazol-3-ium 
tetrafluoroborate [B, (2)-DiPhSIHeptNap·HBF4]. A 500 mL schlenk flask was 
charged with Pd(dba)2 (472 mg, 0.82 mmol), (±)-BINAP (610 mg, 0.98 mmol), 
NaOtBu (2.36 g, 24.6 mmol) and toluene (200 mL) and stirred for 5 min. 1-Bromo-2-
(4-heptyl)-naphthalene (5.0 g, 16.4 mmol) and (1S,2S)-(-)-1,2-
diphenylethylenediamine (1.65 g, 7.80 mmol) were then added and the reaction 
mixture was heated to 120 °C for 12 h. After cooling to room temperature, the 
resulting mixture was filtered through a celite and washed with EtOAc. The filtrate 
was concentrated and the residue was purified by flash chromatography (SiO2, 1:10-
1:3 CH2Cl2/n-hexane) to afford 1S,2S-N,N′-bis[2-(4-heptyl)-naphthalen-1-yl]-1,2-
diphenylethane-1,2-diamine as a pale yellow foam (2.32 g, 45%). 1S,2S-N,N'-Bis[2-
(4-heptyl)naphthalen-1-yl]-1,2-diphenylethane-1,2-diamine (500 mg, 0.76 mmol), 
ammonium tetrafluoroborate (119 mg, 1.14 mmol), triethyl orthoformate (5 ml) and 
formic acid (1 drop) were heated to 110 °C and stirred for 12 h. The resulting brown 
solution was dried in vacuo, and the residue was purified by chromatograph 
(hexane:diethylether 10:1) to  get a yellow solid which was dissolved in 4 ml of 
diethylether. To this solution was added hexane to get the title product as a white 
solid (310 mg, 54%). 1H NMR (CDCl3, 500 MHz) exists as a mixture of three 
atropisomers (28:34:38): δ 8.44-7.14 (m, NCHN and ArH) (correspond to the three 
atropisomers of 23 protons), {6.70 (s, NCHPh), 6.58 (d, J = 12.8 Hz, NCHPh), 6.23 
(s, NCHPh), 6.21 (d, J = 12.8 Hz, NCHPh) (correspond to the three atropisomers of 2 
protons)}, 3.38-2.68 (m, CHNap) (correspond to the three atropisomers of 2 protons), 
2.19-0.12 (m, 4-heptyl) (correspond to the three atropisomers of 28 protons)}. 13C 
{1H} NMR (CDCl3, 125 MHz):  159.01, 158.75, 157.96, 145.01, 143.71, 142.68, 
141.80, 132.96, 132.81, 132.61, 132.49, 132.42, 132.35, 132.19, 132.10, 131.22, 
131.07, 130.65, 130.61, 130.36, 130.21, 130.11, 129.93, 129.87, 129.80, 129.76, 
129.70, 129.63, 129.39, 129.36, 129.08, 128.88, 128.84, 128.60, 128.43, 128.18, 
128.05, 127.66, 127.40, 127.34, 127.01, 126.39, 126.30, 125.49, 125.44, 124.76, 
124.23, 124.12, 123.75, 122.02, 121.03, 121.00, 120.03, 75.87, 74.53, 73.27, 42.33, 
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42.10, 41.04, 40.73, 38.92, 38.85, 38.41, 38.21, 37.78, 37.76, 37.15, 37.11, 22.20, 
22.08, 21.90, 21.84, 21.08, 21.05, 20.97, 20.58, 14.79, 14.78, 14.42, 14.41, 14.37, 
14.24, 14.18. HRMS (ESI): m/z : calcd for C49H55N2[M-BF]+: 695.4360; found: 
695.4356.  
 
 
N N
Ph Ph
Pd
Cl
R =
RR
 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis(2-(1-propylbutyl)-
naphthalen-1-yl)-4,5-dihydro-4,5-diphenyl imidazol-2-ylidene] palladium(II) 
[((2,7)-DiPhSI(4-Hep)Nap)Pd(cin)Cl]. (2)-DiPhSI(4-Hep)tNap·HBF4 (340 mg, 0.45 
mmol), KOtBu (53 mg, 0.47 mmol) and [Pd(cinnamyl)Cl]2 (117 mg, 0.23 mmol) 
were mixed together in a round flask in the glovebox. Dry THF (45 mL) was added 
and the mixture was stirred at room temperature for 16 h. The solvent was removed in 
vacuo, and the residue was separated by flash chromatography on siliga gel (n-
hexane:EtOAc 10:1) to afford the title product as a yellow solid (220 mg, 53%). 
Elemental analysis: calcd for C58H63ClN2Pd: C, 74.90; H, 6.83; N, 3.01. Found: C, 
75.43; H, 7.02; N, 2.89. HRMS (ESI): m/z : calcd for C58H63N2Pd [M-Cl]+: 893.4040; 
found: 893.4048. 
N N
Ph Ph
Pd
Cl
R
R R =
 
Data for (Sa,Sa)-C are as follows (100 mg). 1H NMR (CDCl3, 500 MHz): δ 8.50 (d, J 
= 8.2 Hz, 2H), 7.66 (d, J = 8.7 Hz, 2H), 7.60 (d, J = 9.0 Hz, 2H), 7.41-6.88 (m, 19H), 
6.43 (d, J = 7.1 Hz, 2H), 5.68 (s, 2H), 3.90-3.47 (br m, 4H), 2.18-0.80 (m, 30H). 13C 
NMR (CDCl3, 125 MHz): δ 142.59, 138.64, 138.16, 132.92, 132.64, 131.56, 128.99, 
128.94, 128.87, 128.82, 128.75, 128.68, 127.89, 127.76, 127.16, 127.13, 126.23, 
125.52, 125.32, 125.06, 109.55, 77.85, 49.40, 39.61, 39.27, 38.59, 29.66, 20.69, 
14.99, 14.88. 
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Data for (Ra,Ra)-C are as follows (70 mg). 1H NMR (CDCl3, 500 MHz): δ 8.50 (br, 
2H), 7.90-7.02 (br m, 25H), 6.05 (s, 2H), 5.10-3.42 (br m, 4H), 2.42-0.15 (br m, 30H). 
13C NMR (CDCl3, 125 MHz): δ 212.44, 193.72, 152.80, 145.06, 137.28, 133.01, 
132.65, 131.28, 131.03, 129.36, 129.27, 129.12, 129.07, 128.95, 128.81, 128.77, 
128.63, 128.49, 128.37, 128.15, 127.99, 127.90, 127.77, 127.53, 127.21, 126.73, 
126.26, 125.94, 125.45, 109.01, 92.42, 77.87, 74.44, 47.10, 41.36, 38.75, 37.96, 
35.88, 34.68, 34.53, 31.60, 29.07, 26.92, 25.29, 22.70, 22.66, 22.63, 20.72, 15.04, 
14.49, 11.44. 
 
N N
Ph Ph
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Cl
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Data for (Ra,Sa)-C are as follows (50 mg). 1H NMR (CDCl3, 500 MHz): δ 8.54 (d, J 
= 8.5 Hz, 1H), 8.40 (d, J = 8.0 Hz, 1H), 7.84-6.93 (m, 25H), 6.10 (br, 1H), 5.65 (br, 
1H), 4.36-3.33 (m, 4H), 2.51-0.24 (m, 30H). 13C NMR (CDCl3, 125 MHz): δ 215.15, 
145.37, 138.05, 133.16, 132.86, 131.77, 130.74, 129.04, 128.95, 128.89, 128.83, 
128.73, 128.65, 128.50, 128.28, 127.93, 127.67, 127.22, 127.08, 126.33, 126.18, 
125.56, 88.48, 53.44, 40.04, 39.05, 38.14, 37.94, 37.64, 20.60, 19.96, 15.02, 14.78, 
14.66, 14.58. 
 
Asymmetric Cross Coupling: 
General Protocol for the asymmetric Suzuki-Miyaura Coupling 
In the glovebox, arylhalide (0.125 mmol, 1.0 eq.), boronic acid (1.5 eq.), KOtBu (2.5 
eq.) and palladium complex (2.3 mg, 2 mol%) were mixed in 1.0 ml toluene in a vial 
(10 mL screw-cap threaded). The whole mixture was stirred at room temperature for 
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16 h before quenching with 5 ml H2O ouside the glovebox. The mixture was extracted 
with diethylether (3 x 5ml) before drying with anhydrous MgSO4. After drying on a 
rotary evaporator, the residue was purified by column chromatography. The ee value 
was determined by HPLC. 
 
General Protocol for the asymmetric Kumada Coupling 
In the glovebox, a vial (10 mL screw-cap threaded) equipped with a stir-bar was 
charged with arylhalide (0.25 mmol, 1eq.), Mg (6.6 mg, 0.28 mmol) and 2.0 ml THF. 
Then the whole mixture was heated to 70 0C for 2 h before cooling to room 
temperature. Inside the glovebox, palladium complex (4.6 mg, 2 mol%) and the other 
arylhalide (1.0 or 2.0 eq) were added to the formed Grignard reagent. The mixture was 
stirred at room temperature (or heated to the corresponding temperature outside 
glovebox) for 16 h before quenching with 5ml of water. Extraction with diethylether (3 
x 5ml) was followed by drying with anhydrous MgSO4. After drying on a rotary 
evaporator, the residue was purified by column chromatography. The ee value was 
determined by HPLC. 
 
(Table 2, entry 1) 94% yield, 51% ee. The spectral data were in accordance with those 
reported in the literature.10i 1H NMR (CDCl3, 500 MHz): δ = 8.01 (d, J 
= 8.2 Hz, 2H), 7.94 (d, J = 3.0 Hz, 1H), 7.93 (d, J = 3.2 Hz, 1H), 7.66 
(dd, J = 8.2, 7.0 Hz, 1H), 7.56-7.51 (m, 2H), 7.46-7.43 (m, 2H), 7.32-
7.21 (m, 4H), 2.18 (s, 3H). HPLC: Chiralcel OJ-H Column (250 mm); 
detected at 224 nm; n-hexane / i-propanol = 95/5; flow = 1.0 mL/min; Retention time: 
6.4 min (major), 9.6 min (minor). The absolute configuration was assigned by 
comparison with literature data.18 
 
 (Table 2, entry 7) 91% yield, 60% ee. The spectral data were in accordance with 
those reported in the literature.10e 1H NMR (CDCl3, 500 MHz): δ = 
8.03-7.97 (m, 3H), 7.91 (d, J = 8.2 Hz, 1H), 7.65 (dd, J = 8.2, 7.0 Hz, 
1H), 7.51-7.46 (m, 3H), 7.38-7.19 (m, 5H), 3.80 (s, 3H). HPLC: 
Chiralpak AD-H Column (250 mm); detected at 224 nm; n-hexane / 
i-propanol = 95/5; flow = 0.25 mL/min; Retention time: 18.2 min (minor), 20.1 min 
(major). The absolute configuration was assigned by comparison with literature 
Me
OMe
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data.10d 
 
(Table 2, entry 9) 86% yield, 12% ee.1H NMR (CDCl3, 500 
MHz): δ = 7.99-7.93 (m, 3H), 7.81 (d, J = 8.9 Hz, 1H), 7.66 
(dd, J = 8.2, 7.2 Hz, 1H), 7.51-7.32 (m, 5H), 7.04 (dd, J =8.9, 
2.4 Hz, 1H), 6.49 (d, J = 2.5 Hz, 1H ), 3.79 (s, 3H), 3.52 (s, 
3H). 13C {1H} NMR (CDCl3, 125 MHz): 158.06, 155.23, 135.55, 134.73, 133.75, 
132.78, 129.39, 129.14, 128.36, 128.19, 127.70, 126.15, 125.76, 125.63, 124.61, 
122.16, 116.12, 111.13, 104.00, 56.57, 54.95. HRMS (ESI): m/z : calcd for 
C22H18O2[M]+: 314.1307; found: 314.1309. HPLC: Chiralpak AD-H Column (250 
mm); detected at 224 nm; n-hexane/i-propanol = 95/5; flow = 0.25 mL/min; Retention 
time: 22.0 min (minor), 23.2 min (major). 
 
 (Table 2, entry 10) 83% yield, 28% ee. The spectral data were in accordance with 
those reported in the literature.10F 1H NMR (CDCl3, 500 MHz): δ = 7.88 
(dd, J = 8.1, 0.6 Hz, 1H), 7.82 (d, J = 8.4 Hz, 1H), 7.47-7.28 (m, 7H), 
7.16 (d, J = 8.0 Hz, 1H), 2.2 (s, 3H), 1.96 (s, 3H). HPLC: Chiralcel OJ-
H Column (250 mm); detected at 224 nm; n-hexane / i-propanol = 
100/0; flow = 0.50 mL/min; Retention time: 12.9 min (major), 17.8 min (minor).  
 
 (Table 3, entry 4) 51% yield, 39% ee. The spectral data were in accordance with 
those reported in the literature.19 1H NMR (CDCl3, 500 MHz): δ = 
7.94 (d, J = 9.0 Hz, 1H), 7.88-7.86 (m, 1H), 7.43-7.26 (m, 7H), 7.24 
(d, J = 8.0 Hz, 1H), 3.88 (s, 3H), 2.04 (s, 3H). HPLC: Chiralcel OJ-
H Column (250 mm); detected at 224 nm; n-hexane / i-propanol = 
95/5; flow = 0.50 mL/min; Retention time: 15.2 min (minor), 20.4 min (major).  
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